[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	1147.0238	2	3.2	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-09_FTMSms2hcd	53.554	87	107	48.6	4.3e-17	4.3e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	756.0623	3	1.8	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-09_FTMSms2hcd	52.515	228	248	52.6	1.6e-16	2.5e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	865.7936	3	2.4	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-09_FTMSms2hcd	70.866	163	186	51.3	5.8e-16	1.3e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	989.1557	3	3.1	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	27	V20130429-09_FTMSms2hcd	42.528	119	145	47.9	8.0e-16	8.5e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	845.4153	3	7.7	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-09_FTMSms2hcd	53.701	85	107	49.5	7.0e-15	7.0e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	847.4540	3	0.28	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-09_FTMSms2hcd	48.184	62	84	57.5	2.5e-14	5.7e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	781.1414	4	-0.24	RVIISAPSADAPMFVMGVNHEKYDNSLK	RVIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	28	V20130429-09_FTMSms2hcd	40.171	118	145	38.1	3.0e-14	3.3e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	882.4052	2	0.42	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-09_FTMSms2hcd	49.315	310	323	56.5	8.5e-14	9.4e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	871.1275	3	5.0	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-09_FTMSms2hcd	61.555	163	186	53.6	9.2e-14	1.7e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	681.8243	2	1.6	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-09_FTMSms2hcd	16.386	324	335	42.4	1.4e-12	1.9e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	761.4331	3	-0.85	LVINGNPITIFQERDPSKIK	LVINGNPITIFQERDPSKIK		20	V20130429-09_FTMSms2hcd	50.545	67	86	47.2	2.3e-11	1.5e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	1004.7278	4	0.32	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	35	V20130429-09_FTMSms2hcd	68.706	21	55	44.4	2.3e-11	2.6e-14	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	617.3013	2	-1.0	VVDLMAHMASK	VVDLM(Oxidation)AHM(Oxidation)ASK	Oxidation@328;Oxidation@331	11	V20130429-09_FTMSms2hcd	15.219	324	334	35.9	4.7e-11	6.8e-14	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	807.4622	2	10	LVINGNPITIFQER	LVINGNPITIFQER		14	V20130429-09_FTMSms2hcd	56.792	67	80	48.8	7.2e-11	2.2e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	1021.0600	2	2.5	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-09_FTMSms2hcd	52.107	67	84	51.7	8.0e-11	2.3e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	749.0376	3	-0.40	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-09_FTMSms2hcd	41.142	119	139	39.6	7.2e-10	7.6e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	1114.1969	3	6.6	VDIVAINDPFIDLNYMVYMFQYDSTHGK	VDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	28	V20130429-09_FTMSms2hcd	72.219	28	55	27.5	9.8e-10	9.8e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	737.3916	2	2.0	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-09_FTMSms2hcd	43.142	235	248	55.4	1.1e-9	1.8e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	738.1177	4	0.16	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPMFVM(Oxidation)GVNHEKYDNSLK	Oxidation@133=15	27	V20130429-09_FTMSms2hcd	46.144	119	145	30.0	7.7e-9	8.0e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	706.3977	2	-1.6	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-09_FTMSms2hcd	38.552	201	215	32.8	3.5e-8	9.5e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	362.7094	4	0.18	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-09_FTMSms2hcd	14.257	249	260	26.4	2.5e-7	7.4e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	516.8011	2	0.033	VKVGVNGFGR	VKVGVNGFGR		10	V20130429-09_FTMSms2hcd	25.156	4	13	33.5	5.7e-7	1.6e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	406.2106	2	1.0	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@231	7	V20130429-09_FTMSms2hcd	17.290	228	234	31.1	6.4e-6	1.3e-8	2	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	403.2196	2	0.51	VGVNGFGR	VGVNGFGR		8	V20130429-09_FTMSms2hcd	22.322	6	13	34.8	2.9e-5	5.5e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	25	64.8	9.56	4.3e-17	440.5786	3	0.53	LEKPAKYDDIK	LEKPAKYDDIK		11	V20130429-09_FTMSms2hcd	17.443	249	259	18.4	3.7e-5	6.9e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1-1]	0	O14556	G3PT_HUMAN	GAPDHS	1	1.7	2.63	6.4e-6	406.2106	2	1.0	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@303	7	V20130429-09_FTMSms2hcd	17.290	300	306	31.1	6.4e-6	1.3e-8	2	44501.6	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	635.7853	2	1.0	LGDLYEEEMR	LGDLYEEEM(Oxidation)R	Oxidation@154	10	V20130429-09_FTMSms2hcd	26.669	146	155	40.9	1.1e-22	1.8e-25	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	981.5112	4	2.2	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-09_FTMSms2hcd	57.284	237	270	61.3	5.6e-17	1.4e-19	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	918.9048	2	1.6	DGQVINETSQHHDDLE	DGQVINETSQHHDDLE		16	V20130429-09_FTMSms2hcd	22.561	451	466	34.9	2.5e-14	3.2e-17	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	833.1046	3	17	LLQDSVDFSLADAINTEFKNTR	LLQDSVDFSLADAINTEFKNTR		22	V20130429-09_FTMSms2hcd	62.469	79	100	45.6	2.0e-13	3.7e-16	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	859.9160	4	0.70	LQEEMLQREEAENTLQSFRQDVDNASLAR	LQEEM(Oxidation)LQREEAENTLQSFRQDVDNASLAR	Oxidation@193	29	V20130429-09_FTMSms2hcd	51.234	189	217	39.5	2.3e-12	2.4e-15	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	592.9604	3	2.4	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-09_FTMSms2hcd	30.409	295	310	48.6	9.1e-12	9.9e-15	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	831.4782	2	1.1	KVESLQEEIAFLKK	KVESLQEEIAFLKK		14	V20130429-09_FTMSms2hcd	42.644	223	236	43.7	2.7e-11	1.4e-13	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	714.8605	2	1.4	SLYASSPGGVYATR	SLYASSPGGVYATR		14	V20130429-09_FTMSms2hcd	29.501	51	64	47.0	3.9e-11	5.2e-14	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	912.9780	2	2.0	ETNLDSLPLVDTHSKR	ETNLDSLPLVDTHSKR		16	V20130429-09_FTMSms2hcd	35.793	425	440	44.1	1.1e-10	1.7e-13	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	655.3074	2	1.2	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-09_FTMSms2hcd	35.419	283	292	36.0	3.0e-10	4.0e-13	2	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	852.9171	2	2.8	VEVERDNLAEDIMR	VEVERDNLAEDIM(Oxidation)R	Oxidation@183	14	V20130429-09_FTMSms2hcd	30.649	171	184	34.0	3.4e-10	3.7e-13	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	748.3969	2	0.13	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-09_FTMSms2hcd	30.530	37	50	41.4	3.5e-10	5.4e-13	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	767.4310	2	1.6	KVESLQEEIAFLK	KVESLQEEIAFLK		13	V20130429-09_FTMSms2hcd	48.454	223	235	44.7	3.7e-10	1.0e-12	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	785.9592	2	10	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-09_FTMSms2hcd	65.359	411	424	50.0	4.2e-10	2.0e-12	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	794.4030	2	0.90	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-09_FTMSms2hcd	26.695	101	113	58.5	4.3e-10	5.3e-13	2	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	798.3839	3	1.8	EEAENTLQSFRQDVDNASLAR	EEAENTLQSFRQDVDNASLAR		21	V20130429-09_FTMSms2hcd	46.528	197	217	54.5	5.3e-10	5.4e-13	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	504.2404	3	-0.036	MFGGPGTASRPSSSR	M(Oxidation)FGGPGTASRPSSSR	Oxidation@14	15	V20130429-09_FTMSms2hcd	14.784	14	28	35.4	1.0e-9	1.4e-12	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	589.6063	3	-0.23	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-09_FTMSms2hcd	16.595	365	378	37.5	1.5e-9	1.7e-12	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	547.2663	2	-1.8	FADLSEAANR	FADLSEAANR		10	V20130429-09_FTMSms2hcd	25.509	295	304	39.8	7.8e-9	1.4e-11	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	770.4612	2	3.0	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-09_FTMSms2hcd	45.203	130	143	43.4	1.6e-8	1.2e-10	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	375.8736	3	1.0	FANYIDKVR	FANYIDKVR		9	V20130429-09_FTMSms2hcd	28.069	114	122	39.2	1.6e-8	3.4e-11	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	512.2583	2	-1.2	QQYESVAAK	QQYESVAAK		9	V20130429-09_FTMSms2hcd	11.758	274	282	21.8	1.9e-6	3.1e-9	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	457.7329	2	0.81	SYVTTSTR	SYVTTSTR		8	V20130429-09_FTMSms2hcd	11.818	29	36	28.4	3.2e-6	6.6e-9	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	544.7719	2	3.2	QDVDNASLAR	QDVDNASLAR		10	V20130429-09_FTMSms2hcd	15.860	208	217	39.0	2.4e-5	4.1e-8	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	764.4202	2	3.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-09_FTMSms2hcd	34.422	379	390	31.9	8.1e-5	1.7e-7	4	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	585.3631	2	4.2	ILLAELEQLK	ILLAELEQLK		10	V20130429-09_FTMSms2hcd	53.099	130	139	24.8	1.2e-4	8.1e-7	1	53652.1	HUMAN	Vimentin
[2]		P08670	VIME_HUMAN	VIM	27	68.2	12.58	1.1e-22	556.2739	3	-0.40	RMFGGPGTASRPSSSR	RM(Oxidation)FGGPGTASRPSSSR	Oxidation@14	16	V20130429-09_FTMSms2hcd	12.795	13	28	12.7	8.0e-4	9.1e-7	1	53652.1	HUMAN	Vimentin
[2-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.78	4.3e-10	794.4030	2	0.90	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-09_FTMSms2hcd	26.695	106	118	58.5	4.3e-10	5.3e-13	2	53536.2	HUMAN	Desmin
[2-1]	0	P17661	DESM_HUMAN	DES	2	5.3	5.78	4.3e-10	764.4202	2	3.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-09_FTMSms2hcd	34.422	384	395	31.9	8.1e-5	1.7e-7	4	53536.2	HUMAN	Desmin
[2-2]	0	P41219	PERI_HUMAN	PRPH	1	2.1	5.47	3.0e-10	655.3074	2	1.2	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-09_FTMSms2hcd	35.419	279	288	36.0	3.0e-10	4.0e-13	2	53651.3	HUMAN	Peripherin
[2-3]	0	P07197	NFM_HUMAN	NEFM	1	1.3	2.12	8.1e-5	764.4202	2	3.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-09_FTMSms2hcd	34.422	380	391	31.9	8.1e-5	1.7e-7	4	102472.8	HUMAN	Neurofilament medium polypeptide
[2-4]	0	Q16352	AINX_HUMAN	INA	1	2.4	2.12	8.1e-5	764.4202	2	3.5	HLREYQDLLNVK	HLREYQDLLNVK		12	V20130429-09_FTMSms2hcd	34.422	375	386	31.9	8.1e-5	1.7e-7	4	55391.1	HUMAN	Alpha-internexin
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	1031.1921	3	1.1	YGKDATNVGDEGGFAPNILENKEGLELLK	YGKDATNVGDEGGFAPNILENKEGLELLK		29	V20130429-09_FTMSms2hcd	54.290	200	228	54.5	2.3e-17	2.9e-20	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	913.9335	2	2.3	SGKYDLDFKSPDDPSR	SGKYDLDFKSPDDPSR		16	V20130429-09_FTMSms2hcd	29.114	254	269	57.2	1.7e-16	1.9e-19	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	1148.5872	2	13	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-09_FTMSms2hcd	77.773	373	394	51.0	1.9e-16	2.6e-19	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	753.6481	4	0.27	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-09_FTMSms2hcd	58.253	133	162	61.0	1.9e-15	3.5e-18	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	634.3281	4	2.4	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-09_FTMSms2hcd	43.105	33	56	58.0	5.3e-15	7.3e-18	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	995.8107	3	7.8	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-09_FTMSms2hcd	65.347	282	306	48.5	2.6e-14	2.6e-17	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	731.9146	2	9.1	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-09_FTMSms2hcd	60.048	106	120	39.1	3.0e-13	8.5e-16	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	730.3917	3	2.0	FTASAGIQVVGDDLTVTNPKR	FTASAGIQVVGDDLTVTNPKR		21	V20130429-09_FTMSms2hcd	45.652	307	327	49.5	3.5e-13	6.8e-16	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	514.5938	3	1.7	LAQANGWGVMVSHR	LAQANGWGVM(Oxidation)VSHR	Oxidation@368	14	V20130429-09_FTMSms2hcd	28.347	359	372	39.2	1.1e-12	1.3e-15	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	703.8636	2	2.7	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-09_FTMSms2hcd	44.129	16	28	40.9	5.5e-12	7.4e-15	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	970.5046	2	13	LAMQEFMILPVGAANFR	LAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	17	V20130429-09_FTMSms2hcd	56.329	163	179	50.0	9.4e-12	1.3e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	915.1307	3	-0.34	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-09_FTMSms2hcd	58.202	203	228	45.1	9.7e-12	1.2e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	788.9043	2	0.88	VNQIGSVTESLQACK	VNQIGSVTESLQACK		15	V20130429-09_FTMSms2hcd	39.242	344	358	37.1	2.8e-11	4.0e-14	2	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	731.3645	3	4.4	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-09_FTMSms2hcd	50.976	234	253	30.9	4.9e-11	5.3e-14	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	902.9837	2	9.0	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-09_FTMSms2hcd	52.414	33	50	33.3	9.0e-10	1.6e-12	3	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	636.6667	3	-0.77	LAMQEFMILPVGAANFR	LAMQEFMILPVGAANFR		17	V20130429-09_FTMSms2hcd	68.664	163	179	23.1	1.7e-9	2.3e-12	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	713.3667	2	0.071	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-09_FTMSms2hcd	48.522	270	281	37.4	4.6e-9	6.2e-12	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	722.9050	2	1.5	KLNVTEQEKIDK	KLNVTEQEKIDK		12	V20130429-09_FTMSms2hcd	17.404	81	92	37.6	6.2e-7	1.4e-9	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	572.3119	2	0.73	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-09_FTMSms2hcd	23.094	184	193	42.7	1.2e-6	2.0e-9	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	656.7900	2	-2.4	LMIEMDGTENK	LM(Oxidation)IEM(Oxidation)DGTENK	Oxidation@94;Oxidation@97	11	V20130429-09_FTMSms2hcd	19.029	93	103	16.9	1.6e-6	2.8e-9	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	450.2822	2	1.2	TIAPALVSK	TIAPALVSK		9	V20130429-09_FTMSms2hcd	26.682	72	80	30.9	2.4e-6	8.8e-9	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	452.7350	2	0.57	IEEELGSK	IEEELGSK		8	V20130429-09_FTMSms2hcd	14.598	413	420	33.2	2.5e-4	4.1e-7	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	352.7086	2	1.3	GVPLYR	GVPLYR		6	V20130429-09_FTMSms2hcd	21.703	127	132	17.6	4.9e-4	1.2e-6	2	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	403.7298	2	0.51	YNQLLR	YNQLLR		6	V20130429-09_FTMSms2hcd	21.341	407	412	24.1	0.0069	1.5e-5	1	47169.4	HUMAN	Alpha-enolase
[3]		P06733	ENOA_HUMAN	ENO1	25	78.6	9.70	2.3e-17	383.6902	2	0.17	EIFDSR	EIFDSR		6	V20130429-09_FTMSms2hcd	19.055	10	15	18.8	0.010	2.7e-5	1	47169.4	HUMAN	Alpha-enolase
[3-1]	0	P13929	ENOB_HUMAN	ENO3	5	17.5	9.21	1.9e-16	1148.5872	2	13	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-09_FTMSms2hcd	77.773	373	394	51.0	1.9e-16	2.6e-19	3	46932.2	HUMAN	Beta-enolase
[3-1]	0	P13929	ENOB_HUMAN	ENO3	5	17.5	9.21	1.9e-16	731.9146	2	9.1	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-09_FTMSms2hcd	60.048	106	120	39.1	3.0e-13	8.5e-16	3	46932.2	HUMAN	Beta-enolase
[3-1]	0	P13929	ENOB_HUMAN	ENO3	5	17.5	9.21	1.9e-16	788.9043	2	0.88	VNQIGSVTESIQACK	VNQIGSVTESIQACK		15	V20130429-09_FTMSms2hcd	39.242	344	358	37.1	2.8e-11	4.0e-14	2	46932.2	HUMAN	Beta-enolase
[3-1]	0	P13929	ENOB_HUMAN	ENO3	5	17.5	9.21	1.9e-16	902.9837	2	9.0	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-09_FTMSms2hcd	52.414	33	50	33.3	9.0e-10	1.6e-12	3	46932.2	HUMAN	Beta-enolase
[3-1]	0	P13929	ENOB_HUMAN	ENO3	5	17.5	9.21	1.9e-16	352.7086	2	1.3	GVPLYR	GVPLYR		6	V20130429-09_FTMSms2hcd	21.703	127	132	17.6	4.9e-4	1.2e-6	2	46932.2	HUMAN	Beta-enolase
[3-2]	0	P09104	ENOG_HUMAN	ENO2	3	12.7	9.21	1.9e-16	1148.5872	2	13	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-09_FTMSms2hcd	77.773	373	394	51.0	1.9e-16	2.6e-19	3	47269.0	HUMAN	Gamma-enolase
[3-2]	0	P09104	ENOG_HUMAN	ENO2	3	12.7	9.21	1.9e-16	731.9146	2	9.1	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-09_FTMSms2hcd	60.048	106	120	39.1	3.0e-13	8.5e-16	3	47269.0	HUMAN	Gamma-enolase
[3-2]	0	P09104	ENOG_HUMAN	ENO2	3	12.7	9.21	1.9e-16	902.9837	2	9.0	AAVPSGASTGIYEALELR	AAVPSGASTGIYEALELR		18	V20130429-09_FTMSms2hcd	52.414	33	50	33.3	9.0e-10	1.6e-12	3	47269.0	HUMAN	Gamma-enolase
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	890.8922	2	2.4	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-09_FTMSms2hcd	52.226	1	18	55.4	5.9e-25	7.7e-28	1	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-09_FTMSms2hcd	23.110	313	326	56.0	7.9e-18	1.0e-20	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-09_FTMSms2hcd	17.814	40	62	50.7	8.2e-18	7.7e-21	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	1116.0394	2	3.0	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-09_FTMSms2hcd	47.847	292	312	59.5	4.4e-15	4.4e-18	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	787.0595	3	1.7	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-09_FTMSms2hcd	41.824	291	312	62.6	3.0e-14	3.1e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	800.6580	4	0.30	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-09_FTMSms2hcd	53.189	148	177	35.8	5.5e-14	7.2e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	239	254	42.5	1.2e-13	1.4e-16	10	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	977.5364	2	0.57	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-09_FTMSms2hcd	40.593	96	113	50.9	9.9e-13	2.6e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-09_FTMSms2hcd	25.080	316	326	43.6	2.2e-12	3.5e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	360	373	46.2	5.1e-12	6.2e-15	7	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-09_FTMSms2hcd	47.481	178	191	38.4	1.4e-11	1.7e-14	7	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	85	95	36.9	1.7e-11	2.3e-14	9	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	51	62	43.9	3.2e-11	4.2e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	29	39	40.4	1.9e-10	6.9e-13	9	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	51	61	37.1	3.8e-10	7.5e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-09_FTMSms2hcd	37.748	184	191	30.7	4.3e-10	8.1e-13	7	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	327	336	33.9	1.1e-9	3.7e-11	7	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	316	326	36.2	3.6e-8	5.6e-11	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	19	28	38.8	5.1e-8	1.0e-10	10	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	329	335	30.4	3.6e-7	2.0e-9	7	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	566.7658	2	-2.3	GYSFTTTAER	GYSFTTTAER		10	V20130429-09_FTMSms2hcd	24.979	197	206	39.9	2.2e-6	3.8e-9	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	22	60.5	13.80	5.9e-25	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	62	68	17.9	0.032	2.0e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	918.9227	2	1.5	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-09_FTMSms2hcd	60.491	1	18	60.8	2.9e-23	3.2e-26	1	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-09_FTMSms2hcd	23.110	313	326	56.0	7.9e-18	1.0e-20	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-09_FTMSms2hcd	17.814	40	62	50.7	8.2e-18	7.7e-21	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	1116.0394	2	3.0	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-09_FTMSms2hcd	47.847	292	312	59.5	4.4e-15	4.4e-18	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	787.0595	3	1.7	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-09_FTMSms2hcd	41.824	291	312	62.6	3.0e-14	3.1e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	800.6580	4	0.30	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-09_FTMSms2hcd	53.189	148	177	35.8	5.5e-14	7.2e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	239	254	42.5	1.2e-13	1.4e-16	10	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	977.5364	2	0.57	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-09_FTMSms2hcd	40.593	96	113	50.9	9.9e-13	2.6e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-09_FTMSms2hcd	25.080	316	326	43.6	2.2e-12	3.5e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	360	373	46.2	5.1e-12	6.2e-15	7	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-09_FTMSms2hcd	47.481	178	191	38.4	1.4e-11	1.7e-14	7	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	85	95	36.9	1.7e-11	2.3e-14	9	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	51	62	43.9	3.2e-11	4.2e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	29	39	40.4	1.9e-10	6.9e-13	9	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	51	61	37.1	3.8e-10	7.5e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-09_FTMSms2hcd	37.748	184	191	30.7	4.3e-10	8.1e-13	7	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	327	336	33.9	1.1e-9	3.7e-11	7	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	316	326	36.2	3.6e-8	5.6e-11	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	19	28	38.8	5.1e-8	1.0e-10	10	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	329	335	30.4	3.6e-7	2.0e-9	7	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	566.7658	2	-2.3	GYSFTTTAER	GYSFTTTAER		10	V20130429-09_FTMSms2hcd	24.979	197	206	39.9	2.2e-6	3.8e-9	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	22	60.5	12.89	2.9e-23	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	62	68	17.9	0.032	2.0e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-09_FTMSms2hcd	23.110	315	328	56.0	7.9e-18	1.0e-20	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-09_FTMSms2hcd	17.814	42	64	50.7	8.2e-18	7.7e-21	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	241	256	42.5	1.2e-13	1.4e-16	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	868.1142	3	2.3	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-09_FTMSms2hcd	52.673	65	86	34.7	1.1e-12	1.5e-15	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-09_FTMSms2hcd	25.080	318	328	43.6	2.2e-12	3.5e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	659.6395	3	-0.96	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-09_FTMSms2hcd	38.459	71	86	33.4	7.6e-12	7.9e-15	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-09_FTMSms2hcd	47.481	180	193	38.4	1.4e-11	1.7e-14	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	87	97	36.9	1.7e-11	2.3e-14	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	53	64	43.9	3.2e-11	4.2e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	31	41	40.4	1.9e-10	6.9e-13	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	53	63	37.1	3.8e-10	7.5e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-09_FTMSms2hcd	37.748	186	193	30.7	4.3e-10	8.1e-13	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	329	338	33.9	1.1e-9	3.7e-11	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	318	328	36.2	3.6e-8	5.6e-11	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	21	30	38.8	5.1e-8	1.0e-10	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	695.5349	5	2.4	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-09_FTMSms2hcd	53.421	71	97	31.5	2.1e-7	2.2e-10	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	331	337	30.4	3.6e-7	2.0e-9	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	1049.8065	3	-13	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=35	28	V20130429-09_FTMSms2hcd	59.080	259	286	14.7	2.6e-5	2.5e-8	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	4	P68032	ACTC_HUMAN	ACTC1	19	42.2	9.95	7.9e-18	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	64	70	17.9	0.032	2.0e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-09_FTMSms2hcd	23.110	315	328	56.0	7.9e-18	1.0e-20	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-09_FTMSms2hcd	17.814	42	64	50.7	8.2e-18	7.7e-21	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	241	256	42.5	1.2e-13	1.4e-16	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	868.1142	3	2.3	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-09_FTMSms2hcd	52.673	65	86	34.7	1.1e-12	1.5e-15	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-09_FTMSms2hcd	25.080	318	328	43.6	2.2e-12	3.5e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	659.6395	3	-0.96	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-09_FTMSms2hcd	38.459	71	86	33.4	7.6e-12	7.9e-15	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-09_FTMSms2hcd	47.481	180	193	38.4	1.4e-11	1.7e-14	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	87	97	36.9	1.7e-11	2.3e-14	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	53	64	43.9	3.2e-11	4.2e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	31	41	40.4	1.9e-10	6.9e-13	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	53	63	37.1	3.8e-10	7.5e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-09_FTMSms2hcd	37.748	186	193	30.7	4.3e-10	8.1e-13	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	329	338	33.9	1.1e-9	3.7e-11	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	318	328	36.2	3.6e-8	5.6e-11	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	21	30	38.8	5.1e-8	1.0e-10	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	695.5349	5	2.4	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-09_FTMSms2hcd	53.421	71	97	31.5	2.1e-7	2.2e-10	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	331	337	30.4	3.6e-7	2.0e-9	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	1049.8065	3	-13	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=35	28	V20130429-09_FTMSms2hcd	59.080	259	286	14.7	2.6e-5	2.5e-8	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	4	P68133	ACTS_HUMAN	ACTA1	19	42.2	9.95	7.9e-18	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	64	70	17.9	0.032	2.0e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-09_FTMSms2hcd	23.110	315	328	56.0	7.9e-18	1.0e-20	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-09_FTMSms2hcd	17.814	42	64	50.7	8.2e-18	7.7e-21	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	241	256	42.5	1.2e-13	1.4e-16	10	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	868.1142	3	2.3	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	22	V20130429-09_FTMSms2hcd	52.673	65	86	34.7	1.1e-12	1.5e-15	4	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-09_FTMSms2hcd	25.080	318	328	43.6	2.2e-12	3.5e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	659.6395	3	-0.96	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-09_FTMSms2hcd	38.459	71	86	33.4	7.6e-12	7.9e-15	4	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-09_FTMSms2hcd	47.481	180	193	38.4	1.4e-11	1.7e-14	7	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	53	64	43.9	3.2e-11	4.2e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	31	41	40.4	1.9e-10	6.9e-13	9	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	53	63	37.1	3.8e-10	7.5e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-09_FTMSms2hcd	37.748	186	193	30.7	4.3e-10	8.1e-13	7	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	329	338	33.9	1.1e-9	3.7e-11	7	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	318	328	36.2	3.6e-8	5.6e-11	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	21	30	38.8	5.1e-8	1.0e-10	10	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	331	337	30.4	3.6e-7	2.0e-9	7	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	1049.8065	3	-13	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=35	28	V20130429-09_FTMSms2hcd	59.080	259	286	14.7	2.6e-5	2.5e-8	4	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	3	P62736	ACTA_HUMAN	ACTA2	17	39.3	9.95	7.9e-18	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	64	70	17.9	0.032	2.0e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	790.9056	2	1.1	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-09_FTMSms2hcd	23.110	314	327	56.0	7.9e-18	1.0e-20	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	847.0606	3	0.34	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@45;Oxidation@48	23	V20130429-09_FTMSms2hcd	17.814	41	63	50.7	8.2e-18	7.7e-21	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	240	255	42.5	1.2e-13	1.4e-16	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	868.1142	3	2.3	GILTLKYPIEHGIITNWDDMEK	GILTLKYPIEHGIITNWDDM(Oxidation)EK	Oxidation@83	22	V20130429-09_FTMSms2hcd	52.673	64	85	34.7	1.1e-12	1.5e-15	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	589.3096	2	-1.2	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-09_FTMSms2hcd	25.080	317	327	43.6	2.2e-12	3.5e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	659.6395	3	-0.96	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@83	16	V20130429-09_FTMSms2hcd	38.459	70	85	33.4	7.6e-12	7.9e-15	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-09_FTMSms2hcd	47.481	179	192	38.4	1.4e-11	1.7e-14	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	11.949	52	63	43.9	3.2e-11	4.2e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	30	40	40.4	1.9e-10	6.9e-13	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	599.7645	2	-0.43	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-09_FTMSms2hcd	13.403	52	62	37.1	3.8e-10	7.5e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-09_FTMSms2hcd	37.748	185	192	30.7	4.3e-10	8.1e-13	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	328	337	33.9	1.1e-9	3.7e-11	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	581.3133	2	0.81	EITALAPSTMK	EITALAPSTMK		11	V20130429-09_FTMSms2hcd	31.789	317	327	36.2	3.6e-8	5.6e-11	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	20	29	38.8	5.1e-8	1.0e-10	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	330	336	30.4	3.6e-7	2.0e-9	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	1049.8065	3	-13	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=35	28	V20130429-09_FTMSms2hcd	59.080	258	285	14.7	2.6e-5	2.5e-8	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	3	P63267	ACTH_HUMAN	ACTG2	17	39.4	9.95	7.9e-18	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	63	69	17.9	0.032	2.0e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	240	255	42.5	1.2e-13	1.4e-16	10	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	547.2833	3	-0.39	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-09_FTMSms2hcd	47.481	179	192	38.4	1.4e-11	1.7e-14	7	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	685.8115	2	11	DCYVGDEAQSKR	DCYVGDEAQSKR		12	V20130429-09_FTMSms2hcd	12.403	52	63	37.0	1.1e-10	1.6e-13	1	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	507.7446	2	0.69	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-09_FTMSms2hcd	37.748	185	192	30.7	4.3e-10	8.1e-13	7	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	388.9204	3	0.29	IKIIAPPERK	IKIIAPPERK		10	V20130429-09_FTMSms2hcd	22.017	328	337	33.9	1.1e-9	3.7e-11	7	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	398.2394	2	-0.99	IIAPPER	IIAPPER		7	V20130429-09_FTMSms2hcd	19.162	330	336	30.4	3.6e-7	2.0e-9	7	42003.6	HUMAN	Beta-actin-like protein 2
[4-6]	2	Q562R1	ACTBL_HUMAN	ACTBL2	7	16.8	7.70	1.2e-13	615.8522	2	16	AVFPSMIGRPR	AVFPSMIGRPR		11	V20130429-09_FTMSms2hcd	35.265	30	40	12.3	0.0012	2.9e-6	1	42003.6	HUMAN	Beta-actin-like protein 2
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	939	954	42.5	1.2e-13	1.4e-16	10	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	1060	1073	46.2	5.1e-12	6.2e-15	7	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	785	795	36.9	1.7e-11	2.3e-14	9	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	729	739	40.4	1.9e-10	6.9e-13	9	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	719	728	38.8	5.1e-8	1.0e-10	10	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	Q6S8J3	POTEE_HUMAN	POTEE	6	6.4	7.70	1.2e-13	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	762	768	17.9	0.032	2.0e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	939	954	42.5	1.2e-13	1.4e-16	10	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	1060	1073	46.2	5.1e-12	6.2e-15	7	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	785	795	36.9	1.7e-11	2.3e-14	9	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	729	739	40.4	1.9e-10	6.9e-13	9	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	719	728	38.8	5.1e-8	1.0e-10	10	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	A5A3E0	POTEF_HUMAN	POTEF	6	6.4	7.70	1.2e-13	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	762	768	17.9	0.032	2.0e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[4-9]	0	P0CG38	POTEI_HUMAN	POTEI	5	4.9	6.82	5.1e-12	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	1060	1073	46.2	5.1e-12	6.2e-15	7	121283.5	HUMAN	POTE ankyrin domain family member I
[4-9]	0	P0CG38	POTEI_HUMAN	POTEI	5	4.9	6.82	5.1e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	785	795	36.9	1.7e-11	2.3e-14	9	121283.5	HUMAN	POTE ankyrin domain family member I
[4-9]	0	P0CG38	POTEI_HUMAN	POTEI	5	4.9	6.82	5.1e-12	400.2406	3	1.5	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-09_FTMSms2hcd	35.083	729	739	40.4	1.9e-10	6.9e-13	9	121283.5	HUMAN	POTE ankyrin domain family member I
[4-9]	0	P0CG38	POTEI_HUMAN	POTEI	5	4.9	6.82	5.1e-12	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	719	728	38.8	5.1e-8	1.0e-10	10	121283.5	HUMAN	POTE ankyrin domain family member I
[4-9]	0	P0CG38	POTEI_HUMAN	POTEI	5	4.9	6.82	5.1e-12	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	762	768	17.9	0.032	2.0e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[4-10]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	3	10.9	7.70	1.2e-13	597.6357	3	0.35	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-09_FTMSms2hcd	47.741	239	254	42.5	1.2e-13	1.4e-16	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[4-10]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	3	10.9	7.70	1.2e-13	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	360	373	46.2	5.1e-12	6.2e-15	7	42016.6	HUMAN	Putative beta-actin-like protein 3
[4-10]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	3	10.9	7.70	1.2e-13	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	85	95	36.9	1.7e-11	2.3e-14	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[4-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	4	4.0	6.82	5.1e-12	822.9039	2	1.8	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-09_FTMSms2hcd	18.683	1023	1036	46.2	5.1e-12	6.2e-15	7	117391.0	HUMAN	POTE ankyrin domain family member J
[4-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	4	4.0	6.82	5.1e-12	758.3791	2	1.2	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-09_FTMSms2hcd	30.970	748	758	36.9	1.7e-11	2.3e-14	9	117391.0	HUMAN	POTE ankyrin domain family member J
[4-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	4	4.0	6.82	5.1e-12	488.7286	2	1.7	AGFAGDDAPR	AGFAGDDAPR		10	V20130429-09_FTMSms2hcd	16.824	682	691	38.8	5.1e-8	1.0e-10	10	117391.0	HUMAN	POTE ankyrin domain family member J
[4-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	4	4.0	6.82	5.1e-12	400.7709	2	-0.91	RGILTLK	RGILTLK		7	V20130429-09_FTMSms2hcd	25.500	725	731	17.9	0.032	2.0e-4	10	117391.0	HUMAN	POTE ankyrin domain family member J
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	1006.5404	3	4.1	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-09_FTMSms2hcd	56.190	93	120	65.2	1.6e-18	4.5e-21	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	1088.0743	2	11	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-09_FTMSms2hcd	55.121	401	422	52.5	1.1e-13	1.8e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	826.4608	3	2.8	KGVNLPGAAVDLPAVSEKDIQDLK	KGVNLPGAAVDLPAVSEKDIQDLK		24	V20130429-09_FTMSms2hcd	51.152	207	230	48.5	1.6e-13	7.7e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	668.6672	3	-1.2	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-09_FTMSms2hcd	67.750	231	247	35.6	1.5e-12	1.6e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	803.0908	3	1.2	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-09_FTMSms2hcd	49.896	505	526	47.7	1.7e-12	3.1e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	628.6395	3	0.24	LNFSHGTHEYHAETIK	LNFSHGTHEYHAETIK		16	V20130429-09_FTMSms2hcd	22.627	74	89	37.9	2.9e-12	3.2e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	890.4434	2	2.0	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-09_FTMSms2hcd	49.094	189	206	51.2	3.0e-12	3.6e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	607.2916	2	-0.82	ITLDNAYMEK	ITLDNAYM(Oxidation)EK	Oxidation@149	10	V20130429-09_FTMSms2hcd	26.982	142	151	45.5	6.3e-12	9.2e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	883.4133	4	1.8	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-09_FTMSms2hcd	44.970	1	32	48.1	1.1e-11	1.1e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	722.3833	4	1.1	GFFKKGDVVIVLTGWRPGSGFTNTMR	GFFKKGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	26	V20130429-09_FTMSms2hcd	54.544	501	526	35.2	1.5e-11	3.3e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	1018.5237	2	5.2	QKGADFLVTEVENGGSLGSK	QKGADFLVTEVENGGSLGSK		20	V20130429-09_FTMSms2hcd	44.446	187	206	40.9	6.5e-11	8.1e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	783.7678	3	9.7	GVNLPGAAVDLPAVSEKDIQDLK	GVNLPGAAVDLPAVSEKDIQDLK		23	V20130429-09_FTMSms2hcd	55.030	208	230	36.1	7.4e-11	2.9e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	731.9114	2	0.24	IYVDDGLISLQVK	IYVDDGLISLQVK		13	V20130429-09_FTMSms2hcd	51.934	174	186	35.5	2.2e-10	5.8e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	696.7014	3	1.1	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-09_FTMSms2hcd	53.226	384	400	54.5	2.5e-10	4.0e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	663.3386	3	3.3	FGVEQDVDMVFASFIRK	FGVEQDVDMVFASFIRK		17	V20130429-09_FTMSms2hcd	71.287	231	247	25.4	2.8e-10	3.4e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	610.0170	3	8.2	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-09_FTMSms2hcd	54.974	295	311	34.0	1.5e-9	6.5e-12	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	636.6626	3	1.2	GADFLVTEVENGGSLGSKK	GADFLVTEVENGGSLGSKK		19	V20130429-09_FTMSms2hcd	45.077	189	207	43.9	2.9e-9	3.8e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	398.5539	3	2.1	SVETLKEMIK	SVETLKEM(Oxidation)IK	Oxidation@64	10	V20130429-09_FTMSms2hcd	23.283	57	66	37.6	4.2e-9	8.7e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	613.3082	3	-0.67	RFDEILEASDGIMVAR	RFDEILEASDGIM(Oxidation)VAR	Oxidation@291	16	V20130429-09_FTMSms2hcd	45.337	279	294	29.6	4.8e-9	5.5e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	625.9771	3	12	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-09_FTMSms2hcd	73.771	231	246	28.6	1.8e-8	2.0e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	465.5964	3	-0.28	IISKIENHEGVR	IISKIENHEGVR		12	V20130429-09_FTMSms2hcd	16.947	267	278	42.5	2.5e-8	6.6e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	599.3273	2	-0.046	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-09_FTMSms2hcd	35.649	33	43	30.2	2.3e-7	5.1e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	420.7690	2	0.67	APIIAVTR	APIIAVTR		8	V20130429-09_FTMSms2hcd	26.784	448	455	41.4	8.8e-7	8.3e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	353.2185	2	0.48	VFLAQK	VFLAQK		6	V20130429-09_FTMSms2hcd	18.961	306	311	21.9	5.7e-5	3.5e-7	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	25	57.4	10.33	1.6e-18	385.7016	2	2.0	QAHLYR	Q(Gln->pyro-Glu)AHLYR	Gln->pyro-Glu@462	6	V20130429-09_FTMSms2hcd	15.960	462	467	19.1	0.0055	1.6e-5	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5-1]	0	P30613	KPYR_HUMAN	PKLR	2	3.0	4.89	1.5e-9	610.0170	3	8.2	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-09_FTMSms2hcd	54.974	338	354	34.0	1.5e-9	6.5e-12	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[5-1]	0	P30613	KPYR_HUMAN	PKLR	2	3.0	4.89	1.5e-9	353.2185	2	0.48	VFLAQK	VFLAQK		6	V20130429-09_FTMSms2hcd	18.961	349	354	21.9	5.7e-5	3.5e-7	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-09_FTMSms2hcd	61.099	78	103	51.5	5.2e-16	5.1e-19	5	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	776.3571	4	-0.32	FWEVISDEHGIDPTGTYHGDSDLQLDR	FWEVISDEHGIDPTGTYHGDSDLQLDR		27	V20130429-09_FTMSms2hcd	50.584	20	46	43.7	2.2e-15	2.1e-18	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	1044.0491	2	6.8	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-09_FTMSms2hcd	57.919	104	122	47.2	1.1e-13	1.8e-16	5	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	681.3646	3	2.6	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-09_FTMSms2hcd	58.707	363	380	51.6	6.2e-13	1.2e-15	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	676.0438	3	19	MAVTFIGNSTAIQELFKR	MAVTFIGNSTAIQELFKR		18	V20130429-09_FTMSms2hcd	62.215	363	380	35.6	1.2e-12	3.6e-15	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	668.3528	2	0.47	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-09_FTMSms2hcd	36.133	163	174	46.6	2.1e-12	3.4e-15	4	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	830.4540	2	3.3	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-09_FTMSms2hcd	56.459	283	297	42.2	5.1e-12	1.1e-14	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	808.4225	2	1.1	AILVDLEPGTMDSVR	AILVDLEPGTMDSVR		15	V20130429-09_FTMSms2hcd	49.844	63	77	32.8	1.0e-10	1.4e-13	4	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	651.3220	2	-0.37	ISVYYNEATGGK	ISVYYNEATGGK		12	V20130429-09_FTMSms2hcd	27.045	47	58	43.1	2.6e-10	3.7e-13	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	606.3139	3	2.4	ISVYYNEATGGKYVPR	ISVYYNEATGGKYVPR		16	V20130429-09_FTMSms2hcd	33.613	47	62	37.2	8.5e-10	1.1e-12	1	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	782.2106	5	10	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-09_FTMSms2hcd	68.879	217	252	30.9	1.3e-8	3.7e-11	5	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	520.3009	2	0.99	YLTVAAVFR	YLTVAAVFR		9	V20130429-09_FTMSms2hcd	47.938	310	318	36.4	3.8e-8	1.5e-10	3	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	657.9656	3	0.11	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-09_FTMSms2hcd	19.830	321	336	24.1	3.9e-8	4.6e-11	4	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	731.8489	2	4.3	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-09_FTMSms2hcd	21.094	325	336	27.6	4.4e-8	5.2e-11	4	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	798.7431	3	1.1	IREEYPDRIMNTFSVVPSPK	IREEYPDRIM(Oxidation)NTFSVVPSPK	Oxidation@164	20	V20130429-09_FTMSms2hcd	39.861	155	174	25.8	3.3e-5	4.4e-8	2	49671.3	HUMAN	Tubulin beta chain
[6]		P07437	TBB5_HUMAN	TUBB	23	57.4	8.97	5.2e-16	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49671.3	HUMAN	Tubulin beta chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-09_FTMSms2hcd	61.099	78	103	51.5	5.2e-16	5.1e-19	5	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	677.3522	3	2.2	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-09_FTMSms2hcd	55.757	363	380	53.8	5.9e-15	7.6e-18	3	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	854.4356	2	1.0	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-09_FTMSms2hcd	45.665	283	297	43.6	9.2e-14	1.2e-16	3	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	1044.0491	2	6.8	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-09_FTMSms2hcd	57.919	104	122	47.2	1.1e-13	1.8e-16	5	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	809.4116	2	0.42	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-09_FTMSms2hcd	40.620	63	77	46.1	1.2e-13	1.5e-16	3	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	668.3528	2	0.47	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-09_FTMSms2hcd	36.133	163	174	46.6	2.1e-12	3.4e-15	4	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	782.2106	5	10	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-09_FTMSms2hcd	68.879	217	252	30.9	1.3e-8	3.7e-11	5	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	520.3009	2	0.99	YLTVAAVFR	YLTVAAVFR		9	V20130429-09_FTMSms2hcd	47.938	310	318	36.4	3.8e-8	1.5e-10	3	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	657.9656	3	0.11	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-09_FTMSms2hcd	19.830	321	336	24.1	3.9e-8	4.6e-11	4	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	731.8489	2	4.3	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-09_FTMSms2hcd	21.094	325	336	27.6	4.4e-8	5.2e-11	4	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	798.7431	3	1.1	IREEYPDRIMNTFSVVPSPK	IREEYPDRIM(Oxidation)NTFSVVPSPK	Oxidation@164	20	V20130429-09_FTMSms2hcd	39.861	155	174	25.8	3.3e-5	4.4e-8	2	49831.5	HUMAN	Tubulin beta-4B chain
[6-1]	3	P68371	TBB4B_HUMAN	TUBB4B	19	47.6	8.97	5.2e-16	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49831.5	HUMAN	Tubulin beta-4B chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-09_FTMSms2hcd	61.099	78	103	51.5	5.2e-16	5.1e-19	5	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	677.3522	3	2.2	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-09_FTMSms2hcd	55.757	363	380	53.8	5.9e-15	7.6e-18	3	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	1044.0491	2	6.8	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-09_FTMSms2hcd	57.919	104	122	47.2	1.1e-13	1.8e-16	5	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	808.4225	2	1.1	AILVDLEPGTMDSVR	AILVDLEPGTMDSVR		15	V20130429-09_FTMSms2hcd	49.844	63	77	32.8	1.0e-10	1.4e-13	4	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	782.2106	5	10	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-09_FTMSms2hcd	68.879	217	252	30.9	1.3e-8	3.7e-11	5	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	657.9656	3	0.11	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-09_FTMSms2hcd	19.830	321	336	24.1	3.9e-8	4.6e-11	4	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	731.8489	2	4.3	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-09_FTMSms2hcd	21.094	325	336	27.6	4.4e-8	5.2e-11	4	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[6-2]	1	Q13885	TBB2A_HUMAN	TUBB2A	15	39.6	8.97	5.2e-16	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49907.4	HUMAN	Tubulin beta-2A chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-09_FTMSms2hcd	61.099	78	103	51.5	5.2e-16	5.1e-19	5	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	677.3522	3	2.2	MSATFIGNSTAIQELFKR	M(Oxidation)SATFIGNSTAIQELFKR	Oxidation@363	18	V20130429-09_FTMSms2hcd	55.757	363	380	53.8	5.9e-15	7.6e-18	3	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	1044.0491	2	6.8	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-09_FTMSms2hcd	57.919	104	122	47.2	1.1e-13	1.8e-16	5	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	808.4225	2	1.1	AILVDLEPGTMDSVR	AILVDLEPGTMDSVR		15	V20130429-09_FTMSms2hcd	49.844	63	77	32.8	1.0e-10	1.4e-13	4	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	782.2106	5	10	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-09_FTMSms2hcd	68.879	217	252	30.9	1.3e-8	3.7e-11	5	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	657.9656	3	0.11	MSMKEVDEQMLNVQNK	M(Oxidation)SM(Oxidation)KEVDEQM(Oxidation)LNVQNK	Oxidation@321;Oxidation@323;Oxidation@330	16	V20130429-09_FTMSms2hcd	19.830	321	336	24.1	3.9e-8	4.6e-11	4	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	731.8489	2	4.3	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-09_FTMSms2hcd	21.094	325	336	27.6	4.4e-8	5.2e-11	4	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[6-3]	1	Q9BVA1	TBB2B_HUMAN	TUBB2B	15	39.6	8.97	5.2e-16	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49953.5	HUMAN	Tubulin beta-2B chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	933.4544	3	1.9	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-09_FTMSms2hcd	61.099	78	103	51.5	5.2e-16	5.1e-19	5	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	854.4356	2	1.0	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-09_FTMSms2hcd	45.665	283	297	43.6	9.2e-14	1.2e-16	3	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	809.4116	2	0.42	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-09_FTMSms2hcd	40.620	63	77	46.1	1.2e-13	1.5e-16	3	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	668.3528	2	0.47	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-09_FTMSms2hcd	36.133	163	174	46.6	2.1e-12	3.4e-15	4	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	691.0443	3	18	GHYTEGAELVDAVLDVVRK	GHYTEGAELVDAVLDVVRK		19	V20130429-09_FTMSms2hcd	62.831	104	122	31.8	1.5e-11	3.2e-14	2	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	782.2106	5	10	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-09_FTMSms2hcd	68.879	217	252	30.9	1.3e-8	3.7e-11	5	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	520.3009	2	0.99	YLTVAAVFR	YLTVAAVFR		9	V20130429-09_FTMSms2hcd	47.938	310	318	36.4	3.8e-8	1.5e-10	3	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49586.2	HUMAN	Tubulin beta-4A chain
[6-4]	3	P04350	TBB4A_HUMAN	TUBB4A	14	38.3	8.97	5.2e-16	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49586.2	HUMAN	Tubulin beta-4A chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	854.4356	2	1.0	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-09_FTMSms2hcd	45.665	283	297	43.6	9.2e-14	1.2e-16	3	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	1044.0491	2	6.8	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-09_FTMSms2hcd	57.919	104	122	47.2	1.1e-13	1.8e-16	5	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	668.3528	2	0.47	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-09_FTMSms2hcd	36.133	163	174	46.6	2.1e-12	3.4e-15	4	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	808.4225	2	1.1	AILVDLEPGTMDSVR	AILVDLEPGTMDSVR		15	V20130429-09_FTMSms2hcd	49.844	63	77	32.8	1.0e-10	1.4e-13	4	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	50433.2	HUMAN	Tubulin beta-3 chain
[6-5]	1	Q13509	TBB3_HUMAN	TUBB3	9	21.3	7.76	9.2e-14	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	50433.2	HUMAN	Tubulin beta-3 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	848.9271	2	8.2	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-09_FTMSms2hcd	53.915	337	350	34.5	4.0e-13	4.4e-16	7	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	691.0443	3	18	GHYTEGAELVDAVLDVVRK	GHYTEGAELVDAVLDVVRK		19	V20130429-09_FTMSms2hcd	62.831	104	122	31.8	1.5e-11	3.2e-14	2	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49857.6	HUMAN	Tubulin beta-6 chain
[6-6]	1	Q9BUF5	TBB6_HUMAN	TUBB6	8	15.2	7.41	4.0e-13	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49857.6	HUMAN	Tubulin beta-6 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	809.4116	2	0.42	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-09_FTMSms2hcd	40.620	63	77	46.1	1.2e-13	1.5e-16	3	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[6-7]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	8	13.1	7.69	1.2e-13	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49776.5	HUMAN	Tubulin beta-8 chain
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-09_FTMSms2hcd	51.340	191	204	45.1	7.0e-13	8.5e-16	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@185	10	V20130429-09_FTMSms2hcd	40.610	181	190	43.0	2.6e-10	4.0e-13	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	191	204	33.1	1.8e-9	2.4e-12	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	181	190	38.6	4.5e-7	8.5e-10	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@185	11	V20130429-09_FTMSms2hcd	35.675	180	190	20.4	6.8e-7	1.6e-9	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	83	90	41.0	1.1e-6	1.8e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-8]	0	A6NKZ8	YI016_HUMAN		7	11.6	7.28	7.0e-13	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	170	180	23.7	1.2e-4	1.9e-7	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	546.2824	3	1.3	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-09_FTMSms2hcd	51.340	263	276	45.1	7.0e-13	8.5e-16	9	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	540.9511	3	2.0	LHFFMPGFAPLTSR	LHFFMPGFAPLTSR		14	V20130429-09_FTMSms2hcd	59.119	263	276	33.1	1.8e-9	2.4e-12	9	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[6-9]	0	A6NNZ2	TBB8B_HUMAN		7	9.7	7.28	7.0e-13	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	49573.1	HUMAN	Tubulin beta-8 chain B
[6-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	5	6.4	5.90	2.6e-10	580.3179	2	-0.61	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-09_FTMSms2hcd	40.610	253	262	43.0	2.6e-10	4.0e-13	11	50327.4	HUMAN	Tubulin beta-1 chain
[6-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	5	6.4	5.90	2.6e-10	572.3219	2	1.9	LAVNMVPFPR	LAVNMVPFPR		10	V20130429-09_FTMSms2hcd	47.860	253	262	38.6	4.5e-7	8.5e-10	11	50327.4	HUMAN	Tubulin beta-1 chain
[6-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	5	6.4	5.90	2.6e-10	429.9128	3	-0.27	KLAVNMVPFPR	KLAVNM(Oxidation)VPFPR	Oxidation@257	11	V20130429-09_FTMSms2hcd	35.675	252	262	20.4	6.8e-7	1.6e-9	11	50327.4	HUMAN	Tubulin beta-1 chain
[6-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	5	6.4	5.90	2.6e-10	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-09_FTMSms2hcd	12.524	155	162	41.0	1.1e-6	1.8e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[6-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	5	6.4	5.90	2.6e-10	420.2272	3	-18	FPGQLNADLRK	FPGQLNADLRK		11	V20130429-09_FTMSms2hcd	29.467	242	252	23.7	1.2e-4	1.9e-7	11	50327.4	HUMAN	Tubulin beta-1 chain
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	616.3069	5	11	RFDDAVVQSDMKHWPFMVVNDAGRPK	RFDDAVVQSDM(Oxidation)KHWPFM(Oxidation)VVNDAGRPK	Oxidation@87;Oxidation@93	26	V20130429-09_FTMSms2hcd	41.902	77	102	42.3	3.1e-17	3.5e-20	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	661.3416	3	6.3	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-09_FTMSms2hcd	45.942	138	155	48.2	2.4e-16	3.2e-19	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	660.3013	2	1.3	NSLESYAFNMK	NSLESYAFNM(Oxidation)K	Oxidation@549	11	V20130429-09_FTMSms2hcd	33.434	540	550	42.4	5.8e-16	8.3e-19	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	846.3670	2	0.67	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-09_FTMSms2hcd	22.974	221	236	57.1	2.3e-15	3.2e-18	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	833.4000	2	1.6	NQVAMNPTNTVFDAK	NQVAM(Oxidation)NPTNTVFDAK	Oxidation@61	15	V20130429-09_FTMSms2hcd	30.623	57	71	46.2	9.0e-14	1.1e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	37	49	42.3	5.8e-13	7.1e-16	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	596.6699	3	2.8	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-09_FTMSms2hcd	42.983	172	188	46.9	8.2e-12	2.8e-14	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	816.8958	2	1.1	SFYPEEVSSMVLTK	SFYPEEVSSM(Oxidation)VLTK	Oxidation@122	14	V20130429-09_FTMSms2hcd	44.536	113	126	38.5	6.7e-11	7.6e-14	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	626.3135	2	0.53	MVNHFIAEFK	M(Oxidation)VNHFIAEFK	Oxidation@237	10	V20130429-09_FTMSms2hcd	33.746	237	246	37.7	1.3e-10	1.7e-13	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	614.8173	2	-0.58	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	26	36	48.1	9.8e-10	1.5e-12	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	600.3405	2	-0.45	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-09_FTMSms2hcd	45.310	160	171	40.4	5.6e-9	1.2e-11	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	740.8817	2	1.2	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-09_FTMSms2hcd	44.838	300	311	51.0	1.7e-8	2.1e-11	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	522.6162	3	1.2	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-09_FTMSms2hcd	45.155	349	361	29.9	2.2e-8	3.9e-11	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	627.3129	2	2.0	FEELNADLFR	FEELNADLFR		10	V20130429-09_FTMSms2hcd	48.296	302	311	42.6	2.5e-7	2.9e-10	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	590.8140	2	-0.090	VQVEYKGETK	VQVEYKGETK		10	V20130429-09_FTMSms2hcd	13.588	103	112	29.8	1.6e-6	2.4e-9	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	541.2877	2	0.42	LLQDFFNGK	LLQDFFNGK		9	V20130429-09_FTMSms2hcd	44.825	349	357	33.2	1.0e-5	1.6e-8	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	423.5562	3	-1.1	MKEIAEAYLGK	M(Oxidation)KEIAEAYLGK	Oxidation@127	11	V20130429-09_FTMSms2hcd	25.799	127	137	14.3	0.0015	2.3e-6	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	18	33.6	9.63	3.1e-17	495.2661	2	-1.3	LSKEDIER	LSKEDIER		8	V20130429-09_FTMSms2hcd	13.919	510	517	32.5	0.0015	2.7e-6	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	846.3670	2	0.67	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-09_FTMSms2hcd	22.974	224	239	57.1	2.3e-15	3.2e-18	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	38	50	42.3	5.8e-13	7.1e-16	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	596.6699	3	2.8	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-09_FTMSms2hcd	42.983	173	189	46.9	8.2e-12	2.8e-14	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	614.8173	2	-0.58	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	27	37	48.1	9.8e-10	1.5e-12	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	740.8817	2	1.2	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-09_FTMSms2hcd	44.838	303	314	51.0	1.7e-8	2.1e-11	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	522.6162	3	1.2	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-09_FTMSms2hcd	45.155	352	364	29.9	2.2e-8	3.9e-11	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	627.3129	2	2.0	FEELNADLFR	FEELNADLFR		10	V20130429-09_FTMSms2hcd	48.296	305	314	42.6	2.5e-7	2.9e-10	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	590.8140	2	-0.090	VQVEYKGETK	VQVEYKGETK		10	V20130429-09_FTMSms2hcd	13.588	104	113	29.8	1.6e-6	2.4e-9	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.62	2.3e-15	541.2877	2	0.42	LLQDFFNGK	LLQDFFNGK		9	V20130429-09_FTMSms2hcd	44.825	352	360	33.2	1.0e-5	1.6e-8	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	783.8942	2	0.81	ITPSYVAFTPEGER	ITPSYVAFTPEGER		14	V20130429-09_FTMSms2hcd	39.294	61	74	38.8	4.6e-13	5.8e-16	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	839.4102	2	3.1	NQLTSNPENTVFDAK	NQLTSNPENTVFDAK		15	V20130429-09_FTMSms2hcd	35.042	82	96	44.5	2.0e-12	2.2e-15	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	614.8173	2	-0.58	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	50	60	48.1	9.8e-10	1.5e-12	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	617.3184	2	3.2	DAGTIAGLNVMR	DAGTIAGLNVM(Oxidation)R	Oxidation@196	12	V20130429-09_FTMSms2hcd	32.469	186	197	32.5	1.5e-9	2.3e-12	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	715.8499	2	1.0	TWNDPSVQQDIK	TWNDPSVQQDIK		12	V20130429-09_FTMSms2hcd	30.636	102	113	34.8	1.2e-8	1.4e-11	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	622.8359	4	3.1	VLEDSDLKKSDIDEIVLVGGSTR	VLEDSDLKKSDIDEIVLVGGSTR		23	V20130429-09_FTMSms2hcd	45.890	345	367	15.2	1.6e-5	3.6e-8	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-2]	6	P11021	GRP78_HUMAN	HSPA5	7	15.4	7.38	4.6e-13	551.9995	3	3.3	KKELEEIVQPIISK	KKELEEIVQPIISK		14	V20130429-09_FTMSms2hcd	38.050	620	633	20.9	3.8e-5	3.7e-7	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	37	49	42.3	5.8e-13	7.1e-16	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	844.4558	2	1.8	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-09_FTMSms2hcd	48.083	172	187	43.3	8.0e-11	1.4e-13	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	614.8173	2	-0.58	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	26	36	48.1	9.8e-10	1.5e-12	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	555.2900	2	-0.99	LLQDFFNGR	LLQDFFNGR		9	V20130429-09_FTMSms2hcd	45.796	349	357	34.1	3.9e-7	6.8e-10	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	569.8083	2	-0.83	VQVSYKGETK	VQVSYKGETK		10	V20130429-09_FTMSms2hcd	13.507	103	112	27.1	1.3e-6	2.3e-9	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	7.33	5.8e-13	502.2747	2	0.27	LSKEEIER	LSKEEIER		8	V20130429-09_FTMSms2hcd	12.756	510	517	44.8	4.1e-4	6.7e-7	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-4]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	7.33	5.8e-13	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	39	51	42.3	5.8e-13	7.1e-16	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-4]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	7.33	5.8e-13	844.4558	2	1.8	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-09_FTMSms2hcd	48.083	174	189	43.3	8.0e-11	1.4e-13	2	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-4]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	7.33	5.8e-13	614.8173	2	-0.58	VEILANDQGNR	VEILANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	28	38	48.1	9.8e-10	1.5e-12	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-4]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	7.33	5.8e-13	522.6162	3	1.2	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-09_FTMSms2hcd	45.155	351	363	29.9	2.2e-8	3.9e-11	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-4]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	7.33	5.8e-13	541.2877	2	0.42	LLQDFFNGK	LLQDFFNGK		9	V20130429-09_FTMSms2hcd	44.825	351	359	33.2	1.0e-5	1.6e-8	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-5]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.33	5.8e-13	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	39	51	42.3	5.8e-13	7.1e-16	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-5]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.33	5.8e-13	614.8173	2	-0.58	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	28	38	48.1	9.8e-10	1.5e-12	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-5]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.33	5.8e-13	502.2747	2	0.27	LSKEEIER	LSKEEIER		8	V20130429-09_FTMSms2hcd	12.756	512	519	44.8	4.1e-4	6.7e-7	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.33	5.8e-13	744.3557	2	1.9	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-09_FTMSms2hcd	34.622	39	51	42.3	5.8e-13	7.1e-16	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[7-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.33	5.8e-13	614.8173	2	-0.58	VEILANDQGNR	VEILANDQGNR		11	V20130429-09_FTMSms2hcd	20.807	28	38	48.1	9.8e-10	1.5e-12	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	973.3989	2	-0.25	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=59	17	V20130429-09_FTMSms2hcd	12.455	250	266	59.5	2.9e-19	4.7e-22	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	683.3675	2	-1.2	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-09_FTMSms2hcd	39.352	83	95	55.2	7.1e-15	1.1e-17	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	594.9872	3	-1.5	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-09_FTMSms2hcd	38.078	625	639	53.5	9.4e-15	1.6e-17	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	698.7061	3	0.90	HSQFIGYPITLYLEKER	HSQFIGYPITLYLEKER		17	V20130429-09_FTMSms2hcd	51.818	205	221	48.9	2.6e-14	4.5e-17	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	956.0280	2	2.1	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-09_FTMSms2hcd	33.421	624	639	51.0	4.9e-13	1.5e-15	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	757.3994	2	3.9	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-09_FTMSms2hcd	44.181	379	392	49.0	3.2e-11	4.9e-14	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	571.2833	2	-0.27	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-09_FTMSms2hcd	13.309	439	448	49.1	5.2e-11	8.6e-14	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	904.9769	2	-6.4	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-09_FTMSms2hcd	55.902	205	219	37.6	2.5e-10	3.5e-13	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	612.6077	3	0.045	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@617;Oxidation@620;Oxidation@621	16	V20130429-09_FTMSms2hcd	15.419	608	623	33.6	3.6e-10	4.3e-13	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	764.3761	2	0.74	SLTNDWEDHLAVK	SLTNDWEDHLAVK		13	V20130429-09_FTMSms2hcd	39.651	307	319	32.2	9.7e-10	1.2e-12	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	597.8276	2	0.18	IDIIPNPQER	IDIIPNPQER		10	V20130429-09_FTMSms2hcd	36.094	73	82	32.4	1.2e-7	2.1e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	580.7950	2	-0.57	SIYYITGESK	SIYYITGESK		10	V20130429-09_FTMSms2hcd	29.930	482	491	36.3	1.8e-7	2.7e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	515.6140	3	-0.27	ELISNASDALDKIR	ELISNASDALDKIR		14	V20130429-09_FTMSms2hcd	41.372	42	55	53.4	2.2e-7	3.9e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	625.3131	2	1.4	EQVANSAFVER	EQVANSAFVER		11	V20130429-09_FTMSms2hcd	23.922	492	502	39.8	2.9e-7	4.0e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	621.8558	2	-0.73	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-09_FTMSms2hcd	43.604	96	107	37.2	5.9e-7	1.2e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-09_FTMSms2hcd	20.752	276	284	26.0	9.7e-7	1.4e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	446.2169	2	2.1	FYEAFSK	FYEAFSK		7	V20130429-09_FTMSms2hcd	27.594	429	435	17.7	6.3e-5	1.3e-7	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	415.2685	2	0.35	ALLFIPR	ALLFIPR		7	V20130429-09_FTMSms2hcd	45.851	331	337	27.5	1.9e-4	6.9e-7	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	19	28.0	10.73	2.9e-19	367.2267	2	0.94	SLVSVTK	SLVSVTK		7	V20130429-09_FTMSms2hcd	19.564	532	538	21.7	0.0011	4.8e-6	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	973.3989	2	-0.25	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=59	17	V20130429-09_FTMSms2hcd	12.455	172	188	59.5	2.9e-19	4.7e-22	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	698.7061	3	0.90	HSQFLGYPITLYLEKER	HSQFLGYPITLYLEKER		17	V20130429-09_FTMSms2hcd	51.818	127	143	48.9	2.6e-14	4.5e-17	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	904.9769	2	-6.4	HSQFLGYPITLYLEK	HSQFLGYPITLYLEK		15	V20130429-09_FTMSms2hcd	55.902	127	141	37.6	2.5e-10	3.5e-13	3	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	580.7950	2	-0.57	SIYYITGESK	SIYYITGESK		10	V20130429-09_FTMSms2hcd	29.930	258	267	36.3	1.8e-7	2.7e-10	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	621.8558	2	-0.73	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-09_FTMSms2hcd	43.604	96	107	37.2	5.9e-7	1.2e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-09_FTMSms2hcd	20.752	198	206	26.0	9.7e-7	1.4e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	7	18.9	10.73	2.9e-19	367.2267	2	0.94	SLVSVTK	SLVSVTK		7	V20130429-09_FTMSms2hcd	19.564	305	311	21.7	0.0011	4.8e-6	3	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	683.3675	2	-1.2	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-09_FTMSms2hcd	39.352	88	100	55.2	7.1e-15	1.1e-17	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	596.3215	3	3.0	HLEINPDHSIIETLR	HLEINPDHSIIETLR		15	V20130429-09_FTMSms2hcd	42.004	633	647	46.0	5.3e-13	9.3e-16	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	757.3994	2	3.9	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-09_FTMSms2hcd	44.181	387	400	49.0	3.2e-11	4.9e-14	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	764.3761	2	0.74	SLTNDWEDHLAVK	SLTNDWEDHLAVK		13	V20130429-09_FTMSms2hcd	39.651	315	327	32.2	9.7e-10	1.2e-12	2	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	621.8558	2	-0.73	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-09_FTMSms2hcd	43.604	101	112	37.2	5.9e-7	1.2e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	1	P07900	HS90A_HUMAN	HSP90AA1	6	10.4	8.36	7.1e-15	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-09_FTMSms2hcd	20.752	284	292	26.0	9.7e-7	1.4e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	5	9.9	5.89	2.5e-10	904.9769	2	-6.4	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-09_FTMSms2hcd	55.902	184	198	37.6	2.5e-10	3.5e-13	3	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	5	9.9	5.89	2.5e-10	612.6077	3	0.045	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@490;Oxidation@493;Oxidation@494	16	V20130429-09_FTMSms2hcd	15.419	481	496	33.6	3.6e-10	4.3e-13	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	5	9.9	5.89	2.5e-10	597.8276	2	0.18	IDIIPNPQER	IDIIPNPQER		10	V20130429-09_FTMSms2hcd	36.094	73	82	32.4	1.2e-7	2.1e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	5	9.9	5.89	2.5e-10	625.3131	2	1.4	EQVANSAFVER	EQVANSAFVER		11	V20130429-09_FTMSms2hcd	23.922	365	375	39.8	2.9e-7	4.0e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	5	9.9	5.89	2.5e-10	367.2267	2	0.94	SLVSVTK	SLVSVTK		7	V20130429-09_FTMSms2hcd	19.564	405	411	21.7	0.0011	4.8e-6	3	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-4]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	8.36	7.1e-15	683.3675	2	-1.2	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-09_FTMSms2hcd	39.352	28	40	55.2	7.1e-15	1.1e-17	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[8-5]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.80	5.9e-7	621.8558	2	-0.73	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-09_FTMSms2hcd	43.604	101	112	37.2	5.9e-7	1.2e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[8-5]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.80	5.9e-7	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-09_FTMSms2hcd	20.752	283	291	26.0	9.7e-7	1.4e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[8-6]	1	P14625	ENPL_HUMAN	HSP90B1	2	2.6	4.32	2.2e-7	515.6140	3	-0.27	ELISNASDALDKIR	ELISNASDALDKIR		14	V20130429-09_FTMSms2hcd	41.372	103	116	53.4	2.2e-7	3.9e-10	2	92469.6	HUMAN	Endoplasmin
[8-6]	1	P14625	ENPL_HUMAN	HSP90B1	2	2.6	4.32	2.2e-7	438.7332	2	2.0	TFEINPR	TFEINPR		7	V20130429-09_FTMSms2hcd	26.130	684	690	25.4	4.5e-5	7.2e-8	2	92469.6	HUMAN	Endoplasmin
[8-7]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	6.39	3.2e-11	757.3994	2	3.9	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-09_FTMSms2hcd	44.181	389	402	49.0	3.2e-11	4.9e-14	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	795.0046	3	2.5	KGAGDGSDEEVDGKADGAEAKPAE	KGAGDGS(Phospho)DEEVDGKADGAEAKPAE	Phospho@1943	24	V20130429-09_FTMSms2hcd	15.920	1937	1960	42.9	6.8e-17	8.2e-20	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	975.5100	2	10	LQQELDDLLVDLDHQR	LQQELDDLLVDLDHQR		16	V20130429-09_FTMSms2hcd	57.880	1418	1433	39.5	1.1e-13	1.7e-16	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	1070.2180	3	10	MAQQAADKYLYVDKNFINNPLAQADWAAK	M(Met-loss+Acetyl)AQQAADKYLYVDKNFINNPLAQADWAAK	Met-loss+Acetyl@1	29	V20130429-09_FTMSms2hcd	59.895	1	29	52.5	1.3e-13	2.2e-16	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	666.0085	3	0.77	HSQAVEELAEQLEQTKR	HSQAVEELAEQLEQTKR		17	V20130429-09_FTMSms2hcd	39.809	1194	1210	51.0	4.8e-12	6.0e-15	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	824.7313	3	2.3	IAQLEEELEEEQGNTELINDR	IAQLEEELEEEQGNTELINDR		21	V20130429-09_FTMSms2hcd	48.374	1731	1751	39.5	1.0e-11	9.8e-15	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	539.0082	3	9.8	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-09_FTMSms2hcd	57.723	342	356	43.1	1.3e-11	8.5e-13	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	827.4011	2	5.8	IAEFTTNLTEEEEK	IAEFTTNLTEEEEK		14	V20130429-09_FTMSms2hcd	36.773	1001	1014	31.4	2.5e-11	2.8e-14	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	862.9140	2	0.53	NAEQYKDQADKASTR	NAEQYKDQADKASTR		15	V20130429-09_FTMSms2hcd	12.193	1857	1871	55.6	4.3e-11	4.7e-14	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	855.4802	2	18	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@210	16	V20130429-09_FTMSms2hcd	73.555	210	225	27.8	1.3e-10	4.4e-13	3	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	839.8893	2	0.74	EMEAELEDERKQR	EM(Oxidation)EAELEDERKQR	Oxidation@1594	13	V20130429-09_FTMSms2hcd	11.897	1593	1605	30.9	3.7e-10	4.1e-13	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	666.3139	2	9.9	QLEEAEEEAQR	QLEEAEEEAQR		11	V20130429-09_FTMSms2hcd	16.960	1878	1888	31.5	4.7e-10	7.0e-13	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	863.9898	2	14	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-09_FTMSms2hcd	61.487	210	225	43.3	6.2e-10	2.3e-12	3	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	493.6047	3	-0.44	VIQYLAYVASSHK	VIQYLAYVASSHK		13	V20130429-09_FTMSms2hcd	39.728	187	199	35.6	1.4e-9	2.7e-12	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	524.6230	3	0.27	VSHLLGINVTDFTR	VSHLLGINVTDFTR		14	V20130429-09_FTMSms2hcd	49.266	374	387	37.2	5.3e-9	1.1e-11	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	578.3351	2	-0.33	RGDLPFVVPR	RGDLPFVVPR		10	V20130429-09_FTMSms2hcd	38.392	1923	1932	33.3	1.2e-7	3.7e-10	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	908.4636	2	6.4	IAQLEEQLDNETKER	IAQLEEQLDNETKER		15	V20130429-09_FTMSms2hcd	32.300	1816	1830	19.4	8.3e-6	1.1e-8	1	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	522.5811	3	-0.97	YAEERDRAEAEAR	YAEERDRAEAEAR		13	V20130429-09_FTMSms2hcd	10.380	1460	1472	20.3	2.3e-5	2.7e-8	2	226534.2	HUMAN	Myosin-9
[9]		P35579	MYH9_HUMAN	MYH9	18	13.8	9.45	6.8e-17	572.9154	3	0.81	TEMEDLMSSKDDVGK	TEM(Oxidation)EDLM(Oxidation)SSKDDVGK	Oxidation@1506;Oxidation@1510	15	V20130429-09_FTMSms2hcd	15.973	1504	1518	14.0	4.4e-4	6.2e-7	1	226534.2	HUMAN	Myosin-9
[9-1]	0	P35749	MYH11_HUMAN	MYH11	2	0.8	6.06	1.3e-10	855.4802	2	18	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@217	16	V20130429-09_FTMSms2hcd	73.555	217	232	27.8	1.3e-10	4.4e-13	3	227341.1	HUMAN	Myosin-11
[9-1]	0	P35749	MYH11_HUMAN	MYH11	2	0.8	6.06	1.3e-10	863.9898	2	14	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-09_FTMSms2hcd	61.487	217	232	43.3	6.2e-10	2.3e-12	3	227341.1	HUMAN	Myosin-11
[9-2]	0	Q7Z406	MYH14_HUMAN	MYH14	2	0.8	6.06	1.3e-10	855.4802	2	18	QLLQANPILEAFGNAK	Q(Gln->pyro-Glu)LLQANPILEAFGNAK	Gln->pyro-Glu@237	16	V20130429-09_FTMSms2hcd	73.555	237	252	27.8	1.3e-10	4.4e-13	3	227872.4	HUMAN	Myosin-14
[9-2]	0	Q7Z406	MYH14_HUMAN	MYH14	2	0.8	6.06	1.3e-10	863.9898	2	14	QLLQANPILEAFGNAK	QLLQANPILEAFGNAK		16	V20130429-09_FTMSms2hcd	61.487	237	252	43.3	6.2e-10	2.3e-12	3	227872.4	HUMAN	Myosin-14
[9-3]	0	P35580	MYH10_HUMAN	MYH10	1	0.7	1.26	2.3e-5	522.5811	3	-0.97	YAEERDRAEAEAR	YAEERDRAEAEAR		13	V20130429-09_FTMSms2hcd	10.380	1467	1479	20.3	2.3e-5	2.7e-8	2	229001.0	HUMAN	Myosin-10
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	828.4014	2	0.61	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-09_FTMSms2hcd	21.435	105	119	46.8	8.8e-16	9.5e-19	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	954.9462	2	1.6	AEDGSVIDYELIDQDAR	AEDGSVIDYELIDQDAR		17	V20130429-09_FTMSms2hcd	45.746	180	196	56.0	9.0e-15	9.6e-18	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	922.9576	2	2.9	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-09_FTMSms2hcd	30.207	11	28	46.3	8.6e-14	9.8e-17	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	970.4849	2	0.93	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-09_FTMSms2hcd	40.508	153	169	50.1	1.4e-12	1.7e-15	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	714.3946	4	0.18	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-09_FTMSms2hcd	71.300	89	115	37.5	1.4e-12	6.0e-15	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	550.9984	3	1.1	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-09_FTMSms2hcd	69.551	89	104	43.9	1.8e-12	2.9e-14	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	689.0008	3	2.2	RAEDGSVIDYELIDQDAR	RAEDGSVIDYELIDQDAR		18	V20130429-09_FTMSms2hcd	41.951	179	196	39.0	1.7e-11	1.8e-14	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	604.6277	3	1.5	TDLEKDIISDTSGDFR	TDLEKDIISDTSGDFR		16	V20130429-09_FTMSms2hcd	44.864	153	168	29.7	1.4e-10	1.6e-13	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	536.2794	2	1.1	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	34.068	1	10	35.8	2.7e-10	4.7e-13	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	771.9278	2	-0.18	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-09_FTMSms2hcd	59.520	50	63	52.5	2.7e-10	6.3e-13	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	535.5929	3	1.0	SYSPYDMLESIRK	SYSPYDM(Oxidation)LESIRK	Oxidation@240	13	V20130429-09_FTMSms2hcd	36.226	234	246	23.5	3.0e-8	3.6e-11	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	556.2803	2	0.22	QDIAFAYQR	QDIAFAYQR		9	V20130429-09_FTMSms2hcd	30.562	69	77	36.9	1.9e-7	2.7e-10	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	817.1976	4	20	KEVKGDLENAFLNLVQCIQNKPLYFADR	KEVKGDLENAFLNLVQCIQNKPLYFADR		28	V20130429-09_FTMSms2hcd	73.810	246	273	17.8	2.1e-7	9.6e-10	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	924.1186	3	13	AEDGSVIDYELIDQDARDLYDAGVK	AEDGSVIDYELIDQDARDLYDAGVK		25	V20130429-09_FTMSms2hcd	60.409	180	204	24.2	4.3e-7	4.3e-10	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	381.2327	2	-1.1	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-09_FTMSms2hcd	25.309	170	176	24.2	6.2e-7	2.2e-9	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	526.2664	2	1.4	WISIMTER	WISIM(Oxidation)TER	Oxidation@217	8	V20130429-09_FTMSms2hcd	33.600	213	220	26.4	6.3e-6	1.0e-8	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	544.3046	2	2.4	DALNIETAIK	DALNIETAIK		10	V20130429-09_FTMSms2hcd	39.200	38	47	28.1	7.1e-6	1.2e-8	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	622.8156	2	0.78	TNQELQEINR	TNQELQEINR		10	V20130429-09_FTMSms2hcd	21.120	136	145	37.3	7.3e-6	1.0e-8	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	19	59.3	8.85	8.8e-16	518.7800	2	10	DLYDAGVKR	DLYDAGVKR		9	V20130429-09_FTMSms2hcd	19.646	197	205	28.1	4.1e-4	7.4e-7	1	38604.4	HUMAN	Annexin A2
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	828.4014	2	0.61	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-09_FTMSms2hcd	21.435	105	119	46.8	8.8e-16	9.5e-19	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	922.9576	2	2.9	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-09_FTMSms2hcd	30.207	11	28	46.3	8.6e-14	9.8e-17	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	970.4849	2	0.93	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-09_FTMSms2hcd	40.508	153	169	50.1	1.4e-12	1.7e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	714.3946	4	0.18	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-09_FTMSms2hcd	71.300	89	115	37.5	1.4e-12	6.0e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	550.9984	3	1.1	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-09_FTMSms2hcd	69.551	89	104	43.9	1.8e-12	2.9e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	604.6277	3	1.5	TDLEKDIISDTSGDFR	TDLEKDIISDTSGDFR		16	V20130429-09_FTMSms2hcd	44.864	153	168	29.7	1.4e-10	1.6e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	536.2794	2	1.1	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	34.068	1	10	35.8	2.7e-10	4.7e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	535.5929	3	1.0	SYSPYDMLESIRK	SYSPYDM(Oxidation)LESIRK	Oxidation@240	13	V20130429-09_FTMSms2hcd	36.226	234	246	23.5	3.0e-8	3.6e-11	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	381.2327	2	-1.1	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-09_FTMSms2hcd	25.309	170	176	24.2	6.2e-7	2.2e-9	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	526.2664	2	1.4	WISIMTER	WISIM(Oxidation)TER	Oxidation@217	8	V20130429-09_FTMSms2hcd	33.600	213	220	26.4	6.3e-6	1.0e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	544.3046	2	2.4	DALNIETAIK	DALNIETAIK		10	V20130429-09_FTMSms2hcd	39.200	38	47	28.1	7.1e-6	1.2e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	12	36.6	8.85	8.8e-16	622.8156	2	0.78	TNQELQEINR	TNQELQEINR		10	V20130429-09_FTMSms2hcd	21.120	136	145	37.3	7.3e-6	1.0e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	990.7957	3	1.5	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-09_FTMSms2hcd	50.051	396	423	54.9	2.0e-19	1.8e-22	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	673.3716	4	0.80	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-09_FTMSms2hcd	37.737	6	30	47.7	2.3e-16	9.4e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	794.9445	2	0.73	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-09_FTMSms2hcd	81.838	6	20	39.9	1.3e-15	3.1e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	813.9076	2	2.2	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-09_FTMSms2hcd	21.650	38	51	50.8	1.6e-15	1.9e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	1013.0652	4	16	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-09_FTMSms2hcd	69.922	219	255	51.0	5.2e-13	6.2e-15	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	839.1324	3	-0.55	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-09_FTMSms2hcd	55.294	267	290	47.7	1.1e-12	4.9e-15	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-09_FTMSms2hcd	74.423	220	255	35.1	7.6e-12	3.5e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	844.4730	3	10	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-09_FTMSms2hcd	51.010	267	290	43.3	2.2e-11	1.2e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	1200.5725	3	12	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-09_FTMSms2hcd	67.923	181	212	26.6	2.3e-9	2.5e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	560.8027	2	-1.4	STTTGHLIYK	STTTGHLIYK		10	V20130429-09_FTMSms2hcd	18.000	21	30	35.1	2.8e-9	4.8e-12	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	432.9913	4	0.89	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-09_FTMSms2hcd	42.017	167	180	32.5	3.2e-9	7.7e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	438.9188	3	0.18	EHALLAYTLGVK	EHALLAYTLGVK		12	V20130429-09_FTMSms2hcd	41.385	135	146	31.2	3.4e-9	8.0e-12	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-09_FTMSms2hcd	31.211	256	266	49.0	1.4e-7	1.0e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	449.2746	2	1.7	QTVAVGVIK	Q(Gln->pyro-Glu)TVAVGVIK	Gln->pyro-Glu@431	9	V20130429-09_FTMSms2hcd	36.278	431	439	23.6	1.3e-6	7.0e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11]		P68104	EF1A1_HUMAN	EEF1A1	15	44.6	10.81	2.0e-19	457.7879	2	1.7	QTVAVGVIK	QTVAVGVIK		9	V20130429-09_FTMSms2hcd	26.544	431	439	33.1	4.3e-6	1.3e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	990.7957	3	1.5	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-09_FTMSms2hcd	50.051	396	423	54.9	2.0e-19	1.8e-22	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	673.3716	4	0.80	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-09_FTMSms2hcd	37.737	6	30	47.7	2.3e-16	9.4e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	794.9445	2	0.73	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-09_FTMSms2hcd	81.838	6	20	39.9	1.3e-15	3.1e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	813.9076	2	2.2	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-09_FTMSms2hcd	21.650	38	51	50.8	1.6e-15	1.9e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	1013.0652	4	16	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-09_FTMSms2hcd	69.922	219	255	51.0	5.2e-13	6.2e-15	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	839.1324	3	-0.55	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-09_FTMSms2hcd	55.294	267	290	47.7	1.1e-12	4.9e-15	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-09_FTMSms2hcd	74.423	220	255	35.1	7.6e-12	3.5e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	844.4730	3	10	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-09_FTMSms2hcd	51.010	267	290	43.3	2.2e-11	1.2e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	1200.5725	3	12	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-09_FTMSms2hcd	67.923	181	212	26.6	2.3e-9	2.5e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	560.8027	2	-1.4	STTTGHLIYK	STTTGHLIYK		10	V20130429-09_FTMSms2hcd	18.000	21	30	35.1	2.8e-9	4.8e-12	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	432.9913	4	0.89	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-09_FTMSms2hcd	42.017	167	180	32.5	3.2e-9	7.7e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	438.9188	3	0.18	EHALLAYTLGVK	EHALLAYTLGVK		12	V20130429-09_FTMSms2hcd	41.385	135	146	31.2	3.4e-9	8.0e-12	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-09_FTMSms2hcd	31.211	256	266	49.0	1.4e-7	1.0e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	449.2746	2	1.7	QTVAVGVIK	Q(Gln->pyro-Glu)TVAVGVIK	Gln->pyro-Glu@431	9	V20130429-09_FTMSms2hcd	36.278	431	439	23.6	1.3e-6	7.0e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	15	44.6	10.81	2.0e-19	457.7879	2	1.7	QTVAVGVIK	QTVAVGVIK		9	V20130429-09_FTMSms2hcd	26.544	431	439	33.1	4.3e-6	1.3e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	673.3716	4	0.80	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-09_FTMSms2hcd	37.737	6	30	47.7	2.3e-16	9.4e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	794.9445	2	0.73	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-09_FTMSms2hcd	81.838	6	20	39.9	1.3e-15	3.1e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	813.9076	2	2.2	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-09_FTMSms2hcd	21.650	38	51	50.8	1.6e-15	1.9e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	863.1556	3	14	VETGILRPGMVVTFAPVNITTEVK	VETGILRPGM(Oxidation)VVTFAPVNITTEVK	Oxidation@276	24	V20130429-09_FTMSms2hcd	56.392	267	290	35.2	4.1e-10	3.9e-12	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	560.8027	2	-1.4	STTTGHLIYK	STTTGHLIYK		10	V20130429-09_FTMSms2hcd	18.000	21	30	35.1	2.8e-9	4.8e-12	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	438.9188	3	0.18	EHALLAYTLGVK	EHALLAYTLGVK		12	V20130429-09_FTMSms2hcd	41.385	135	146	31.2	3.4e-9	8.0e-12	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	784.2348	5	1.7	EGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	EGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK		36	V20130429-09_FTMSms2hcd	73.288	220	255	28.3	8.6e-9	5.8e-11	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	513.3091	2	0.70	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-09_FTMSms2hcd	31.211	256	266	49.0	1.4e-7	1.0e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	449.2746	2	1.7	QTVAVGVIK	Q(Gln->pyro-Glu)TVAVGVIK	Gln->pyro-Glu@431	9	V20130429-09_FTMSms2hcd	36.278	431	439	23.6	1.3e-6	7.0e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[11-2]	2	Q05639	EF1A2_HUMAN	EEF1A2	10	28.3	9.16	2.3e-16	457.7879	2	1.7	QTVAVGVIK	QTVAVGVIK		9	V20130429-09_FTMSms2hcd	26.544	431	439	33.1	4.3e-6	1.3e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	1073.0713	2	2.8	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-09_FTMSms2hcd	70.346	38	58	47.2	1.0e-17	1.8e-20	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	702.6140	4	1.2	IQEIIEQLDVTTSEYEKEKLNER	IQEIIEQLDVTTSEYEKEKLNER		23	V20130429-09_FTMSms2hcd	50.089	371	393	56.9	3.4e-16	5.1e-19	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	823.9556	2	0.36	VGEVIVTKDDAMLLK	VGEVIVTKDDAM(Oxidation)LLK	Oxidation@356	15	V20130429-09_FTMSms2hcd	37.299	345	359	48.1	4.6e-13	1.0e-15	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	524.9731	3	1.1	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-09_FTMSms2hcd	59.054	143	157	39.7	7.9e-13	3.5e-15	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	740.7884	5	0.53	QSKPVTTPEEIAQVATISANGDKEIGNIISDAMKK	QSKPVTTPEEIAQVATISANGDKEIGNIISDAM(Oxidation)KK	Oxidation@190	35	V20130429-09_FTMSms2hcd	58.733	158	192	46.5	9.8e-13	2.2e-15	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	646.9880	3	0.89	TLNDELEIIEGMKFDR	TLNDELEIIEGM(Oxidation)KFDR	Oxidation@217	16	V20130429-09_FTMSms2hcd	50.025	206	221	42.2	6.2e-12	6.5e-15	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	401.5782	3	1.9	TLKIPAMTIAK	TLKIPAM(Oxidation)TIAK	Oxidation@477	11	V20130429-09_FTMSms2hcd	28.860	471	481	33.5	3.1e-11	1.6e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	816.9126	2	-0.51	VGGTSDVEVNEKKDR	VGGTSDVEVNEKKDR		15	V20130429-09_FTMSms2hcd	11.709	406	420	63.2	4.4e-9	5.2e-12	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	577.3856	2	-2.4	LKVGLQVVAVK	LKVGLQVVAVK		11	V20130429-09_FTMSms2hcd	37.221	291	301	23.8	9.0e-8	3.2e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	480.7596	2	1.1	VTDALNATR	VTDALNATR		9	V20130429-09_FTMSms2hcd	16.360	421	429	42.5	2.4e-6	3.6e-9	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	506.2885	2	0.32	GANPVEIRR	GANPVEIRR		9	V20130429-09_FTMSms2hcd	15.690	134	142	34.6	1.5e-5	5.0e-8	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	1151.8101	4	15	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVAS(Phospho)LLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|541|547	47	V20130429-09_FTMSms2hcd	77.401	527	573	14.4	2.4e-4	3.6e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[12]		P10809	CH60_HUMAN	HSPD1	13	41.0	9.90	1.0e-17	471.3114	2	1.4	IGIEIIKR	IGIEIIKR		8	V20130429-09_FTMSms2hcd	32.046	463	470	38.5	6.9e-4	6.2e-6	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	675.3306	3	9.4	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-09_FTMSms2hcd	53.010	237	254	33.3	1.1e-12	1.1e-15	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	669.9928	3	0.27	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-09_FTMSms2hcd	60.911	237	254	35.2	2.0e-12	2.1e-15	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	909.4511	5	11	KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR	KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR		40	V20130429-09_FTMSms2hcd	60.370	436	475	35.0	1.1e-10	1.8e-13	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	693.8969	2	9.0	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-09_FTMSms2hcd	65.463	715	726	49.5	1.3e-10	3.5e-13	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	647.3804	2	0.78	LAILGIHNEVSK	LAILGIHNEVSK		12	V20130429-09_FTMSms2hcd	36.629	566	577	38.2	3.3e-10	1.6e-12	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	623.3429	3	-1.2	LLETIDQLYLEYAKR	LLETIDQLYLEYAKR		15	V20130429-09_FTMSms2hcd	57.974	503	517	38.6	1.0e-9	2.5e-12	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	558.2881	2	-0.18	ATLPDADKER	ATLPDADKER		10	V20130429-09_FTMSms2hcd	13.811	556	565	40.5	2.3e-7	4.3e-10	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	458.4757	4	0.36	ASIHEAWTDGKEAMLR	ASIHEAWTDGKEAM(Oxidation)LR	Oxidation@416	16	V20130429-09_FTMSms2hcd	28.397	403	418	13.5	5.3e-7	6.2e-10	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	715.3853	2	-0.85	TINEVENQILTR	TINEVENQILTR		12	V20130429-09_FTMSms2hcd	38.621	727	738	37.4	5.7e-7	9.7e-10	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	493.2456	3	0.42	LSNRPAFMPSEGR	LSNRPAFM(Oxidation)PSEGR	Oxidation@354	13	V20130429-09_FTMSms2hcd	20.399	347	359	22.3	2.4e-6	2.8e-9	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	409.8878	3	0.65	HRPELIDYGK	HRPELIDYGK		10	V20130429-09_FTMSms2hcd	21.422	186	195	24.1	4.0e-5	7.8e-8	1	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	457.9290	3	-1.4	LASDLLEWIRR	LASDLLEWIRR		11	V20130429-09_FTMSms2hcd	54.738	282	292	38.0	1.4e-4	3.1e-7	2	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	635.3207	2	0.52	LEDFRDYRR	LEDFRDYRR		9	V20130429-09_FTMSms2hcd	21.487	313	321	22.2	2.9e-4	4.2e-7	4	103058.4	HUMAN	Alpha-actinin-1
[13]		P12814	ACTN1_HUMAN	ACTN1	14	21.3	7.18	1.1e-12	707.3320	2	-3.3	VPENTMHAMQQK	VPENTMHAMQQK		12	V20130429-09_FTMSms2hcd	31.802	301	312	10.1	0.0015	1.9e-6	1	103058.4	HUMAN	Alpha-actinin-1
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	675.3306	3	9.4	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-09_FTMSms2hcd	53.010	256	273	33.3	1.1e-12	1.1e-15	2	104854.9	HUMAN	Alpha-actinin-4
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	669.9928	3	0.27	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-09_FTMSms2hcd	60.911	256	273	35.2	2.0e-12	2.1e-15	2	104854.9	HUMAN	Alpha-actinin-4
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	693.8969	2	9.0	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-09_FTMSms2hcd	65.463	734	745	49.5	1.3e-10	3.5e-13	2	104854.9	HUMAN	Alpha-actinin-4
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	715.3853	2	-0.85	TINEVENQILTR	TINEVENQILTR		12	V20130429-09_FTMSms2hcd	38.621	746	757	37.4	5.7e-7	9.7e-10	2	104854.9	HUMAN	Alpha-actinin-4
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	457.9290	3	-1.4	LASDLLEWIRR	LASDLLEWIRR		11	V20130429-09_FTMSms2hcd	54.738	301	311	38.0	1.4e-4	3.1e-7	2	104854.9	HUMAN	Alpha-actinin-4
[13-1]	0	O43707	ACTN4_HUMAN	ACTN4	6	6.8	7.18	1.1e-12	635.3207	2	0.52	LEDFRDYRR	LEDFRDYRR		9	V20130429-09_FTMSms2hcd	21.487	332	340	22.2	2.9e-4	4.2e-7	4	104854.9	HUMAN	Alpha-actinin-4
[13-2]	0	P35609	ACTN2_HUMAN	ACTN2	1	1.0	0.85	2.9e-4	635.3207	2	0.52	LEDFRDYRR	LEDFRDYRR		9	V20130429-09_FTMSms2hcd	21.487	320	328	22.2	2.9e-4	4.2e-7	4	103854.7	HUMAN	Alpha-actinin-2
[13-3]	0	Q08043	ACTN3_HUMAN	ACTN3	1	1.0	0.85	2.9e-4	635.3207	2	0.52	LEDFRDYRR	LEDFRDYRR		9	V20130429-09_FTMSms2hcd	21.487	327	335	22.2	2.9e-4	4.2e-7	4	103242.2	HUMAN	Alpha-actinin-3
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	741.9030	2	0.17	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-09_FTMSms2hcd	40.482	81	93	43.8	1.7e-13	3.8e-16	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	663.8528	2	0.72	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-09_FTMSms2hcd	44.047	81	92	31.9	2.9e-10	5.3e-13	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	702.3844	3	17	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-09_FTMSms2hcd	62.620	61	78	39.5	7.0e-10	1.7e-12	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	567.7745	2	-0.75	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-09_FTMSms2hcd	12.713	69	78	36.4	1.6e-9	2.5e-12	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	494.6236	3	1.1	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-09_FTMSms2hcd	23.664	25	37	34.7	2.2e-9	1.1e-11	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	489.6060	3	-0.078	TVTAMDVVYALKR	TVTAMDVVYALKR		13	V20130429-09_FTMSms2hcd	48.626	81	93	36.8	6.9e-9	1.6e-11	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	424.2578	4	1.3	VLRDNIQGITKPAIR	VLRDNIQGITKPAIR		15	V20130429-09_FTMSms2hcd	31.095	22	36	26.6	1.2e-8	1.8e-10	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	463.2827	4	0.38	VLRDNIQGITKPAIRR	VLRDNIQGITKPAIRR		16	V20130429-09_FTMSms2hcd	27.864	22	37	22.5	1.4e-8	2.4e-10	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	590.8155	2	2.5	ISGLIYEETR	ISGLIYEETR		10	V20130429-09_FTMSms2hcd	33.119	47	56	44.5	4.4e-8	6.7e-11	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	663.3815	2	1.6	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-09_FTMSms2hcd	27.352	25	36	46.6	6.0e-8	2.2e-10	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	526.6357	3	1.8	ISGLIYEETRGVLK	ISGLIYEETRGVLK		14	V20130429-09_FTMSms2hcd	43.343	47	60	43.2	1.0e-7	3.6e-10	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	12	59.2	7.61	1.7e-13	495.2933	2	1.5	VFLENVIR	VFLENVIR		8	V20130429-09_FTMSms2hcd	43.439	61	68	39.3	7.2e-6	2.1e-8	1	11367.4	HUMAN	Histone H4
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	1004.4574	2	7.2	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-09_FTMSms2hcd	51.029	41	60	46.5	3.7e-15	4.0e-18	5	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	851.4611	2	5.4	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-09_FTMSms2hcd	57.144	65	79	50.0	2.0e-12	3.8e-15	3	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	744.4441	2	1.2	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-09_FTMSms2hcd	67.416	230	243	43.5	4.9e-9	2.9e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	508.2931	2	0.68	DVNAAIATIK	DVNAAIATIK		10	V20130429-09_FTMSms2hcd	32.670	327	336	33.5	1.0e-6	1.9e-9	5	50152.1	HUMAN	Tubulin alpha-1B chain
[15]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.96	5.4e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-09_FTMSms2hcd	15.589	157	164	18.7	4.4e-5	1.0e-7	5	50152.1	HUMAN	Tubulin alpha-1B chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	1004.4574	2	7.2	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-09_FTMSms2hcd	51.029	41	60	46.5	3.7e-15	4.0e-18	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	851.4611	2	5.4	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-09_FTMSms2hcd	57.144	65	79	50.0	2.0e-12	3.8e-15	3	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	744.4441	2	1.2	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-09_FTMSms2hcd	67.416	230	243	43.5	4.9e-9	2.9e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	508.2931	2	0.68	DVNAAIATIK	DVNAAIATIK		10	V20130429-09_FTMSms2hcd	32.670	327	336	33.5	1.0e-6	1.9e-9	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.96	5.4e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-09_FTMSms2hcd	15.589	157	164	18.7	4.4e-5	1.0e-7	5	49895.8	HUMAN	Tubulin alpha-1C chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	1004.4574	2	7.2	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-09_FTMSms2hcd	51.029	41	60	46.5	3.7e-15	4.0e-18	5	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	851.4611	2	5.4	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-09_FTMSms2hcd	57.144	65	79	50.0	2.0e-12	3.8e-15	3	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	508.2931	2	0.68	DVNAAIATIK	DVNAAIATIK		10	V20130429-09_FTMSms2hcd	32.670	327	336	33.5	1.0e-6	1.9e-9	5	50136.1	HUMAN	Tubulin alpha-1A chain
[15-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.96	5.4e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-09_FTMSms2hcd	15.589	157	164	18.7	4.4e-5	1.0e-7	5	50136.1	HUMAN	Tubulin alpha-1A chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	1004.4574	2	7.2	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-09_FTMSms2hcd	51.029	41	60	46.5	3.7e-15	4.0e-18	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	508.2931	2	0.68	DVNAAIATIK	DVNAAIATIK		10	V20130429-09_FTMSms2hcd	32.670	327	336	33.5	1.0e-6	1.9e-9	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.96	5.4e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-09_FTMSms2hcd	15.589	157	164	18.7	4.4e-5	1.0e-7	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	744.4441	2	1.2	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-09_FTMSms2hcd	67.416	230	243	43.5	4.9e-9	2.9e-11	5	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	49924.9	HUMAN	Tubulin alpha-4A chain
[15-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.96	5.4e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-09_FTMSms2hcd	15.589	157	164	18.7	4.4e-5	1.0e-7	5	49924.9	HUMAN	Tubulin alpha-4A chain
[15-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.96	5.4e-16	800.0663	3	2.4	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-09_FTMSms2hcd	48.746	85	105	56.5	5.4e-16	5.7e-19	6	50094.0	HUMAN	Tubulin alpha-8 chain
[15-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.96	5.4e-16	604.5565	4	-0.40	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-09_FTMSms2hcd	40.547	85	105	56.1	1.5e-13	1.6e-16	6	50094.0	HUMAN	Tubulin alpha-8 chain
[15-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.96	5.4e-16	744.4441	2	1.2	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-09_FTMSms2hcd	67.416	230	243	43.5	4.9e-9	2.9e-11	5	50094.0	HUMAN	Tubulin alpha-8 chain
[15-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.96	5.4e-16	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	50094.0	HUMAN	Tubulin alpha-8 chain
[15-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.96	5.4e-16	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	50094.0	HUMAN	Tubulin alpha-8 chain
[15-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	8.51	3.7e-15	1004.4574	2	7.2	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-09_FTMSms2hcd	51.029	41	60	46.5	3.7e-15	4.0e-18	5	49859.0	HUMAN	Tubulin alpha-3E chain
[15-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	8.51	3.7e-15	878.9858	2	0.62	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-09_FTMSms2hcd	51.959	265	280	41.5	3.2e-11	7.9e-14	6	49859.0	HUMAN	Tubulin alpha-3E chain
[15-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	8.51	3.7e-15	859.9462	2	1.8	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-09_FTMSms2hcd	33.996	216	229	44.9	7.3e-9	9.3e-12	7	49859.0	HUMAN	Tubulin alpha-3E chain
[15-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	8.51	3.7e-15	912.9980	2	1.8	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-09_FTMSms2hcd	44.575	353	370	33.4	6.9e-8	1.5e-10	7	49859.0	HUMAN	Tubulin alpha-3E chain
[15-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	8.51	3.7e-15	508.2931	2	0.68	DVNAAIATIK	DVNAAIATIK		10	V20130429-09_FTMSms2hcd	32.670	327	336	33.5	1.0e-6	1.9e-9	5	49859.0	HUMAN	Tubulin alpha-3E chain
[15-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.21	4.9e-9	744.4441	2	1.2	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-09_FTMSms2hcd	67.416	169	182	43.5	4.9e-9	2.9e-11	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	801.9495	2	1.7	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-09_FTMSms2hcd	55.425	198	212	43.0	5.4e-14	1.4e-16	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	584.3256	3	5.8	VAHALAEGLGVIACIGEK	VAHALAEGLGVIACIGEK		18	V20130429-09_FTMSms2hcd	54.872	151	168	38.1	1.6e-11	4.9e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	733.8650	2	-0.46	TATPQQAQEVHEK	TATPQQAQEVHEK		13	V20130429-09_FTMSms2hcd	11.123	213	225	46.2	1.9e-11	2.3e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	538.9462	3	0.37	RHVFGESDELIGQK	RHVFGESDELIGQK		14	V20130429-09_FTMSms2hcd	27.439	137	150	35.0	4.8e-10	6.3e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	486.9132	3	1.9	HVFGESDELIGQK	HVFGESDELIGQK		13	V20130429-09_FTMSms2hcd	31.256	138	150	26.7	6.2e-10	7.6e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	617.8050	2	0.41	SNVSDAVAQSTR	SNVSDAVAQSTR		12	V20130429-09_FTMSms2hcd	18.791	232	243	48.9	2.6e-9	3.6e-12	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	425.5628	3	-0.063	VIADNVKDWSK	VIADNVKDWSK		11	V20130429-09_FTMSms2hcd	26.967	187	197	48.4	2.7e-8	4.0e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	477.7453	2	0.12	FFVGGNWK	FFVGGNWK		8	V20130429-09_FTMSms2hcd	39.715	44	51	29.6	1.6e-7	2.3e-10	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	1053.2272	3	8.1	ELASQPDVDGFLVGGASLKPEFVDIINAKQ	ELASQPDVDGFLVGGASLKPEFVDIINAKQ		30	V20130429-09_FTMSms2hcd	65.971	257	286	27.9	1.7e-7	4.7e-10	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	707.9000	2	1.9	QSLGELIGTLNAAK	QSLGELIGTLNAAK		14	V20130429-09_FTMSms2hcd	52.923	57	70	20.1	5.7e-6	1.3e-8	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	630.8248	2	-0.55	LDEREAGITEK	LDEREAGITEK		11	V20130429-09_FTMSms2hcd	17.218	169	179	31.6	0.0017	2.5e-6	1	30791.3	HUMAN	Triosephosphate isomerase
[16]		P60174	TPIS_HUMAN	TPI1	12	56.6	7.88	5.4e-14	819.4153	2	1.8	VTNGAFTGEISPGMIK	VTNGAFTGEISPGM(Oxidation)IK	Oxidation@120	16	V20130429-09_FTMSms2hcd	36.982	107	122	10.7	0.021	2.5e-5	1	30791.3	HUMAN	Triosephosphate isomerase
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	708.3071	2	1.9	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-09_FTMSms2hcd	12.468	183	196	37.0	4.1e-12	7.1e-15	2	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	1050.5361	2	17	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-09_FTMSms2hcd	69.094	103	120	46.5	2.8e-11	3.4e-14	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	847.9131	2	1.3	QMEQISQFLQAAER	QM(Oxidation)EQISQFLQAAER	Oxidation@90	14	V20130429-09_FTMSms2hcd	47.029	89	102	48.0	4.4e-11	4.7e-14	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	640.2992	2	-0.15	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-09_FTMSms2hcd	20.817	161	171	41.2	1.3e-10	2.1e-13	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	574.9423	3	0.078	DDGLFSGDPNWFPKK	DDGLFSGDPNWFPKK		15	V20130429-09_FTMSms2hcd	50.407	140	154	37.4	3.3e-10	3.8e-13	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	797.8615	2	-0.96	DDGLFSGDPNWFPK	DDGLFSGDPNWFPK		14	V20130429-09_FTMSms2hcd	58.292	140	153	27.7	1.0e-9	1.3e-12	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	506.7602	2	-0.069	IQASTMAFK	IQASTM(Oxidation)AFK	Oxidation@85	9	V20130429-09_FTMSms2hcd	20.531	80	88	33.2	2.4e-9	4.2e-12	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	616.3445	2	-0.81	TLMNLGGLAVAR	TLM(Oxidation)NLGGLAVAR	Oxidation@130	12	V20130429-09_FTMSms2hcd	38.434	128	139	38.6	2.5e-9	5.0e-12	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	609.8175	2	1.5	NVIGLQMGTNR	NVIGLQM(Oxidation)GTNR	Oxidation@178	11	V20130429-09_FTMSms2hcd	24.381	172	182	39.5	3.5e-9	4.7e-12	1	22391.7	HUMAN	Transgelin-2
[17]		P37802	TAGL2_HUMAN	TAGLN2	10	58.3	6.87	4.1e-12	602.3150	2	-0.14	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-09_FTMSms2hcd	22.892	1	12	50.0	1.6e-7	2.3e-10	1	22391.7	HUMAN	Transgelin-2
[17-1]	0	Q9UI15	TAGL3_HUMAN	TAGLN3	1	7.0	6.57	4.1e-12	708.3071	2	1.9	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-09_FTMSms2hcd	12.468	183	196	37.0	4.1e-12	7.1e-15	2	22472.9	HUMAN	Transgelin-3
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	916.4611	2	2.0	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-09_FTMSms2hcd	46.245	77	91	38.8	4.3e-16	5.0e-19	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	973.5137	2	9.4	MVNPTVFFDIAVDGEPLGR	M(Met-loss)VNPTVFFDIAVDGEPLGR	Met-loss@1	19	V20130429-09_FTMSms2hcd	66.722	1	19	51.6	4.0e-14	6.6e-17	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	917.4399	3	0.96	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-09_FTMSms2hcd	47.834	92	118	55.4	4.8e-14	4.5e-17	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	779.3649	2	2.4	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-09_FTMSms2hcd	42.796	56	69	51.6	6.1e-12	7.4e-15	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	758.4026	2	1.6	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-09_FTMSms2hcd	36.603	119	131	35.0	2.2e-10	3.5e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	655.7896	2	0.31	EGMNIVEAMER	EGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	11	V20130429-09_FTMSms2hcd	19.305	134	144	33.9	2.9e-10	5.0e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	769.3721	2	1.3	VKEGMNIVEAMER	VKEGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	13	V20130429-09_FTMSms2hcd	18.039	132	144	40.9	3.7e-10	4.5e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	577.7898	2	-0.43	FEDENFILK	FEDENFILK		9	V20130429-09_FTMSms2hcd	41.533	83	91	28.2	2.5e-7	3.4e-10	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18]		P62937	PPIA_HUMAN	PPIA	9	68.5	9.02	4.3e-16	460.5910	3	1.1	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-09_FTMSms2hcd	47.123	20	31	28.0	5.1e-5	1.1e-7	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[18-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	6.78	6.1e-12	779.3649	2	2.4	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-09_FTMSms2hcd	42.796	56	69	51.6	6.1e-12	7.4e-15	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	781.3400	2	-5.0	GFGFVDFNSEEDAK	GFGFVDFNSEEDAK		14	V20130429-09_FTMSms2hcd	47.557	611	624	40.0	3.7e-15	5.7e-18	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	734.0154	3	2.9	GLSEDTTEETLKESFDGSVR	GLSEDTTEETLKESFDGSVR		20	V20130429-09_FTMSms2hcd	42.554	578	597	40.0	5.8e-15	5.6e-18	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	1251.1396	2	2.5	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-09_FTMSms2hcd	70.892	487	508	48.6	1.6e-14	2.3e-17	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	640.3462	3	0.41	TGISDVFAKNDLAVVDVR	TGISDVFAKNDLAVVDVR		18	V20130429-09_FTMSms2hcd	52.307	325	342	42.5	7.9e-12	1.5e-14	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	722.8978	2	-1.6	ATFIKVPQNQNGK	ATFIKVPQNQNGK		13	V20130429-09_FTMSms2hcd	25.087	509	521	41.2	2.4e-11	4.7e-14	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	674.8571	4	0.86	KQKVEGTEPTTAFNLFVGNLNFNK	KQKVEGTEPTTAFNLFVGNLNFNK		24	V20130429-09_FTMSms2hcd	58.615	295	318	31.4	2.3e-7	4.5e-10	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	469.2535	2	0.85	TGISDVFAK	TGISDVFAK		9	V20130429-09_FTMSms2hcd	35.378	325	333	29.4	2.6e-7	5.1e-10	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	699.3248	2	-0.54	TEADAEKTFEEK	TEADAEKTFEEK		12	V20130429-09_FTMSms2hcd	18.406	438	449	24.9	1.1e-6	1.4e-9	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	589.7888	2	1.3	EVFEDAAEIR	EVFEDAAEIR		10	V20130429-09_FTMSms2hcd	33.276	411	420	31.8	7.1e-6	1.1e-8	1	76615.0	HUMAN	Nucleolin
[19]		P19338	NUCL_HUMAN	NCL	10	19.7	8.51	3.7e-15	406.7350	2	0.30	LELQGPR	LELQGPR		7	V20130429-09_FTMSms2hcd	22.098	555	561	29.1	0.0018	6.9e-6	1	76615.0	HUMAN	Nucleolin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	858.4057	3	0.40	ADKDYHFKVDNDENEHQLSLR	ADKDYHFKVDNDENEHQLSLR		21	V20130429-09_FTMSms2hcd	29.101	25	45	61.4	3.0e-18	3.0e-21	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	1122.1157	2	6.1	MSVQPTVSLGGFEITPPVVLR	M(Oxidation)SVQPTVSLGGFEITPPVVLR	Oxidation@81	21	V20130429-09_FTMSms2hcd	64.939	81	101	48.4	4.4e-16	1.3e-18	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	918.4269	2	4.6	MTDQEAIQDLWQWR	M(Oxidation)TDQEAIQDLWQWR	Oxidation@278	14	V20130429-09_FTMSms2hcd	57.511	278	291	56.6	3.8e-12	4.1e-15	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	918.7300	4	-6.0	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-09_FTMSms2hcd	62.577	46	80	42.5	3.9e-11	9.6e-14	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	655.3160	3	0.19	MTDQEAIQDLWQWRK	M(Oxidation)TDQEAIQDLWQWRK	Oxidation@278	15	V20130429-09_FTMSms2hcd	49.948	278	292	39.9	6.4e-11	6.8e-14	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	982.4941	3	4.0	TVSLGAGAKDELHIVEAEAMNYEGSPIK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIK	Oxidation@65	28	V20130429-09_FTMSms2hcd	53.447	46	73	41.8	1.2e-10	1.5e-13	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	565.8061	2	-0.23	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-09_FTMSms2hcd	15.180	240	250	33.9	4.6e-8	7.9e-11	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	373.2448	2	0.68	VTLATLK	VTLATLK		7	V20130429-09_FTMSms2hcd	27.081	74	80	24.9	2.9e-4	1.8e-6	1	32575.3	HUMAN	Nucleophosmin
[20]		P06748	NPM_HUMAN	NPM1	9	37.1	10.18	3.0e-18	392.2230	2	-1.6	FINYVK	FINYVK		6	V20130429-09_FTMSms2hcd	24.859	268	273	21.2	3.1e-4	1.3e-6	1	32575.3	HUMAN	Nucleophosmin
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	715.5846	4	-0.81	GFGFVTFSSMAEVDAAMAARPHSIDGR	GFGFVTFSSM(Oxidation)AEVDAAM(Oxidation)AARPHSIDGR	Oxidation@72;Oxidation@79	27	V20130429-09_FTMSms2hcd	51.763	63	89	39.5	1.5e-13	1.3e-16	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	565.9279	3	2.5	GFGFVTFDDHDPVDK	GFGFVTFDDHDPVDK		15	V20130429-09_FTMSms2hcd	46.807	154	168	26.4	6.0e-13	7.2e-16	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	956.4663	3	-1.5	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-09_FTMSms2hcd	69.431	23	46	43.6	1.1e-12	1.2e-15	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	705.8473	2	0.026	YHTINGHNAEVR	YHTINGHNAEVR		12	V20130429-09_FTMSms2hcd	12.661	174	185	40.0	2.1e-10	2.6e-13	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	689.3188	2	0.64	GGGGNFGPGPGSNFR	GGGGNFGPGPGSNFR		15	V20130429-09_FTMSms2hcd	27.131	214	228	38.0	5.1e-9	6.9e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	611.2803	2	0.41	QEMQEVQSSR	QEMQEVQSSR		10	V20130429-09_FTMSms2hcd	11.632	191	200	36.5	3.1e-8	5.3e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	570.0444	4	0.33	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-09_FTMSms2hcd	55.307	154	173	34.0	2.6e-7	3.3e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	529.2983	2	0.49	TLETVPLER	TLETVPLER		9	V20130429-09_FTMSms2hcd	30.329	4	12	33.9	8.6e-7	1.9e-9	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[21]		P22626	ROA2_HUMAN	HNRNPA2B1	9	36.0	7.65	1.5e-13	507.2246	2	-1.6	GGNFGFGDSR	GGNFGFGDSR		10	V20130429-09_FTMSms2hcd	25.736	204	213	21.4	1.0e-5	2.3e-8	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	715.3639	2	1.6	AFGPGLQGGSAGSPAR	AFGPGLQGGSAGSPAR		16	V20130429-09_FTMSms2hcd	26.589	1072	1087	52.4	1.5e-12	2.2e-15	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	767.3893	2	1.1	AEAGVPAEFSIWTR	AEAGVPAEFSIWTR		14	V20130429-09_FTMSms2hcd	52.333	2251	2264	39.4	3.2e-10	4.3e-13	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	1151.2861	4	-10	EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK	EAM(Oxidation)QQADDWLGIPQVITPEEIVDPNVDEHSVM(Oxidation)TYLSQFPK	Oxidation@229;Oxidation@258	40	V20130429-09_FTMSms2hcd	76.462	227	266	20.2	8.4e-10	1.1e-12	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	823.9461	2	6.1	TGVAVNKPAEFTVDAK	TGVAVNKPAEFTVDAK		16	V20130429-09_FTMSms2hcd	30.815	685	700	35.6	2.7e-9	4.9e-12	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	543.3168	2	2.0	LYSVSYLLK	LYSVSYLLK		9	V20130429-09_FTMSms2hcd	47.311	2613	2621	31.1	2.5e-8	5.6e-11	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	643.3673	2	0.80	LPQLPITNFSR	LPQLPITNFSR		11	V20130429-09_FTMSms2hcd	49.703	180	190	37.0	3.8e-8	9.8e-11	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	717.8657	2	1.2	ANLPQSFQVDTSK	ANLPQSFQVDTSK		13	V20130429-09_FTMSms2hcd	33.395	1465	1477	45.3	8.4e-8	1.1e-10	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	533.2757	2	4.1	LSPFMADIR	LSPFM(Oxidation)ADIR	Oxidation@660	9	V20130429-09_FTMSms2hcd	36.252	656	664	23.4	1.1e-6	2.0e-9	1	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	486.2874	2	0.25	LLGWIQNK	LLGWIQNK		8	V20130429-09_FTMSms2hcd	39.702	172	179	25.8	5.5e-5	1.4e-7	3	280741.3	HUMAN	Filamin-A
[22]		P21333	FLNA_HUMAN	FLNA	10	5.6	7.10	1.5e-12	460.5596	3	-7.3	YGGPYHIGGSPFK	YGGPYHIGGSPFK		13	V20130429-09_FTMSms2hcd	33.759	2501	2513	12.7	8.3e-5	1.1e-7	1	280741.3	HUMAN	Filamin-A
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	594.8228	2	0.99	GPGLSQAFVGQK	GPGLSQAFVGQK		12	V20130429-09_FTMSms2hcd	31.045	2642	2653	34.9	2.7e-11	4.0e-14	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	555.3015	2	0.70	IHALPTGDASK	IHALPTGDASK		11	V20130429-09_FTMSms2hcd	16.973	1628	1638	28.1	6.5e-9	1.2e-11	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	461.6333	3	9.0	LIALLEVLSQKR	LIALLEVLSQKR		12	V20130429-09_FTMSms2hcd	59.305	70	81	41.6	6.9e-9	2.1e-10	2	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	627.8247	2	-1.2	LEPGGGAEAQAVR	LEPGGGAEAQAVR		13	V20130429-09_FTMSms2hcd	19.188	1015	1027	39.5	1.2e-8	1.8e-11	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	1162.5624	2	-0.79	VEESTQVGGDPFPAVFGDFLGR	VEESTQVGGDPFPAVFGDFLGR		22	V20130429-09_FTMSms2hcd	70.810	2207	2228	26.9	8.2e-8	8.3e-11	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	487.2484	2	1.2	CSGPGLGAGVR	CSGPGLGAGVR		11	V20130429-09_FTMSms2hcd	20.373	1448	1458	21.3	1.2e-5	2.3e-8	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	676.6838	3	3.5	VPQLPITNFNRDWQDGK	VPQLPITNFNRDWQDGK		17	V20130429-09_FTMSms2hcd	48.717	173	189	17.1	2.3e-5	3.1e-8	1	291024.6	HUMAN	Filamin-C
[22-1]	7	Q14315	FLNC_HUMAN	FLNC	8	3.9	6.43	2.7e-11	486.2874	2	0.25	LLGWIQNK	LLGWIQNK		8	V20130429-09_FTMSms2hcd	39.702	165	172	25.8	5.5e-5	1.4e-7	3	291024.6	HUMAN	Filamin-C
[22-2]	1	O75369	FLNB_HUMAN	FLNB	2	0.8	5.13	6.9e-9	461.6333	3	9.0	LIALLEVLSQKR	LIALLEVLSQKR		12	V20130429-09_FTMSms2hcd	59.305	50	61	41.6	6.9e-9	2.1e-10	2	278166.3	HUMAN	Filamin-B
[22-2]	1	O75369	FLNB_HUMAN	FLNB	2	0.8	5.13	6.9e-9	486.2874	2	0.25	LLGWIQNK	LLGWIQNK		8	V20130429-09_FTMSms2hcd	39.702	145	152	25.8	5.5e-5	1.4e-7	3	278166.3	HUMAN	Filamin-B
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13890.3	HUMAN	Histone H2B type 1-K
[23]		O60814	H2B1K_HUMAN	HIST1H2BK	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13890.3	HUMAN	Histone H2B type 1-K
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13944.3	HUMAN	Histone H2B type F-S
[23-1]	0	P57053	H2BFS_HUMAN	H2BFS	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13944.3	HUMAN	Histone H2B type F-S
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13936.3	HUMAN	Histone H2B type 1-D
[23-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13936.3	HUMAN	Histone H2B type 1-D
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13920.3	HUMAN	Histone H2B type 2-F
[23-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13920.3	HUMAN	Histone H2B type 2-F
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13892.2	HUMAN	Histone H2B type 1-H
[23-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13892.2	HUMAN	Histone H2B type 1-H
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13922.3	HUMAN	Histone H2B type 1-N
[23-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13922.3	HUMAN	Histone H2B type 1-N
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13989.4	HUMAN	Histone H2B type 1-M
[23-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13989.4	HUMAN	Histone H2B type 1-M
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	633.3242	2	-0.085	KESYSVYVYK	KESYSVYVYK		10	V20130429-09_FTMSms2hcd	25.604	35	44	39.3	4.3e-10	5.1e-13	9	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	569.2775	2	1.3	ESYSVYVYK	ESYSVYVYK		9	V20130429-09_FTMSms2hcd	30.539	36	44	19.6	1.8e-6	2.7e-9	9	13952.3	HUMAN	Histone H2B type 1-L
[23-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	8	38.1	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13952.3	HUMAN	Histone H2B type 1-L
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13904.3	HUMAN	Histone H2B type 1-J
[23-9]	1	P06899	H2B1J_HUMAN	HIST1H2BJ	7	39.7	8.88	7.9e-16	761.8960	2	-3.5	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-09_FTMSms2hcd	25.656	33	44	12.2	0.050	6.4e-5	6	13904.3	HUMAN	Histone H2B type 1-J
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13906.3	HUMAN	Histone H2B type 1-O
[23-10]	1	P23527	H2B1O_HUMAN	HIST1H2BO	7	39.7	8.88	7.9e-16	761.8960	2	-3.5	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-09_FTMSms2hcd	25.656	33	44	12.2	0.050	6.4e-5	6	13906.3	HUMAN	Histone H2B type 1-O
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13950.3	HUMAN	Histone H2B type 1-B
[23-11]	1	P33778	H2B1B_HUMAN	HIST1H2BB	7	39.7	8.88	7.9e-16	761.8960	2	-3.5	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-09_FTMSms2hcd	25.656	33	44	12.2	0.050	6.4e-5	6	13950.3	HUMAN	Histone H2B type 1-B
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13920.3	HUMAN	Histone H2B type 2-E
[23-12]	1	Q16778	H2B2E_HUMAN	HIST2H2BE	7	39.7	8.88	7.9e-16	761.8960	2	-3.5	SRKESYSIYVYK	SRKESYSIYVYK		12	V20130429-09_FTMSms2hcd	25.656	33	44	12.2	0.050	6.4e-5	6	13920.3	HUMAN	Histone H2B type 2-E
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	880.4101	2	-0.73	AMGIMNSFVNDIFER	AM(Oxidation)GIMNSFVNDIFER	Oxidation@60=67	15	V20130429-09_FTMSms2hcd	64.203	59	73	53.5	7.9e-16	8.7e-19	14	13908.2	HUMAN	Histone H2B type 3-B
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	880.4097	2	-1.2	AMGIMNSFVNDIFER	AMGIM(Oxidation)NSFVNDIFER	Oxidation@63=42	15	V20130429-09_FTMSms2hcd	58.999	59	73	40.0	2.8e-14	3.1e-17	14	13908.2	HUMAN	Histone H2B type 3-B
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	888.4155	2	8.2	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-09_FTMSms2hcd	54.915	59	73	50.8	5.0e-13	5.1e-16	14	13908.2	HUMAN	Histone H2B type 3-B
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	45	58	49.8	3.0e-10	7.5e-13	15	13908.2	HUMAN	Histone H2B type 3-B
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-09_FTMSms2hcd	18.935	48	58	32.5	7.4e-7	1.1e-9	15	13908.2	HUMAN	Histone H2B type 3-B
[23-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	6	30.2	8.88	7.9e-16	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	101	109	31.9	1.3e-5	1.6e-7	15	13908.2	HUMAN	Histone H2B type 3-B
[23-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	5.86	3.0e-10	754.9200	2	-6.9	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-09_FTMSms2hcd	17.752	46	59	49.8	3.0e-10	7.5e-13	15	14167.6	HUMAN	Histone H2B type 1-A
[23-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	5.86	3.0e-10	576.2889	2	1.2	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@49	11	V20130429-09_FTMSms2hcd	18.935	49	59	32.5	7.4e-7	1.1e-9	15	14167.6	HUMAN	Histone H2B type 1-A
[23-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	18.1	5.86	3.0e-10	477.3055	2	0.76	LLLPGELAK	LLLPGELAK		9	V20130429-09_FTMSms2hcd	41.165	102	110	31.9	1.3e-5	1.6e-7	15	14167.6	HUMAN	Histone H2B type 1-A
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	548.6134	3	1.3	AQLGGPEAAKSDETAAK	AQLGGPEAAKSDETAAK		17	V20130429-09_FTMSms2hcd	15.652	189	205	48.9	9.7e-14	1.2e-16	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	953.4999	2	0.47	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-09_FTMSms2hcd	48.598	172	188	54.1	7.5e-13	1.1e-15	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	892.4675	2	2.9	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-09_FTMSms2hcd	46.700	97	112	42.6	8.8e-12	1.3e-14	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	849.4426	2	-2.2	TKDGVVEITGKHEER	TKDGVVEITGKHEER		15	V20130429-09_FTMSms2hcd	14.901	113	127	37.8	1.9e-10	2.6e-13	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	476.4724	4	0.38	GPSWDPFRDWYPHSR	GPSWDPFRDWYPHSR		15	V20130429-09_FTMSms2hcd	51.412	13	27	25.1	3.0e-7	3.3e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	569.7620	2	2.4	QLSSGVSEIR	Q(Gln->pyro-Glu)LS(Phospho)SGVSEIR	Gln->pyro-Glu@80;Phospho@82=15	10	V20130429-09_FTMSms2hcd	40.185	80	89	25.3	4.7e-7	6.6e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	578.2746	2	1.2	QLSSGVSEIR	QLS(Phospho)SGVSEIR	Phospho@82|83	10	V20130429-09_FTMSms2hcd	27.838	80	89	23.0	1.2e-6	1.7e-9	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	538.2912	2	0.85	QLSSGVSEIR	QLSSGVSEIR		10	V20130429-09_FTMSms2hcd	23.257	80	89	25.3	3.6e-6	5.7e-9	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	9	47.8	7.75	9.7e-14	494.3089	2	0.72	RVPFSLLR	RVPFSLLR		8	V20130429-09_FTMSms2hcd	38.788	5	12	31.2	5.6e-5	3.4e-7	1	22782.7	HUMAN	Heat shock protein beta-1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	847.8530	2	-0.81	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-09_FTMSms2hcd	12.295	353	370	60.6	8.7e-20	1.3e-22	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	814.8943	2	-0.16	SSGPYGGGGQYFAKPR	SSGPYGGGGQYFAKPR		16	V20130429-09_FTMSms2hcd	25.401	337	352	56.8	9.2e-14	1.0e-16	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	591.4923	5	2.1	GFGFVTYATVEEVDAAMNARPHKVDGR	GFGFVTYATVEEVDAAM(Oxidation)NARPHKVDGR	Oxidation@72	27	V20130429-09_FTMSms2hcd	48.769	56	82	41.4	8.2e-13	8.2e-16	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	650.3306	2	0.0024	SESPKEPEQLR	SESPKEPEQLR		11	V20130429-09_FTMSms2hcd	15.471	4	14	50.7	1.9e-9	2.7e-12	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	761.0636	3	12	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-09_FTMSms2hcd	52.466	147	166	29.0	6.4e-9	1.0e-11	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	714.3785	2	0.59	SESPKEPEQLRK	SESPKEPEQLRK		12	V20130429-09_FTMSms2hcd	12.597	4	15	43.3	9.4e-9	1.4e-11	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25]		P09651	ROA1_HUMAN	HNRNPA1	7	28.5	11.01	8.7e-20	479.9197	3	0.056	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-09_FTMSms2hcd	14.676	93	105	30.9	1.4e-7	1.8e-10	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[25-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	10.3	4.24	6.4e-9	761.0636	3	12	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-09_FTMSms2hcd	52.466	147	166	29.0	6.4e-9	1.0e-11	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[25-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	10.3	4.24	6.4e-9	479.9197	3	0.056	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-09_FTMSms2hcd	14.676	93	105	30.9	1.4e-7	1.8e-10	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	890.9035	2	0.74	TDYNASVSVPDSSGPER	TDYNASVSVPDSSGPER		17	V20130429-09_FTMSms2hcd	27.949	70	86	50.5	8.5e-16	1.0e-18	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	506.9835	3	-0.45	LLIHQSLAGGIIGVK	LLIHQSLAGGIIGVK		15	V20130429-09_FTMSms2hcd	45.466	149	163	44.0	3.5e-12	1.1e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	863.8114	3	12	IITITGTQDQIQNAQYLLQNSVK	IITITGTQDQIQNAQYLLQNSVK		23	V20130429-09_FTMSms2hcd	59.279	434	456	40.0	3.7e-11	1.5e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	615.0316	3	0.86	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-09_FTMSms2hcd	70.987	87	103	41.6	6.4e-11	7.5e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	959.0232	2	3.3	GSYGDLGGPIITTQVTIPK	GSYGDLGGPIITTQVTIPK		19	V20130429-09_FTMSms2hcd	50.844	378	396	29.9	1.1e-8	2.7e-11	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	518.6476	3	1.4	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-09_FTMSms2hcd	51.565	208	221	44.8	9.3e-8	7.8e-10	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[26]		P61978	HNRPK_HUMAN	HNRNPK	7	22.7	8.86	8.5e-16	670.9060	2	0.88	IILDLISESPIK	IILDLISESPIK		12	V20130429-09_FTMSms2hcd	58.495	208	219	44.9	5.7e-7	2.9e-9	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	675.0191	3	2.2	ITLPVDFVTADKFDENAK	ITLPVDFVTADKFDENAK		18	V20130429-09_FTMSms2hcd	54.096	280	297	45.1	2.7e-14	3.7e-17	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	545.6022	3	-0.060	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-09_FTMSms2hcd	37.055	157	171	45.0	3.1e-13	3.6e-16	2	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	856.4634	2	2.1	ACANPAAGSVILLENLR	ACANPAAGSVILLENLR		17	V20130429-09_FTMSms2hcd	57.576	107	123	35.8	3.3e-11	6.9e-14	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	1124.5864	3	1.0	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-09_FTMSms2hcd	64.032	217	246	33.9	4.8e-9	9.7e-12	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	885.0024	2	1.1	ALESPERPFLAILGGAK	ALESPERPFLAILGGAK		17	V20130429-09_FTMSms2hcd	55.889	200	216	45.9	2.3e-7	9.1e-10	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	539.3148	3	2.1	MSLSNKLTLDKLDVK	M(Met-loss+Acetyl)SLSNKLTLDKLDVK	Met-loss+Acetyl@1	15	V20130429-09_FTMSms2hcd	43.055	1	15	33.4	3.3e-7	1.6e-9	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	566.3118	2	0.56	AEPAKIEAFR	AEPAKIEAFR		10	V20130429-09_FTMSms2hcd	23.860	142	151	31.8	7.2e-5	1.1e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27]		P00558	PGK1_HUMAN	PGK1	8	31.9	8.05	2.7e-14	549.3137	2	0.020	VLPGVDALSNI	VLPGVDALSNI		11	V20130429-09_FTMSms2hcd	55.451	407	417	14.8	1.4e-4	4.7e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[27-1]	0	P07205	PGK2_HUMAN	PGK2	1	3.6	7.47	3.1e-13	545.6022	3	-0.060	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-09_FTMSms2hcd	37.055	157	171	45.0	3.1e-13	3.6e-16	2	44796.5	HUMAN	Phosphoglycerate kinase 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	715.0312	3	0.57	ARPFPDGLAEDIDKGEVSAR	ARPFPDGLAEDIDKGEVSAR		20	V20130429-09_FTMSms2hcd	41.068	606	625	50.0	6.1e-15	7.1e-18	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	785.0856	3	10	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-09_FTMSms2hcd	68.276	668	688	45.1	5.7e-11	1.1e-13	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	901.4799	3	5.2	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-09_FTMSms2hcd	74.969	457	481	38.5	7.1e-10	1.5e-12	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	554.3234	2	-1.2	VFSGLVSTGLK	VFSGLVSTGLK		11	V20130429-09_FTMSms2hcd	39.962	416	426	38.8	8.0e-9	3.3e-11	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	485.2774	2	-0.084	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-09_FTMSms2hcd	23.025	717	726	29.5	1.9e-7	6.1e-10	2	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	546.2963	2	0.86	MVNFTVDQIR	M(Met-loss)VNFTVDQIR	Met-loss@1	10	V20130429-09_FTMSms2hcd	35.471	1	10	36.0	3.1e-7	5.4e-10	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	722.8884	2	0.90	EGIPALDNFLDKL	EGIPALDNFLDKL		13	V20130429-09_FTMSms2hcd	71.699	846	858	38.0	9.5e-7	1.7e-9	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	8	13.8	8.39	6.1e-15	461.7357	2	1.4	SDPVVSYR	SDPVVSYR		8	V20130429-09_FTMSms2hcd	19.659	573	580	15.3	1.9e-4	3.7e-7	1	95339.0	HUMAN	Elongation factor 2
[28-1]	0	Q15029	U5S1_HUMAN	EFTUD2	1	1.0	3.31	1.9e-7	485.2774	2	-0.084	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-09_FTMSms2hcd	23.025	804	813	29.5	1.9e-7	6.1e-10	2	109436.7	HUMAN	116 kDa U5 small nuclear ribonucleoprotein component
[29]		P62158	CALM_HUMAN	CALM1	5	56.4	9.64	3.0e-17	1130.5471	3	-0.11	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-09_FTMSms2hcd	72.784	1	31	52.4	3.0e-17	3.2e-20	1	16837.7	HUMAN	Calmodulin
[29]		P62158	CALM_HUMAN	CALM1	5	56.4	9.64	3.0e-17	877.9410	2	2.2	VFDKDGNGYISAAELR	VFDKDGNGYISAAELR		16	V20130429-09_FTMSms2hcd	36.577	92	107	61.7	5.5e-16	6.2e-19	1	16837.7	HUMAN	Calmodulin
[29]		P62158	CALM_HUMAN	CALM1	5	56.4	9.64	3.0e-17	782.3812	2	0.91	MADQLTEEQIAEFK	M(Met-loss+Acetyl)ADQLTEEQIAEFK	Met-loss+Acetyl@1	14	V20130429-09_FTMSms2hcd	48.348	1	14	49.5	1.6e-11	2.0e-14	1	16837.7	HUMAN	Calmodulin
[29]		P62158	CALM_HUMAN	CALM1	5	56.4	9.64	3.0e-17	1030.2191	4	5.7	SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR	SLGQNPTEAELQDM(Oxidation)INEVDADGNGTIDFPEFLTM(Oxidation)M(Oxidation)AR	Oxidation@52;Oxidation@72;Oxidation@73	37	V20130429-09_FTMSms2hcd	67.763	39	75	32.9	2.8e-11	3.3e-14	1	16837.7	HUMAN	Calmodulin
[29]		P62158	CALM_HUMAN	CALM1	5	56.4	9.64	3.0e-17	615.6364	3	1.8	EAFSLFDKDGDGTITTK	EAFSLFDKDGDGTITTK		17	V20130429-09_FTMSms2hcd	42.581	15	31	37.8	9.5e-11	1.0e-13	1	16837.7	HUMAN	Calmodulin
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	482.3015	3	0.92	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-09_FTMSms2hcd	44.996	18	30	38.7	1.6e-12	3.0e-14	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	658.9011	2	0.97	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-09_FTMSms2hcd	51.604	18	29	35.7	6.5e-11	6.2e-13	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	665.3336	2	0.99	GFAFVQYVNER	GFAFVQYVNER		11	V20130429-09_FTMSms2hcd	46.436	51	61	39.0	1.0e-8	1.6e-11	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	849.9633	2	5.8	MIAGQVLDINLAAEPK	M(Oxidation)IAGQVLDINLAAEPK	Oxidation@74	16	V20130429-09_FTMSms2hcd	48.795	74	89	19.6	1.3e-7	3.1e-10	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	562.3058	2	4.4	KSDVEAIFSK	KSDVEAIFSK		10	V20130429-09_FTMSms2hcd	29.958	30	39	39.5	6.5e-7	1.1e-9	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	410.2471	3	0.64	LKGDDLQAIKK	LKGDDLQAIKK		11	V20130429-09_FTMSms2hcd	18.315	188	198	36.8	1.5e-6	6.6e-9	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	622.8160	2	1.4	MASNVTNKTDPR	M(Met-loss+Acetyl)ASNVTNKTDPR	Met-loss+Acetyl@1	12	V20130429-09_FTMSms2hcd	15.301	1	12	30.4	1.7e-6	2.3e-9	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30]		P07910	HNRPC_HUMAN	HNRNPC	8	26.5	7.04	1.6e-12	472.2897	2	-0.25	VPPPPPIAR	VPPPPPIAR		9	V20130429-09_FTMSms2hcd	24.056	143	151	25.0	6.9e-6	1.9e-8	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.04	1.6e-12	482.3015	3	0.92	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-09_FTMSms2hcd	44.996	18	30	38.7	1.6e-12	3.0e-14	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.04	1.6e-12	658.9011	2	0.97	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-09_FTMSms2hcd	51.604	18	29	35.7	6.5e-11	6.2e-13	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[30-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	3	7.5	7.04	1.6e-12	562.3058	2	4.4	KSDVEAIFSK	KSDVEAIFSK		10	V20130429-09_FTMSms2hcd	29.958	30	39	39.5	6.5e-7	1.1e-9	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	872.1165	3	1.2	VDKGVVPLAGTNGETTTQGLDGLSER	VDKGVVPLAGTNGETTTQGLDGLSER		26	V20130429-09_FTMSms2hcd	41.184	109	134	43.1	2.3e-12	3.5e-15	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	708.3696	3	1.4	IGEHTPSALAIMENANVLAR	IGEHTPSALAIM(Oxidation)ENANVLAR	Oxidation@165	20	V20130429-09_FTMSms2hcd	41.197	154	173	36.1	2.5e-9	3.5e-12	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	666.8547	2	1.2	GILAADESTGSIAK	GILAADESTGSIAK		14	V20130429-09_FTMSms2hcd	30.483	29	42	38.4	2.2e-8	3.1e-11	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	823.9106	2	2.8	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-09_FTMSms2hcd	16.468	44	57	49.1	9.9e-8	1.2e-10	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	671.8609	2	2.3	ADDGRPFPQVIK	ADDGRPFPQVIK		12	V20130429-09_FTMSms2hcd	31.575	88	99	30.0	1.4e-6	2.3e-9	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	470.7459	2	-0.16	ELSDIAHR	ELSDIAHR		8	V20130429-09_FTMSms2hcd	16.519	15	22	22.1	2.4e-5	4.7e-8	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	382.2393	2	0.094	VLAAVYK	VLAAVYK		7	V20130429-09_FTMSms2hcd	22.138	209	215	23.4	2.5e-5	1.2e-7	3	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31]		P04075	ALDOA_HUMAN	ALDOA	8	28.0	7.01	2.3e-12	601.6403	3	-2.2	RLQSIGTENTEENRR	RLQSIGTENTEENRR		15	V20130429-09_FTMSms2hcd	14.888	43	57	16.2	3.5e-4	4.4e-7	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[31-1]	0	P05062	ALDOB_HUMAN	ALDOB	1	1.9	1.54	2.5e-5	382.2393	2	0.094	VLAAVYK	VLAAVYK		7	V20130429-09_FTMSms2hcd	22.138	209	215	23.4	2.5e-5	1.2e-7	3	39473.4	HUMAN	Fructose-bisphosphate aldolase B
[31-2]	0	P09972	ALDOC_HUMAN	ALDOC	1	1.9	1.54	2.5e-5	382.2393	2	0.094	VLAAVYK	VLAAVYK		7	V20130429-09_FTMSms2hcd	22.138	209	215	23.4	2.5e-5	1.2e-7	3	39456.2	HUMAN	Fructose-bisphosphate aldolase C
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	787.9715	2	13	MATLKDQLIYNLLK	M(Met-loss+Acetyl)ATLKDQLIYNLLK	Met-loss+Acetyl@1	14	V20130429-09_FTMSms2hcd	63.845	1	14	38.4	4.4e-13	6.1e-15	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	955.1750	3	-5.9	GLYGIKDDVFLSVPCILGQNGISDLVK	GLYGIKDDVFLSVPCILGQNGISDLVK		27	V20130429-09_FTMSms2hcd	74.913	279	305	29.6	4.5e-10	1.1e-12	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	748.3912	2	0.017	IVSGKDYNVTANSK	IVSGKDYNVTANSK		14	V20130429-09_FTMSms2hcd	17.512	77	90	46.7	1.3e-9	1.9e-12	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	567.7855	2	0.013	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-09_FTMSms2hcd	19.270	306	315	43.8	6.9e-9	1.0e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	465.2949	2	0.71	FIIPNVVK	FIIPNVVK		8	V20130429-09_FTMSms2hcd	44.957	119	126	28.7	3.7e-7	1.5e-9	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	457.2961	2	2.2	LVIITAGAR	LVIITAGAR		9	V20130429-09_FTMSms2hcd	31.298	91	99	35.5	1.1e-5	5.8e-8	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32]		P00338	LDHA_HUMAN	LDHA	7	26.5	7.39	4.4e-13	371.7322	2	0.17	LNLVQR	LNLVQR		6	V20130429-09_FTMSms2hcd	21.758	107	112	25.6	0.059	2.2e-4	3	36689.1	HUMAN	L-lactate dehydrogenase A chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	755.8899	2	-1.5	IVADKDYSVTANSK	IVADKDYSVTANSK		14	V20130429-09_FTMSms2hcd	19.214	78	91	57.5	1.5e-11	2.0e-14	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	847.9532	2	1.9	LIAPVAEEEATVPNNK	LIAPVAEEEATVPNNK		16	V20130429-09_FTMSms2hcd	34.328	8	23	32.0	8.0e-10	1.4e-12	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	643.8690	2	-0.56	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-09_FTMSms2hcd	17.740	309	319	40.1	1.1e-7	2.5e-10	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	588.7991	2	1.2	SADTLWDIQK	SADTLWDIQK		10	V20130429-09_FTMSms2hcd	38.801	320	329	25.6	6.2e-7	8.9e-10	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	587.6508	3	18	SADTLWDIQKDLKDL	SADTLWDIQKDLKDL		15	V20130429-09_FTMSms2hcd	62.430	320	334	11.7	0.0015	2.7e-6	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	511.6037	3	0.68	SADTLWDIQKDLK	SADTLWDIQKDLK		13	V20130429-09_FTMSms2hcd	46.926	320	332	14.0	0.021	3.1e-5	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[32-1]	6	P07195	LDHB_HUMAN	LDHB	7	18.6	6.56	1.5e-11	371.7322	2	0.17	LNLVQR	LNLVQR		6	V20130429-09_FTMSms2hcd	21.758	108	113	25.6	0.059	2.2e-4	3	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.32	6.0e-13	669.3679	2	2.5	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-09_FTMSms2hcd	49.118	1	12	48.9	6.0e-13	1.2e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[33]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.32	6.0e-13	942.4805	2	2.1	FQDGDLTLYQSNTILR	FQDGDLTLYQSNTILR		16	V20130429-09_FTMSms2hcd	49.105	56	71	48.9	2.6e-12	3.5e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[33]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.32	6.0e-13	1016.5310	2	2.4	AFLASPEYVNLPINGNGKQ	AFLASPEYVNLPINGNGKQ		19	V20130429-09_FTMSms2hcd	51.221	192	210	43.7	3.7e-12	5.4e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[33]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.32	6.0e-13	1003.1623	3	0.21	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-09_FTMSms2hcd	57.417	20	45	40.2	5.7e-10	6.1e-13	1	23356.0	HUMAN	Glutathione S-transferase P
[33]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.32	6.0e-13	709.3975	3	8.2	ALPGQLKPFETLLSQNQGGK	ALPGQLKPFETLLSQNQGGK		20	V20130429-09_FTMSms2hcd	53.342	122	141	48.1	9.4e-10	3.7e-12	1	23356.0	HUMAN	Glutathione S-transferase P
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	773.8495	2	0.18	AAHSEGNTTAGLDMR	AAHSEGNTTAGLDM(Oxidation)R	Oxidation@480	15	V20130429-09_FTMSms2hcd	12.115	467	481	34.9	4.0e-13	5.3e-16	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	759.4585	2	11	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-09_FTMSms2hcd	67.522	26	40	39.7	1.4e-12	1.7e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	681.0289	3	11	LGGSLADSYLDEGFLLDKK	LGGSLADSYLDEGFLLDKK		19	V20130429-09_FTMSms2hcd	54.631	205	223	43.0	1.3e-11	2.2e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	651.3770	2	0.28	MASLSLAPVNIFK	M(Met-loss+Acetyl)ASLSLAPVNIFK	Met-loss+Acetyl@1	13	V20130429-09_FTMSms2hcd	65.584	1	13	30.9	8.6e-8	2.3e-10	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	665.8345	2	1.5	GATQQILDEAER	GATQQILDEAER		12	V20130429-09_FTMSms2hcd	31.957	377	388	48.6	7.8e-7	1.1e-9	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[34]		P78371	TCPB_HUMAN	CCT2	6	15.3	7.41	4.0e-13	435.7743	2	0.68	LAVEAVLR	LAVEAVLR		8	V20130429-09_FTMSms2hcd	36.360	182	189	38.5	0.0015	8.0e-6	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	947.9819	2	-0.72	MASGVAVSDGVIKVFNDMK	M(Met-loss+Acetyl)ASGVAVSDGVIKVFNDM(Oxidation)K	Met-loss+Acetyl@1;Oxidation@18	19	V20130429-09_FTMSms2hcd	51.485	1	19	45.3	5.5e-15	6.7e-18	1	18502.7	HUMAN	Cofilin-1
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	669.3174	2	1.2	YALYDATYETK	YALYDATYETK		11	V20130429-09_FTMSms2hcd	32.440	82	92	40.0	8.1e-11	1.2e-13	2	18502.7	HUMAN	Cofilin-1
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	670.8937	2	1.3	LGGSAVISLEGKPL	LGGSAVISLEGKPL		14	V20130429-09_FTMSms2hcd	46.170	153	166	37.1	1.5e-8	6.4e-11	1	18502.7	HUMAN	Cofilin-1
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	572.8144	2	0.61	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-09_FTMSms2hcd	35.538	1	13	37.9	2.0e-7	3.5e-10	1	18502.7	HUMAN	Cofilin-1
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	584.3223	4	13	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-09_FTMSms2hcd	61.327	93	112	31.3	2.9e-7	8.4e-10	2	18502.7	HUMAN	Cofilin-1
[35]		P23528	COF1_HUMAN	CFL1	6	38.6	8.42	5.5e-15	664.0282	3	0.81	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-09_FTMSms2hcd	65.636	96	112	23.1	2.3e-5	4.9e-8	2	18502.7	HUMAN	Cofilin-1
[35-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	6.17	8.1e-11	669.3174	2	1.2	YALYDATYETK	YALYDATYETK		11	V20130429-09_FTMSms2hcd	32.440	82	92	40.0	8.1e-11	1.2e-13	2	18736.8	HUMAN	Cofilin-2
[35-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	6.17	8.1e-11	584.3223	4	13	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-09_FTMSms2hcd	61.327	93	112	31.3	2.9e-7	8.4e-10	2	18736.8	HUMAN	Cofilin-2
[35-1]	0	Q9Y281	COF2_HUMAN	CFL2	3	18.7	6.17	8.1e-11	664.0282	3	0.81	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-09_FTMSms2hcd	65.636	96	112	23.1	2.3e-5	4.9e-8	2	18736.8	HUMAN	Cofilin-2
[36]		P35232	PHB_HUMAN	PHB	5	37.1	9.88	1.1e-17	791.0897	3	1.2	FGLALAVAGGVVNSALYNVDAGHR	FGLALAVAGGVVNSALYNVDAGHR		24	V20130429-09_FTMSms2hcd	66.588	12	35	50.0	1.1e-17	2.2e-20	1	29804.3	HUMAN	Prohibitin
[36]		P35232	PHB_HUMAN	PHB	5	37.1	9.88	1.1e-17	781.6636	4	2.5	AATFGLILDDVSLTHLTFGKEFTEAVEAK	AATFGLILDDVSLTHLTFGKEFTEAVEAK		29	V20130429-09_FTMSms2hcd	73.154	158	186	45.2	1.8e-11	3.7e-14	1	29804.3	HUMAN	Prohibitin
[36]		P35232	PHB_HUMAN	PHB	5	37.1	9.88	1.1e-17	767.4174	4	8.0	GVQDIVVGEGTHFLIPWVQKPIIFDCR	GVQDIVVGEGTHFLIPWVQKPIIFDCR		27	V20130429-09_FTMSms2hcd	72.474	44	70	35.5	1.3e-10	4.6e-13	1	29804.3	HUMAN	Prohibitin
[36]		P35232	PHB_HUMAN	PHB	5	37.1	9.88	1.1e-17	607.3744	2	1.1	VLPSITTEILK	VLPSITTEILK		11	V20130429-09_FTMSms2hcd	50.038	118	128	28.6	1.3e-7	6.7e-10	1	29804.3	HUMAN	Prohibitin
[36]		P35232	PHB_HUMAN	PHB	5	37.1	9.88	1.1e-17	575.2983	2	-0.47	FDAGELITQR	FDAGELITQR		10	V20130429-09_FTMSms2hcd	38.498	134	143	39.6	1.5e-7	2.2e-10	1	29804.3	HUMAN	Prohibitin
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.65	1.4e-13	958.0365	2	0.51	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-09_FTMSms2hcd	54.358	39	56	54.0	1.4e-13	5.7e-16	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.65	1.4e-13	822.4759	2	4.8	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-09_FTMSms2hcd	58.481	39	54	40.5	8.9e-11	3.9e-13	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.65	1.4e-13	735.8837	2	0.95	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-09_FTMSms2hcd	43.907	57	70	41.6	2.7e-10	4.0e-13	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.65	1.4e-13	445.7733	2	1.5	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-09_FTMSms2hcd	34.817	109	116	28.4	8.1e-10	4.4e-12	1	15054.4	HUMAN	Profilin-1
[37]		P07737	PROF1_HUMAN	PFN1	5	38.6	7.65	1.4e-13	690.3626	2	1.0	STGGAPTFNVTVTK	STGGAPTFNVTVTK		14	V20130429-09_FTMSms2hcd	32.901	92	105	33.2	3.8e-8	5.3e-11	1	15054.4	HUMAN	Profilin-1
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	729.0223	3	2.0	SLAGSSGPGASSGTSGDHGELVVR	SLAGSSGPGASSGTSGDHGELVVR		24	V20130429-09_FTMSms2hcd	26.747	60	83	78.8	1.9e-14	1.8e-17	1	31122.1	HUMAN	Elongation factor 1-delta
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	650.3672	2	0.33	GVVQELQQAISK	GVVQELQQAISK		12	V20130429-09_FTMSms2hcd	50.222	96	107	44.8	3.1e-8	7.0e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	687.3763	2	2.2	SIQLDGLVWGASK	SIQLDGLVWGASK		13	V20130429-09_FTMSms2hcd	52.346	220	232	39.0	5.1e-8	9.5e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	536.7750	2	0.50	MATNFLAHEK	M(Met-loss+Acetyl)ATNFLAHEK	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	32.347	1	10	39.9	5.1e-8	8.4e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	679.8684	2	1.5	IASLEVENQSLR	IASLEVENQSLR		12	V20130429-09_FTMSms2hcd	33.003	84	95	45.6	3.8e-7	6.9e-10	1	31122.1	HUMAN	Elongation factor 1-delta
[38]		P29692	EF1D_HUMAN	EEF1D	6	28.5	8.13	1.9e-14	487.2959	2	1.6	LVPVGYGIR	LVPVGYGIR		9	V20130429-09_FTMSms2hcd	33.871	233	241	25.1	8.1e-6	2.6e-8	1	31122.1	HUMAN	Elongation factor 1-delta
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	725.8624	2	0.19	TTPSVVAFTADGER	TTPSVVAFTADGER		14	V20130429-09_FTMSms2hcd	35.767	86	99	41.0	7.5e-11	9.9e-14	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	1028.4833	2	-1.2	STNGDTFLGGEDFDQALLR	STNGDTFLGGEDFDQALLR		19	V20130429-09_FTMSms2hcd	56.135	266	284	45.4	3.0e-10	3.1e-13	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	506.6191	3	-0.46	AQFEGIVTDLIRR	AQFEGIVTDLIRR		13	V20130429-09_FTMSms2hcd	52.174	349	361	44.5	4.9e-9	1.2e-11	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	645.8451	2	2.2	VQQTVQDLFGR	VQQTVQDLFGR		11	V20130429-09_FTMSms2hcd	39.187	395	405	39.5	7.1e-7	1.1e-9	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	479.7511	2	-0.32	VLENAEGAR	VLENAEGAR		9	V20130429-09_FTMSms2hcd	11.372	77	85	38.5	1.1e-5	2.0e-8	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	814.4095	3	19	KDSETGENIRQAASSLQQASLK	KDSETGENIRQAASS(Phospho)LQQASLK	Phospho@639=11	22	V20130429-09_FTMSms2hcd	46.338	625	646	14.6	0.0050	5.9e-6	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	621.8434	2	-0.44	DAGQISGLNVLR	DAGQISGLNVLR		12	V20130429-09_FTMSms2hcd	51.698	207	218	11.2	0.036	6.9e-5	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[39]		P38646	GRP75_HUMAN	HSPA9	8	14.7	6.19	7.5e-11	1221.1111	2	20	KDSETGENIRQAASSLQQASLK	KDSETGENIRQAAS(Phospho)SLQQASLK	Phospho@638|639	22	V20130429-09_FTMSms2hcd	46.369	625	646	12.1	0.052	6.2e-5	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[40]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.71	1.6e-15	887.5095	3	0.21	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-09_FTMSms2hcd	68.345	142	167	45.9	1.6e-15	1.9e-17	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[40]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.71	1.6e-15	835.4758	3	0.22	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-09_FTMSms2hcd	73.986	143	167	42.1	7.7e-15	6.1e-17	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[40]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.71	1.6e-15	520.7779	2	0.18	DGAHVVISSR	DGAHVVISSR		10	V20130429-09_FTMSms2hcd	15.099	37	46	37.2	1.3e-7	2.6e-10	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[40]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.71	1.6e-15	478.2946	2	-0.35	TLALELAPK	TLALELAPK		9	V20130429-09_FTMSms2hcd	38.195	176	184	34.0	2.2e-7	1.2e-9	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[40]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.71	1.6e-15	422.7648	2	-3.3	TALLGLTR	TALLGLTR		8	V20130429-09_FTMSms2hcd	34.729	168	175	31.0	0.0017	4.6e-6	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[41]		P07951	TPM2_HUMAN	TPM2	5	17.3	9.12	2.8e-16	551.2867	4	0.063	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-09_FTMSms2hcd	42.413	106	125	43.9	2.8e-16	3.5e-19	4	32851.0	HUMAN	Tropomyosin beta chain
[41]		P07951	TPM2_HUMAN	TPM2	5	17.3	9.12	2.8e-16	738.8445	2	0.32	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-09_FTMSms2hcd	13.712	113	125	59.8	7.5e-10	8.5e-13	4	32851.0	HUMAN	Tropomyosin beta chain
[41]		P07951	TPM2_HUMAN	TPM2	5	17.3	9.12	2.8e-16	496.9200	3	3.6	ATDAEADVASLNRR	ATDAEADVASLNRR		14	V20130429-09_FTMSms2hcd	24.489	78	91	33.4	4.6e-8	6.2e-11	2	32851.0	HUMAN	Tropomyosin beta chain
[41]		P07951	TPM2_HUMAN	TPM2	5	17.3	9.12	2.8e-16	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-09_FTMSms2hcd	37.728	92	105	36.8	1.1e-6	1.7e-9	4	32851.0	HUMAN	Tropomyosin beta chain
[41]		P07951	TPM2_HUMAN	TPM2	5	17.3	9.12	2.8e-16	539.6164	3	-0.26	KATDAEADVASLNRR	KATDAEADVASLNRR		15	V20130429-09_FTMSms2hcd	22.393	77	91	22.5	1.0e-5	1.4e-8	2	32851.0	HUMAN	Tropomyosin beta chain
[41-1]	0	P09493	TPM1_HUMAN	TPM1	5	17.3	9.12	2.8e-16	551.2867	4	0.063	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-09_FTMSms2hcd	42.413	106	125	43.9	2.8e-16	3.5e-19	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[41-1]	0	P09493	TPM1_HUMAN	TPM1	5	17.3	9.12	2.8e-16	738.8445	2	0.32	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-09_FTMSms2hcd	13.712	113	125	59.8	7.5e-10	8.5e-13	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[41-1]	0	P09493	TPM1_HUMAN	TPM1	5	17.3	9.12	2.8e-16	496.9200	3	3.6	ATDAEADVASLNRR	ATDAEADVASLNRR		14	V20130429-09_FTMSms2hcd	24.489	78	91	33.4	4.6e-8	6.2e-11	2	32708.8	HUMAN	Tropomyosin alpha-1 chain
[41-1]	0	P09493	TPM1_HUMAN	TPM1	5	17.3	9.12	2.8e-16	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-09_FTMSms2hcd	37.728	92	105	36.8	1.1e-6	1.7e-9	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[41-1]	0	P09493	TPM1_HUMAN	TPM1	5	17.3	9.12	2.8e-16	539.6164	3	-0.26	KATDAEADVASLNRR	KATDAEADVASLNRR		15	V20130429-09_FTMSms2hcd	22.393	77	91	22.5	1.0e-5	1.4e-8	2	32708.8	HUMAN	Tropomyosin alpha-1 chain
[41-2]	1	P06753	TPM3_HUMAN	TPM3	4	17.3	9.12	2.8e-16	551.2867	4	0.063	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-09_FTMSms2hcd	42.413	106	125	43.9	2.8e-16	3.5e-19	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[41-2]	1	P06753	TPM3_HUMAN	TPM3	4	17.3	9.12	2.8e-16	738.8445	2	0.32	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-09_FTMSms2hcd	13.712	113	125	59.8	7.5e-10	8.5e-13	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[41-2]	1	P06753	TPM3_HUMAN	TPM3	4	17.3	9.12	2.8e-16	454.7295	4	-1.2	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-09_FTMSms2hcd	20.255	153	167	23.6	1.6e-7	1.8e-10	2	32819.1	HUMAN	Tropomyosin alpha-3 chain
[41-2]	1	P06753	TPM3_HUMAN	TPM3	4	17.3	9.12	2.8e-16	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-09_FTMSms2hcd	37.728	92	105	36.8	1.1e-6	1.7e-9	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[41-3]	1	P67936	TPM4_HUMAN	TPM4	4	19.8	9.12	2.8e-16	551.2867	4	0.063	LATALQKLEEAEKAADESER	LATALQKLEEAEKAADESER		20	V20130429-09_FTMSms2hcd	42.413	70	89	43.9	2.8e-16	3.5e-19	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[41-3]	1	P67936	TPM4_HUMAN	TPM4	4	19.8	9.12	2.8e-16	738.8445	2	0.32	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-09_FTMSms2hcd	13.712	77	89	59.8	7.5e-10	8.5e-13	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[41-3]	1	P67936	TPM4_HUMAN	TPM4	4	19.8	9.12	2.8e-16	454.7295	4	-1.2	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-09_FTMSms2hcd	20.255	117	131	23.6	1.6e-7	1.8e-10	2	28522.0	HUMAN	Tropomyosin alpha-4 chain
[41-3]	1	P67936	TPM4_HUMAN	TPM4	4	19.8	9.12	2.8e-16	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-09_FTMSms2hcd	37.728	56	69	36.8	1.1e-6	1.7e-9	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	600.3175	2	0.90	TPVPSDIDISR	TPVPSDIDISR		11	V20130429-09_FTMSms2hcd	32.007	314	324	39.6	1.1e-8	1.9e-11	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	752.8610	2	1.4	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-09_FTMSms2hcd	29.970	505	517	48.5	4.2e-8	5.1e-11	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	585.3560	2	0.53	GVPTGFILPIR	GVPTGFILPIR		11	V20130429-09_FTMSms2hcd	54.371	879	889	35.3	2.5e-7	1.4e-9	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	743.8806	2	0.19	LDIDPETITWQR	LDIDPETITWQR		12	V20130429-09_FTMSms2hcd	48.638	521	532	44.6	3.0e-7	3.8e-10	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	626.5750	4	2.7	IYGADDIELLPEAQHKAEVYTK	IYGADDIELLPEAQHKAEVYTK		22	V20130429-09_FTMSms2hcd	45.116	833	854	33.0	5.9e-7	8.9e-10	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	450.7794	2	0.26	VLLSALER	VLLSALER		8	V20130429-09_FTMSms2hcd	37.107	355	362	27.6	0.0010	2.7e-6	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[42]		P11586	C1TC_HUMAN	MTHFD1	7	9.3	5.02	1.1e-8	456.7609	2	-0.42	MAPAEILNGK	M(Met-loss)APAEILNGK	Met-loss@1	10	V20130429-09_FTMSms2hcd	43.635	1	10	12.9	0.012	5.3e-5	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[43]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.93	6.2e-16	935.0085	2	18	YVASYLLAALGGNSSPSAK	YVASYLLAALGGNSSPSAK		19	V20130429-09_FTMSms2hcd	58.120	3	21	51.9	6.2e-16	1.5e-18	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[43]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.93	6.2e-16	886.9567	2	2.1	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-09_FTMSms2hcd	35.146	26	41	44.3	8.0e-12	1.1e-14	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[43]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.93	6.2e-16	871.7982	3	2.7	ILDSVGIEADDDRLNKVISELNGK	ILDSVGIEADDDRLNKVISELNGK		24	V20130429-09_FTMSms2hcd	56.738	26	49	52.9	2.0e-9	4.7e-12	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[43]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.93	6.2e-16	628.8455	2	-0.61	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-09_FTMSms2hcd	47.472	50	61	39.0	4.7e-8	8.7e-11	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[44]		P22392	NDKB_HUMAN	NME2	4	38.2	8.50	3.9e-15	901.4603	2	1.1	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-09_FTMSms2hcd	26.305	89	105	59.1	3.9e-15	4.7e-18	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[44]		P22392	NDKB_HUMAN	NME2	4	38.2	8.50	3.9e-15	448.9266	3	1.4	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-09_FTMSms2hcd	32.101	7	18	43.4	8.7e-13	2.4e-15	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[44]		P22392	NDKB_HUMAN	NME2	4	38.2	8.50	3.9e-15	578.5575	4	9.7	SAEKEISLWFKPEELVDYK	SAEKEISLWFKPEELVDYK		19	V20130429-09_FTMSms2hcd	56.805	125	143	25.9	1.4e-8	2.5e-11	1	17298.2	HUMAN	Nucleoside diphosphate kinase B
[44]		P22392	NDKB_HUMAN	NME2	4	38.2	8.50	3.9e-15	392.5574	3	0.42	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-09_FTMSms2hcd	42.453	57	66	30.6	5.2e-7	1.2e-9	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[44-1]	1	P15531	NDKA_HUMAN	NME1	3	25.7	8.50	3.9e-15	901.4603	2	1.1	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-09_FTMSms2hcd	26.305	89	105	59.1	3.9e-15	4.7e-18	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[44-1]	1	P15531	NDKA_HUMAN	NME1	3	25.7	8.50	3.9e-15	448.9266	3	1.4	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-09_FTMSms2hcd	32.101	7	18	43.4	8.7e-13	2.4e-15	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[44-1]	1	P15531	NDKA_HUMAN	NME1	3	25.7	8.50	3.9e-15	575.3255	2	1.9	DRPFFAGLVK	DRPFFAGLVK		10	V20130429-09_FTMSms2hcd	44.220	57	66	21.6	3.8e-4	9.3e-7	1	17148.9	HUMAN	Nucleoside diphosphate kinase A
[44-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.50	3.9e-15	901.4603	2	1.1	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@75	17	V20130429-09_FTMSms2hcd	26.305	74	90	59.1	3.9e-15	4.7e-18	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[44-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.50	3.9e-15	634.3326	2	0.82	FKPEELVDYK	FKPEELVDYK		10	V20130429-09_FTMSms2hcd	35.578	119	128	35.8	2.6e-8	3.7e-11	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[44-2]	1	O60361	NDK8_HUMAN	NME2P1	3	27.0	8.50	3.9e-15	392.5574	3	0.42	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-09_FTMSms2hcd	42.453	42	51	30.6	5.2e-7	1.2e-9	2	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	481.5182	4	1.5	KQGGLGPMNIPLVSDPKR	KQGGLGPM(Oxidation)NIPLVSDPKR	Oxidation@100	18	V20130429-09_FTMSms2hcd	34.171	93	110	33.4	1.2e-8	3.6e-11	1	22110.5	HUMAN	Peroxiredoxin-1
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	606.3414	2	1.0	QITVNDLPVGR	QITVNDLPVGR		11	V20130429-09_FTMSms2hcd	36.697	141	151	42.5	6.0e-8	1.6e-10	2	22110.5	HUMAN	Peroxiredoxin-1
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	453.9426	3	10	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-09_FTMSms2hcd	52.401	129	140	43.5	1.0e-7	1.0e-9	2	22110.5	HUMAN	Peroxiredoxin-1
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	598.8204	2	2.1	LVQAFQFTDK	LVQAFQFTDK		10	V20130429-09_FTMSms2hcd	39.109	159	168	41.6	2.4e-7	4.5e-10	1	22110.5	HUMAN	Peroxiredoxin-1
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	763.0483	3	1.3	ATAVMPDGQFKDISLSDYKGK	ATAVM(Oxidation)PDGQFKDISLSDYKGK	Oxidation@21	21	V20130429-09_FTMSms2hcd	36.760	17	37	20.1	9.7e-6	1.1e-8	1	22110.5	HUMAN	Peroxiredoxin-1
[45]		Q06830	PRDX1_HUMAN	PRDX1	6	36.2	5.00	1.2e-8	460.7582	2	0.40	GLFIIDDK	GLFIIDDK		8	V20130429-09_FTMSms2hcd	43.794	129	136	25.5	1.3e-4	3.0e-7	2	22110.5	HUMAN	Peroxiredoxin-1
[45-1]	0	Q13162	PRDX4_HUMAN	PRDX4	2	4.4	4.49	1.0e-7	453.9426	3	10	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-09_FTMSms2hcd	52.401	201	212	43.5	1.0e-7	1.0e-9	2	30540.2	HUMAN	Peroxiredoxin-4
[45-1]	0	Q13162	PRDX4_HUMAN	PRDX4	2	4.4	4.49	1.0e-7	460.7582	2	0.40	GLFIIDDK	GLFIIDDK		8	V20130429-09_FTMSms2hcd	43.794	201	208	25.5	1.3e-4	3.0e-7	2	30540.2	HUMAN	Peroxiredoxin-4
[45-2]	0	P32119	PRDX2_HUMAN	PRDX2	1	5.6	4.62	6.0e-8	606.3414	2	1.0	QITVNDLPVGR	QITVNDLPVGR		11	V20130429-09_FTMSms2hcd	36.697	140	150	42.5	6.0e-8	1.6e-10	2	21892.1	HUMAN	Peroxiredoxin-2
[46]		Q00839	HNRPU_HUMAN	HNRNPU	5	7.3	7.36	5.1e-13	857.9606	2	0.97	SSGPTSLFAVTVAPPGAR	SSGPTSLFAVTVAPPGAR		18	V20130429-09_FTMSms2hcd	50.624	187	204	44.0	5.1e-13	8.8e-16	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[46]		Q00839	HNRPU_HUMAN	HNRNPU	5	7.3	7.36	5.1e-13	824.4261	2	0.0087	NFILDQTNVSAAAQR	NFILDQTNVSAAAQR		15	V20130429-09_FTMSms2hcd	39.780	576	590	42.0	4.6e-10	6.0e-13	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[46]		Q00839	HNRPU_HUMAN	HNRNPU	5	7.3	7.36	5.1e-13	601.8537	2	0.87	VSELKEELKK	VSELKEELKK		10	V20130429-09_FTMSms2hcd	15.947	13	22	41.5	1.3e-7	4.2e-10	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[46]		Q00839	HNRPU_HUMAN	HNRNPU	5	7.3	7.36	5.1e-13	534.2606	2	0.62	MSSSPVNVKK	M(Met-loss+Acetyl)SS(Phospho)SPVNVKK	Met-loss+Acetyl@1;Phospho@2|3|4	10	V20130429-09_FTMSms2hcd	12.847	1	10	17.4	4.8e-6	7.1e-9	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[46]		Q00839	HNRPU_HUMAN	HNRNPU	5	7.3	7.36	5.1e-13	410.2409	2	2.7	FIEIAAR	FIEIAAR		7	V20130429-09_FTMSms2hcd	29.732	566	572	26.9	5.6e-5	1.8e-7	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[47]		O43175	SERA_HUMAN	PHGDH	5	15.4	8.72	1.5e-15	889.2290	4	3.0	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMR	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLM(Oxidation)R	Oxidation@343	34	V20130429-09_FTMSms2hcd	74.714	311	344	49.4	1.5e-15	6.4e-18	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[47]		O43175	SERA_HUMAN	PHGDH	5	15.4	8.72	1.5e-15	744.8691	2	1.4	AGTGVDNVDLEAATR	AGTGVDNVDLEAATR		15	V20130429-09_FTMSms2hcd	31.376	76	90	41.2	2.2e-9	2.7e-12	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[47]		O43175	SERA_HUMAN	PHGDH	5	15.4	8.72	1.5e-15	673.3900	2	3.1	GTIQVITQGTSLK	GTIQVITQGTSLK		13	V20130429-09_FTMSms2hcd	36.372	352	364	21.8	2.3e-7	7.7e-10	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[47]		O43175	SERA_HUMAN	PHGDH	5	15.4	8.72	1.5e-15	550.3103	2	2.5	GGIVDEGALLR	GGIVDEGALLR		11	V20130429-09_FTMSms2hcd	39.014	237	247	33.8	1.7e-4	4.2e-7	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[47]		O43175	SERA_HUMAN	PHGDH	5	15.4	8.72	1.5e-15	450.2874	2	0.27	TLGILGLGR	TLGILGLGR		9	V20130429-09_FTMSms2hcd	45.864	147	155	30.9	2.2e-4	9.4e-7	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[48]		P04083	ANXA1_HUMAN	ANXA1	4	18.2	6.54	1.7e-11	775.9134	2	1.4	GTDVNVFNTILTTR	GTDVNVFNTILTTR		14	V20130429-09_FTMSms2hcd	55.412	215	228	45.0	1.7e-11	2.8e-14	1	38714.6	HUMAN	Annexin A1
[48]		P04083	ANXA1_HUMAN	ANXA1	4	18.2	6.54	1.7e-11	786.0609	3	4.8	GGPGSAVSPYPTFNPSSDVAALHK	GGPGSAVSPYPTFNPSSDVAALHK		24	V20130429-09_FTMSms2hcd	44.194	30	53	37.9	5.1e-11	5.3e-14	1	38714.6	HUMAN	Annexin A1
[48]		P04083	ANXA1_HUMAN	ANXA1	4	18.2	6.54	1.7e-11	631.8052	2	1.6	TPAQFDADELR	TPAQFDADELR		11	V20130429-09_FTMSms2hcd	31.490	114	124	48.5	1.7e-9	2.4e-12	1	38714.6	HUMAN	Annexin A1
[48]		P04083	ANXA1_HUMAN	ANXA1	4	18.2	6.54	1.7e-11	772.4403	2	2.8	GVDEATIIDILTKR	GVDEATIIDILTKR		14	V20130429-09_FTMSms2hcd	58.521	59	72	42.2	1.7e-9	5.4e-12	1	38714.6	HUMAN	Annexin A1
[49]		P31947	1433S_HUMAN	SFN	4	25.8	9.67	2.7e-17	844.9058	4	2.7	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-09_FTMSms2hcd	72.957	196	224	46.6	2.7e-17	2.7e-20	1	27774.3	HUMAN	14-3-3 protein sigma
[49]		P31947	1433S_HUMAN	SFN	4	25.8	9.67	2.7e-17	773.8527	2	0.099	SNEEGSEEKGPEVR	SNEEGSEEKGPEVR		14	V20130429-09_FTMSms2hcd	10.433	69	82	37.4	2.2e-11	2.8e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[49]		P31947	1433S_HUMAN	SFN	4	25.8	9.67	2.7e-17	733.3851	2	-1.1	YLAEVATGDDKKR	YLAEVATGDDKKR		13	V20130429-09_FTMSms2hcd	16.768	130	142	51.8	9.4e-9	1.3e-11	1	27774.3	HUMAN	14-3-3 protein sigma
[49]		P31947	1433S_HUMAN	SFN	4	25.8	9.67	2.7e-17	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	42	49	23.9	5.3e-4	1.9e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[49-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.4	7.02	2.1e-12	774.8615	2	1.4	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-09_FTMSms2hcd	20.934	28	41	53.9	2.1e-12	2.6e-15	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[49-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.4	7.02	2.1e-12	752.8971	2	1.1	VVSSIEQKTEGAEK	VVSSIEQKTEGAEK		14	V20130429-09_FTMSms2hcd	17.025	61	74	30.4	2.8e-9	4.3e-12	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[49-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.4	7.02	2.1e-12	581.7909	2	-2.3	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=10	9	V20130429-09_FTMSms2hcd	14.862	1	9	33.0	3.5e-9	5.1e-12	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[49-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	18.4	7.02	2.1e-12	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	42	49	23.9	5.3e-4	1.9e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[49-2]	2	P31946	1433B_HUMAN	YWHAB	3	15.4	9.29	1.3e-16	799.8730	2	-1.1	AVTEQGHELSNEER	AVTEQGHELSNEER		14	V20130429-09_FTMSms2hcd	14.849	30	43	67.0	1.3e-16	1.6e-19	1	28082.6	HUMAN	14-3-3 protein beta/alpha
[49-2]	2	P31946	1433B_HUMAN	YWHAB	3	15.4	9.29	1.3e-16	615.6104	3	0.72	LAEQAERYDDMAAAMK	LAEQAERYDDM(Oxidation)AAAM(Oxidation)K	Oxidation@24;Oxidation@28	16	V20130429-09_FTMSms2hcd	19.711	14	29	17.0	6.8e-7	8.2e-10	2	28082.6	HUMAN	14-3-3 protein beta/alpha
[49-2]	2	P31946	1433B_HUMAN	YWHAB	3	15.4	9.29	1.3e-16	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	44	51	23.9	5.3e-4	1.9e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[49-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.39	3.2e-11	766.8645	2	2.0	AVTEQGAELSNEER	AVTEQGAELSNEER		14	V20130429-09_FTMSms2hcd	20.097	28	41	55.2	3.2e-11	4.0e-14	1	27764.5	HUMAN	14-3-3 protein theta
[49-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.39	3.2e-11	589.3105	2	0.36	MEKTELIQK	Acetyl-M(Oxidation)EKTELIQK		9	V20130429-09_FTMSms2hcd	20.491	1	9	31.1	2.4e-5	3.6e-8	1	27764.5	HUMAN	14-3-3 protein theta
[49-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.39	3.2e-11	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	42	49	23.9	5.3e-4	1.9e-6	7	27764.5	HUMAN	14-3-3 protein theta
[49-4]	2	Q04917	1433F_HUMAN	YWHAH	3	13.8	4.05	6.8e-7	615.6104	3	0.72	LAEQAERYDDMASAMK	LAEQAERYDDMASAM(Oxidation)K	Oxidation@27=43	16	V20130429-09_FTMSms2hcd	19.711	13	28	17.0	6.8e-7	8.2e-10	1	28219.0	HUMAN	14-3-3 protein eta
[49-4]	2	Q04917	1433F_HUMAN	YWHAH	3	13.8	4.05	6.8e-7	578.8073	2	0.36	MGDREQLLQR	M(Met-loss+Acetyl)GDREQLLQR	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	23.052	1	10	42.8	1.8e-6	3.6e-9	1	28219.0	HUMAN	14-3-3 protein eta
[49-4]	2	Q04917	1433F_HUMAN	YWHAH	3	13.8	4.05	6.8e-7	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	43	50	23.9	5.3e-4	1.9e-6	7	28219.0	HUMAN	14-3-3 protein eta
[49-5]	1	P61981	1433G_HUMAN	YWHAG	2	9.7	2.44	6.8e-7	615.6104	3	0.72	LAEQAERYDDMAAAMK	LAEQAERYDDM(Oxidation)AAAM(Oxidation)K	Oxidation@23;Oxidation@27	16	V20130429-09_FTMSms2hcd	19.711	13	28	17.0	6.8e-7	8.2e-10	2	28302.8	HUMAN	14-3-3 protein gamma
[49-5]	1	P61981	1433G_HUMAN	YWHAG	2	9.7	2.44	6.8e-7	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	43	50	23.9	5.3e-4	1.9e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[49-6]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	0.88	5.3e-4	454.2661	2	0.20	NLLSVAYK	NLLSVAYK		8	V20130429-09_FTMSms2hcd	35.554	43	50	23.9	5.3e-4	1.9e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[50]		P09429	HMGB1_HUMAN	HMGB1	4	23.7	7.05	1.9e-12	728.3229	2	-0.69	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-09_FTMSms2hcd	44.562	13	24	34.2	1.9e-12	2.8e-15	3	24894.0	HUMAN	High mobility group protein B1
[50]		P09429	HMGB1_HUMAN	HMGB1	4	23.7	7.05	1.9e-12	430.9725	4	1.7	KHPDASVNFSEFSKK	KHPDASVNFSEFSKK		15	V20130429-09_FTMSms2hcd	26.185	30	44	31.1	4.2e-10	4.8e-13	1	24894.0	HUMAN	High mobility group protein B1
[50]		P09429	HMGB1_HUMAN	HMGB1	4	23.7	7.05	1.9e-12	564.7881	2	0.46	YEKDIAAYR	YEKDIAAYR		9	V20130429-09_FTMSms2hcd	18.735	155	163	44.0	1.5e-9	2.7e-12	2	24894.0	HUMAN	High mobility group protein B1
[50]		P09429	HMGB1_HUMAN	HMGB1	4	23.7	7.05	1.9e-12	760.9271	2	2.5	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-09_FTMSms2hcd	27.373	113	127	51.0	2.8e-9	7.1e-12	2	24894.0	HUMAN	High mobility group protein B1
[50-1]	0	P26583	HMGB2_HUMAN	HMGB2	2	10.0	7.05	1.9e-12	728.3229	2	-0.69	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-09_FTMSms2hcd	44.562	13	24	34.2	1.9e-12	2.8e-15	3	24034.0	HUMAN	High mobility group protein B2
[50-1]	0	P26583	HMGB2_HUMAN	HMGB2	2	10.0	7.05	1.9e-12	564.7881	2	0.46	YEKDIAAYR	YEKDIAAYR		9	V20130429-09_FTMSms2hcd	18.735	155	163	44.0	1.5e-9	2.7e-12	2	24034.0	HUMAN	High mobility group protein B2
[50-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	2	12.8	7.05	1.9e-12	728.3229	2	-0.69	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-09_FTMSms2hcd	44.562	13	24	34.2	1.9e-12	2.8e-15	3	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[50-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	2	12.8	7.05	1.9e-12	760.9271	2	2.5	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-09_FTMSms2hcd	27.373	113	127	51.0	2.8e-9	7.1e-12	2	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	778.9169	2	-0.86	LQEAGILSAEELQR	LQEAGILSAEELQR		14	V20130429-09_FTMSms2hcd	40.989	2795	2808	35.5	1.7e-8	2.6e-11	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	644.3467	2	-3.2	AQVEQELTTLR	AQVEQELTTLR		11	V20130429-09_FTMSms2hcd	34.582	2319	2329	40.5	8.6e-7	1.5e-9	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	789.1620	4	12	EQELQQTLQQEQSVLDQLRGEAEAARR	EQELQQTLQQEQSVLDQLRGEAEAARR		27	V20130429-09_FTMSms2hcd	56.618	2199	2225	26.3	1.9e-6	3.3e-9	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	622.3370	2	2.1	SIQEELQQLR	SIQEELQQLR		10	V20130429-09_FTMSms2hcd	41.081	1554	1563	27.4	1.1e-5	1.8e-8	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	501.7476	2	2.9	QLAEEDAAR	QLAEEDAAR		9	V20130429-09_FTMSms2hcd	11.385	1955	1963	21.5	3.3e-5	6.8e-8	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	572.3063	2	4.3	LQAEEVAQQK	LQAEEVAQQK		10	V20130429-09_FTMSms2hcd	16.674	1783	1792	18.0	8.8e-5	1.5e-7	1	531795.0	HUMAN	Plectin
[51]		Q15149	PLEC_HUMAN	PLEC	7	1.9	4.92	1.7e-8	593.8138	2	-19	RQELEAELAK	RQELEAELAK		10	V20130429-09_FTMSms2hcd	40.148	1887	1896	14.3	0.093	1.4e-4	1	531795.0	HUMAN	Plectin
[52]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.56	1.6e-11	789.8982	2	1.3	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-09_FTMSms2hcd	21.314	65	79	69.1	1.6e-11	2.0e-14	5	21364.9	HUMAN	Histone H1.2
[52]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.56	1.6e-11	958.5123	2	2.6	MSETAPAAPAAAPPAEKAPVK	M(Met-loss+Acetyl)SETAPAAPAAAPPAEKAPVK	Met-loss+Acetyl@1	21	V20130429-09_FTMSms2hcd	26.563	1	21	29.9	1.3e-10	2.5e-13	1	21364.9	HUMAN	Histone H1.2
[52]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.56	1.6e-11	663.8863	2	1.9	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-09_FTMSms2hcd	30.090	34	46	43.1	1.9e-9	6.8e-12	3	21364.9	HUMAN	Histone H1.2
[52]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.56	1.6e-11	554.2863	2	-2.5	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-09_FTMSms2hcd	24.872	65	75	36.1	1.9e-8	3.0e-11	5	21364.9	HUMAN	Histone H1.2
[52-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.56	1.6e-11	789.8982	2	1.3	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-09_FTMSms2hcd	21.314	65	79	69.1	1.6e-11	2.0e-14	5	21865.4	HUMAN	Histone H1.4
[52-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.56	1.6e-11	663.8863	2	1.9	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-09_FTMSms2hcd	30.090	34	46	43.1	1.9e-9	6.8e-12	3	21865.4	HUMAN	Histone H1.4
[52-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.56	1.6e-11	554.2863	2	-2.5	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-09_FTMSms2hcd	24.872	65	75	36.1	1.9e-8	3.0e-11	5	21865.4	HUMAN	Histone H1.4
[52-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.56	1.6e-11	789.8982	2	1.3	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-09_FTMSms2hcd	21.314	66	80	69.1	1.6e-11	2.0e-14	5	22350.1	HUMAN	Histone H1.3
[52-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.56	1.6e-11	663.8863	2	1.9	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-09_FTMSms2hcd	30.090	35	47	43.1	1.9e-9	6.8e-12	3	22350.1	HUMAN	Histone H1.3
[52-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.56	1.6e-11	554.2863	2	-2.5	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-09_FTMSms2hcd	24.872	66	76	36.1	1.9e-8	3.0e-11	5	22350.1	HUMAN	Histone H1.3
[52-3]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.56	1.6e-11	789.8982	2	1.3	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-09_FTMSms2hcd	21.314	69	83	69.1	1.6e-11	2.0e-14	5	22019.2	HUMAN	Histone H1t
[52-3]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.56	1.6e-11	554.2863	2	-2.5	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-09_FTMSms2hcd	24.872	69	79	36.1	1.9e-8	3.0e-11	5	22019.2	HUMAN	Histone H1t
[52-4]	0	Q02539	H11_HUMAN	HIST1H1A	2	7.0	6.56	1.6e-11	789.8982	2	1.3	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-09_FTMSms2hcd	21.314	68	82	69.1	1.6e-11	2.0e-14	5	21842.3	HUMAN	Histone H1.1
[52-4]	0	Q02539	H11_HUMAN	HIST1H1A	2	7.0	6.56	1.6e-11	554.2863	2	-2.5	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-09_FTMSms2hcd	24.872	68	78	36.1	1.9e-8	3.0e-11	5	21842.3	HUMAN	Histone H1.1
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	489.7591	2	3.3	APGFAQMLK	APGFAQM(Oxidation)LK	Oxidation@14	9	V20130429-09_FTMSms2hcd	26.237	8	16	31.4	5.8e-9	9.0e-12	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	677.8828	2	0.49	LVPGGGATEIELAK	LVPGGGATEIELAK		14	V20130429-09_FTMSms2hcd	35.907	408	421	41.4	8.5e-9	2.3e-11	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	689.8391	2	0.94	ETEGDVTSVKDAK	ETEGDVTSVKDAK		13	V20130429-09_FTMSms2hcd	13.851	226	238	29.8	7.6e-8	1.1e-10	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	573.8028	2	-1.5	DIDEVSSLLR	DIDEVSSLLR		10	V20130429-09_FTMSms2hcd	46.974	156	165	21.4	2.1e-4	3.3e-7	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	353.7160	2	0.12	MALHVPK	M(Met-loss+Acetyl)ALHVPK	Met-loss+Acetyl@1	7	V20130429-09_FTMSms2hcd	23.821	1	7	16.9	0.0013	6.0e-6	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[53]		P50990	TCPQ_HUMAN	CCT8	6	11.3	5.17	5.8e-9	443.2612	2	-0.13	TVGATALPR	TVGATALPR		9	V20130429-09_FTMSms2hcd	39.229	327	335	15.1	0.096	3.2e-4	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[54]		P30101	PDIA3_HUMAN	PDIA3	4	12.1	8.78	1.2e-15	859.1071	3	1.1	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-09_FTMSms2hcd	60.250	306	329	46.0	1.2e-15	1.4e-18	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[54]		P30101	PDIA3_HUMAN	PDIA3	4	12.1	8.78	1.2e-15	505.9246	3	0.13	FLQDYFDGNLKR	FLQDYFDGNLKR		12	V20130429-09_FTMSms2hcd	42.067	352	363	37.0	2.9e-8	4.0e-11	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[54]		P30101	PDIA3_HUMAN	PDIA3	4	12.1	8.78	1.2e-15	790.4213	2	1.7	EATNPPVIQEEKPK	EATNPPVIQEEKPK		14	V20130429-09_FTMSms2hcd	20.648	483	496	34.9	5.0e-7	8.3e-10	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[54]		P30101	PDIA3_HUMAN	PDIA3	4	12.1	8.78	1.2e-15	584.8387	2	1.4	TADGIVSHLKK	TADGIVSHLKK		11	V20130429-09_FTMSms2hcd	20.307	120	130	14.8	1.6e-5	6.8e-8	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[55]		P52272	HNRPM_HUMAN	HNRNPM	3	8.4	8.64	2.1e-15	924.7211	4	1.8	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-09_FTMSms2hcd	76.010	245	277	47.9	2.1e-15	3.5e-18	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[55]		P52272	HNRPM_HUMAN	HNRNPM	3	8.4	8.64	2.1e-15	771.9045	2	0.48	MAAGVEAAAEVAATEIK	M(Met-loss+Acetyl)AAGVEAAAEVAATEIK	Met-loss+Acetyl@1	17	V20130429-09_FTMSms2hcd	60.542	1	17	46.3	6.3e-15	9.6e-18	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[55]		P52272	HNRPM_HUMAN	HNRNPM	3	8.4	8.64	2.1e-15	632.8539	2	5.5	AFITNIPFDVK	AFITNIPFDVK		11	V20130429-09_FTMSms2hcd	53.636	73	83	25.2	3.5e-5	8.1e-8	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[56]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.28	7.2e-13	640.7570	2	0.62	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-09_FTMSms2hcd	13.774	132	143	35.5	7.2e-13	1.8e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[56]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.28	7.2e-13	704.8038	2	-0.41	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-09_FTMSms2hcd	10.301	132	144	45.2	2.7e-12	4.6e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[56]		P02765	FETUA_HUMAN	AHSG	3	3.5	7.28	7.2e-13	744.7877	2	0.60	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=6	13	V20130429-09_FTMSms2hcd	11.358	132	144	36.3	4.9e-10	1.3e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[57]		P15259	PGAM2_HUMAN	PGAM2	4	16.2	7.40	2.3e-13	842.4593	2	0.51	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-09_FTMSms2hcd	61.939	163	176	38.5	2.3e-13	4.4e-16	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[57]		P15259	PGAM2_HUMAN	PGAM2	4	16.2	7.40	2.3e-13	544.2897	3	-0.12	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-09_FTMSms2hcd	22.905	91	106	34.4	2.6e-9	3.7e-12	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[57]		P15259	PGAM2_HUMAN	PGAM2	4	16.2	7.40	2.3e-13	384.2282	3	0.81	VLIAAHGNSLR	VLIAAHGNSLR		11	V20130429-09_FTMSms2hcd	22.810	181	191	36.6	1.6e-8	6.6e-11	2	28766.4	HUMAN	Phosphoglycerate mutase 2
[57]		P15259	PGAM2_HUMAN	PGAM2	4	16.2	7.40	2.3e-13	530.2813	2	-2.7	HYGGLTGLNK	HYGGLTGLNK		10	V20130429-09_FTMSms2hcd	20.518	91	100	16.5	2.0e-4	3.4e-7	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[57-1]	0	P18669	PGAM1_HUMAN	PGAM1	4	16.1	7.40	2.3e-13	842.4593	2	0.51	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-09_FTMSms2hcd	61.939	163	176	38.5	2.3e-13	4.4e-16	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[57-1]	0	P18669	PGAM1_HUMAN	PGAM1	4	16.1	7.40	2.3e-13	544.2897	3	-0.12	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-09_FTMSms2hcd	22.905	91	106	34.4	2.6e-9	3.7e-12	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[57-1]	0	P18669	PGAM1_HUMAN	PGAM1	4	16.1	7.40	2.3e-13	384.2282	3	0.81	VLIAAHGNSLR	VLIAAHGNSLR		11	V20130429-09_FTMSms2hcd	22.810	181	191	36.6	1.6e-8	6.6e-11	2	28804.2	HUMAN	Phosphoglycerate mutase 1
[57-1]	0	P18669	PGAM1_HUMAN	PGAM1	4	16.1	7.40	2.3e-13	530.2813	2	-2.7	HYGGLTGLNK	HYGGLTGLNK		10	V20130429-09_FTMSms2hcd	20.518	91	100	16.5	2.0e-4	3.4e-7	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[57-2]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	11.8	7.40	2.3e-13	842.4593	2	0.51	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-09_FTMSms2hcd	61.939	163	176	38.5	2.3e-13	4.4e-16	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[57-2]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	11.8	7.40	2.3e-13	544.2897	3	-0.12	HYGGLTGLNKAETAAK	HYGGLTGLNKAETAAK		16	V20130429-09_FTMSms2hcd	22.905	91	106	34.4	2.6e-9	3.7e-12	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[57-2]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	3	11.8	7.40	2.3e-13	530.2813	2	-2.7	HYGGLTGLNK	HYGGLTGLNK		10	V20130429-09_FTMSms2hcd	20.518	91	100	16.5	2.0e-4	3.4e-7	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[58]		P11940	PABP1_HUMAN	PABPC1	4	8.3	7.61	7.8e-14	964.9656	2	5.3	SLGYAYVNFQQPADAER	SLGYAYVNFQQPADAER		17	V20130429-09_FTMSms2hcd	42.835	51	67	36.9	7.8e-14	8.5e-17	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[58]		P11940	PABP1_HUMAN	PABPC1	4	8.3	7.61	7.8e-14	579.3381	2	1.0	FSPAGPILSIR	FSPAGPILSIR		11	V20130429-09_FTMSms2hcd	46.048	31	41	38.1	7.6e-10	1.8e-12	4	70671.5	HUMAN	Polyadenylate-binding protein 1
[58]		P11940	PABP1_HUMAN	PABPC1	4	8.3	7.61	7.8e-14	514.9832	3	-1.0	IVATKPLYVALAQR	IVATKPLYVALAQR		14	V20130429-09_FTMSms2hcd	40.070	357	370	25.2	1.9e-8	3.1e-10	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[58]		P11940	PABP1_HUMAN	PABPC1	4	8.3	7.61	7.8e-14	641.8207	2	-0.50	ALDTMNFDVIK	ALDTM(Oxidation)NFDVIK	Oxidation@72	11	V20130429-09_FTMSms2hcd	40.312	68	78	13.8	0.0019	2.5e-6	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[58-1]	0	Q9H361	PABP3_HUMAN	PABPC3	2	4.0	5.45	7.6e-10	579.3381	2	1.0	FSPAGPILSIR	FSPAGPILSIR		11	V20130429-09_FTMSms2hcd	46.048	31	41	38.1	7.6e-10	1.8e-12	4	70031.5	HUMAN	Polyadenylate-binding protein 3
[58-1]	0	Q9H361	PABP3_HUMAN	PABPC3	2	4.0	5.45	7.6e-10	514.9832	3	-1.0	IVATKPLYVALAQR	IVATKPLYVALAQR		14	V20130429-09_FTMSms2hcd	40.070	357	370	25.2	1.9e-8	3.1e-10	2	70031.5	HUMAN	Polyadenylate-binding protein 3
[58-2]	0	Q13310	PABP4_HUMAN	PABPC4	2	4.3	7.49	7.8e-14	964.9656	2	5.3	SLGYAYVNFQQPADAER	SLGYAYVNFQQPADAER		17	V20130429-09_FTMSms2hcd	42.835	51	67	36.9	7.8e-14	8.5e-17	2	70783.5	HUMAN	Polyadenylate-binding protein 4
[58-2]	0	Q13310	PABP4_HUMAN	PABPC4	2	4.3	7.49	7.8e-14	641.8207	2	-0.50	ALDTMNFDVIK	ALDTM(Oxidation)NFDVIK	Oxidation@72	11	V20130429-09_FTMSms2hcd	40.312	68	78	13.8	0.0019	2.5e-6	2	70783.5	HUMAN	Polyadenylate-binding protein 4
[58-3]	0	Q4VXU2	PAP1L_HUMAN	PABPC1L	1	1.8	5.45	7.6e-10	579.3381	2	1.0	FSPAGPILSIR	FSPAGPILSIR		11	V20130429-09_FTMSms2hcd	46.048	31	41	38.1	7.6e-10	1.8e-12	4	68392.9	HUMAN	Polyadenylate-binding protein 1-like
[58-4]	0	Q5JQF8	PAP1M_HUMAN	PABPC1L2A	1	5.5	5.45	7.6e-10	579.3381	2	1.0	FSPAGPILSIR	FSPAGPILSIR		11	V20130429-09_FTMSms2hcd	46.048	22	32	38.1	7.6e-10	1.8e-12	4	22799.2	HUMAN	Polyadenylate-binding protein 1-like 2
[59]		P06732	KCRM_HUMAN	CKM	4	13.1	6.03	1.4e-10	893.4855	2	2.5	LGSSEVEQVQLVVDGVK	LGSSEVEQVQLVVDGVK		17	V20130429-09_FTMSms2hcd	49.729	342	358	37.7	1.4e-10	2.9e-13	1	43101.5	HUMAN	Creatine kinase M-type
[59]		P06732	KCRM_HUMAN	CKM	4	13.1	6.03	1.4e-10	754.4105	2	8.9	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-09_FTMSms2hcd	55.056	157	170	49.9	2.3e-9	4.2e-12	1	43101.5	HUMAN	Creatine kinase M-type
[59]		P06732	KCRM_HUMAN	CKM	4	13.1	6.03	1.4e-10	659.8195	2	0.74	GQSIDDMIPAQK	GQSIDDM(Oxidation)IPAQK	Oxidation@376	12	V20130429-09_FTMSms2hcd	23.326	370	381	42.8	5.6e-9	7.9e-12	1	43101.5	HUMAN	Creatine kinase M-type
[59]		P06732	KCRM_HUMAN	CKM	4	13.1	6.03	1.4e-10	454.2485	2	1.5	FEEILTR	FEEILTR		7	V20130429-09_FTMSms2hcd	30.168	308	314	29.7	3.4e-4	6.8e-7	1	43101.5	HUMAN	Creatine kinase M-type
[60]		P61604	CH10_HUMAN	HSPE1	5	44.1	4.55	8.1e-8	658.3837	2	1.6	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-09_FTMSms2hcd	30.077	41	54	49.1	8.1e-8	2.5e-10	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[60]		P61604	CH10_HUMAN	HSPE1	5	44.1	4.55	8.1e-8	599.8436	2	0.76	GKGGEIQPVSVK	GKGGEIQPVSVK		12	V20130429-09_FTMSms2hcd	18.366	55	66	24.4	8.7e-8	2.4e-10	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[60]		P61604	CH10_HUMAN	HSPE1	5	44.1	4.55	8.1e-8	507.2860	2	2.1	GGEIQPVSVK	GGEIQPVSVK		10	V20130429-09_FTMSms2hcd	22.151	57	66	21.9	2.1e-6	6.9e-9	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[60]		P61604	CH10_HUMAN	HSPE1	5	44.1	4.55	8.1e-8	510.6048	3	-0.0061	VVLDDKDYFLFR	VVLDDKDYFLFR		12	V20130429-09_FTMSms2hcd	50.611	81	92	31.4	2.1e-6	3.0e-9	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[60]		P61604	CH10_HUMAN	HSPE1	5	44.1	4.55	8.1e-8	454.2551	2	-0.76	FLPLFDR	FLPLFDR		7	V20130429-09_FTMSms2hcd	48.875	9	15	31.9	1.0e-3	2.3e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[61]		P55072	TERA_HUMAN	VCP	4	8.9	6.66	9.2e-12	833.4309	3	0.34	ETVVEVPQVTWEDIGGLEDVKR	ETVVEVPQVTWEDIGGLEDVKR		22	V20130429-09_FTMSms2hcd	58.508	466	487	39.8	9.2e-12	1.3e-14	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[61]		P55072	TERA_HUMAN	VCP	4	8.9	6.66	9.2e-12	845.9276	2	-0.86	MASGADSKGDDLSTAILK	M(Met-loss+Acetyl)ASGADSKGDDLSTAILK	Met-loss+Acetyl@1	18	V20130429-09_FTMSms2hcd	38.101	1	18	33.0	1.3e-11	1.6e-14	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[61]		P55072	TERA_HUMAN	VCP	4	8.9	6.66	9.2e-12	534.2623	2	-1.6	MDELQLFR	M(Oxidation)DELQLFR	Oxidation@46	8	V20130429-09_FTMSms2hcd	41.666	46	53	24.4	1.8e-5	2.5e-8	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[61]		P55072	TERA_HUMAN	VCP	4	8.9	6.66	9.2e-12	872.4639	3	6.4	AFEEAEKNAPAIIFIDELDAIAPK	AFEEAEKNAPAIIFIDELDAIAPK		24	V20130429-09_FTMSms2hcd	75.622	289	312	14.4	6.5e-4	1.4e-6	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[62]		P23246	SFPQ_HUMAN	SFPQ	4	10.3	7.21	9.6e-13	880.4388	3	1.2	NLSPYVSNELLEEAFSQFGPIER	NLSPYVSNELLEEAFSQFGPIER		23	V20130429-09_FTMSms2hcd	74.848	377	399	37.4	9.6e-13	1.1e-15	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[62]		P23246	SFPQ_HUMAN	SFPQ	4	10.3	7.21	9.6e-13	655.3426	3	0.45	LFVGNLPADITEDEFKR	LFVGNLPADITEDEFKR		17	V20130429-09_FTMSms2hcd	52.580	299	315	46.5	1.6e-11	2.3e-14	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[62]		P23246	SFPQ_HUMAN	SFPQ	4	10.3	7.21	9.6e-13	626.8200	2	9.5	YGEPGEVFINK	YGEPGEVFINK		11	V20130429-09_FTMSms2hcd	33.665	320	330	13.3	5.1e-4	7.0e-7	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[62]		P23246	SFPQ_HUMAN	SFPQ	4	10.3	7.21	9.6e-13	478.0268	5	-1.5	QHHPPYHQQHHQGPPPGGPGGR	Q(Gln->pyro-Glu)HHPPYHQQHHQGPPPGGPGGR	Gln->pyro-Glu@246	22	V20130429-09_FTMSms2hcd	10.615	246	267	20.6	8.5e-4	8.2e-7	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[63]		Q15366	PCBP2_HUMAN	PCBP2	4	20.8	5.87	8.3e-11	846.6848	4	10	AFAMIIDKLEEDISSSMTNSTAASRPPVTLR	AFAM(Oxidation)IIDKLEEDISSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@74;Oxidation@87	31	V20130429-09_FTMSms2hcd	63.282	71	101	37.1	8.3e-11	1.3e-13	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[63]		Q15366	PCBP2_HUMAN	PCBP2	4	20.8	5.87	8.3e-11	735.7465	3	0.54	QVTITGSAASISLAQYLINVR	QVTITGSAASISLAQYLINVR		21	V20130429-09_FTMSms2hcd	66.360	334	354	33.3	2.2e-10	8.5e-13	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[63]		Q15366	PCBP2_HUMAN	PCBP2	4	20.8	5.87	8.3e-11	679.9064	2	0.96	IITLAGPTNAIFK	IITLAGPTNAIFK		13	V20130429-09_FTMSms2hcd	51.857	58	70	33.6	5.5e-8	3.2e-10	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[63]		Q15366	PCBP2_HUMAN	PCBP2	4	20.8	5.87	8.3e-11	579.7930	2	3.3	IANPVEGSTDR	IANPVEGSTDR		11	V20130429-09_FTMSms2hcd	20.294	323	333	14.7	1.2e-4	1.8e-7	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[64]		P15311	EZRI_HUMAN	EZR	5	13.0	4.45	5.5e-8	746.3841	3	1.9	AKFYPEDVAEELIQDITQK	AKFYPEDVAEELIQDITQK		19	V20130429-09_FTMSms2hcd	74.051	82	100	25.9	5.5e-8	6.8e-11	1	69413.4	HUMAN	Ezrin
[64]		P15311	EZRI_HUMAN	EZR	5	13.0	4.45	5.5e-8	708.8382	2	-1.6	AQEEAERLEADR	AQEEAERLEADR		12	V20130429-09_FTMSms2hcd	16.755	382	393	38.1	1.4e-7	1.9e-10	1	69413.4	HUMAN	Ezrin
[64]		P15311	EZRI_HUMAN	EZR	5	13.0	4.45	5.5e-8	552.7961	2	1.1	IGFPWSEIR	IGFPWSEIR		9	V20130429-09_FTMSms2hcd	53.239	238	246	36.7	1.1e-6	1.6e-9	3	69413.4	HUMAN	Ezrin
[64]		P15311	EZRI_HUMAN	EZR	5	13.0	4.45	5.5e-8	591.8021	2	2.3	APDFVFYAPR	APDFVFYAPR		10	V20130429-09_FTMSms2hcd	46.021	264	273	33.6	2.0e-6	2.9e-9	3	69413.4	HUMAN	Ezrin
[64]		P15311	EZRI_HUMAN	EZR	5	13.0	4.45	5.5e-8	922.8113	3	10	EGILSDEIYCPPETAVLLGSYAVQAK	EGILSDEIYCPPETAVLLGSYAVQAK		26	V20130429-09_FTMSms2hcd	69.469	108	133	17.6	7.5e-4	1.2e-6	1	69413.4	HUMAN	Ezrin
[64-1]	1	P26038	MOES_HUMAN	MSN	3	5.2	3.93	1.1e-6	552.7961	2	1.1	IGFPWSEIR	IGFPWSEIR		9	V20130429-09_FTMSms2hcd	53.239	238	246	36.7	1.1e-6	1.6e-9	3	67820.6	HUMAN	Moesin
[64-1]	1	P26038	MOES_HUMAN	MSN	3	5.2	3.93	1.1e-6	694.3503	2	0.64	AQQELEEQTRR	AQQELEEQTRR		11	V20130429-09_FTMSms2hcd	11.240	361	371	43.8	1.2e-6	1.7e-9	1	67820.6	HUMAN	Moesin
[64-1]	1	P26038	MOES_HUMAN	MSN	3	5.2	3.93	1.1e-6	591.8021	2	2.3	APDFVFYAPR	APDFVFYAPR		10	V20130429-09_FTMSms2hcd	46.021	264	273	33.6	2.0e-6	2.9e-9	3	67820.6	HUMAN	Moesin
[64-2]	0	P35241	RADI_HUMAN	RDX	2	3.3	3.60	1.1e-6	552.7961	2	1.1	IGFPWSEIR	IGFPWSEIR		9	V20130429-09_FTMSms2hcd	53.239	238	246	36.7	1.1e-6	1.6e-9	3	68564.5	HUMAN	Radixin
[64-2]	0	P35241	RADI_HUMAN	RDX	2	3.3	3.60	1.1e-6	591.8021	2	2.3	APDFVFYAPR	APDFVFYAPR		10	V20130429-09_FTMSms2hcd	46.021	264	273	33.6	2.0e-6	2.9e-9	3	68564.5	HUMAN	Radixin
[65]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14091.6	HUMAN	Histone H2A type 1
[65]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	14091.6	HUMAN	Histone H2A type 1
[65]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	14091.6	HUMAN	Histone H2A type 1
[65]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14091.6	HUMAN	Histone H2A type 1
[65-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14107.6	HUMAN	Histone H2A type 1-D
[65-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	14107.6	HUMAN	Histone H2A type 1-D
[65-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	14107.6	HUMAN	Histone H2A type 1-D
[65-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14107.6	HUMAN	Histone H2A type 1-D
[65-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	13988.5	HUMAN	Histone H2A type 2-C
[65-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	13988.5	HUMAN	Histone H2A type 2-C
[65-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	13988.5	HUMAN	Histone H2A type 2-C
[65-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	13988.5	HUMAN	Histone H2A type 2-C
[65-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14095.6	HUMAN	Histone H2A type 2-A
[65-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	14095.6	HUMAN	Histone H2A type 2-A
[65-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	14095.6	HUMAN	Histone H2A type 2-A
[65-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14095.6	HUMAN	Histone H2A type 2-A
[65-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	13906.4	HUMAN	Histone H2A type 1-H
[65-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	13906.4	HUMAN	Histone H2A type 1-H
[65-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	13906.4	HUMAN	Histone H2A type 1-H
[65-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	13906.4	HUMAN	Histone H2A type 1-H
[65-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	13936.4	HUMAN	Histone H2A type 1-J
[65-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	13936.4	HUMAN	Histone H2A type 1-J
[65-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	13936.4	HUMAN	Histone H2A type 1-J
[65-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	13936.4	HUMAN	Histone H2A type 1-J
[65-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14019.5	HUMAN	Histone H2A.J
[65-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	6.22	6.5e-11	636.8439	2	0.88	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-09_FTMSms2hcd	35.605	90	100	41.9	1.8e-8	3.0e-11	7	14019.5	HUMAN	Histone H2A.J
[65-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	6.22	6.5e-11	526.8021	4	-0.35	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-09_FTMSms2hcd	45.507	83	100	37.9	1.5e-7	8.4e-10	7	14019.5	HUMAN	Histone H2A.J
[65-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14019.5	HUMAN	Histone H2A.J
[65-7]	2	P04908	H2A1B_HUMAN	HIST1H2AB	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14135.6	HUMAN	Histone H2A type 1-B/E
[65-7]	2	P04908	H2A1B_HUMAN	HIST1H2AB	4	35.4	6.22	6.5e-11	650.8475	2	1.7	NDEELNKLLGR	NDEELNKLLGR		11	V20130429-09_FTMSms2hcd	37.234	90	100	45.2	8.8e-8	1.4e-10	3	14135.6	HUMAN	Histone H2A type 1-B/E
[65-7]	2	P04908	H2A1B_HUMAN	HIST1H2AB	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14135.6	HUMAN	Histone H2A type 1-B/E
[65-7]	2	P04908	H2A1B_HUMAN	HIST1H2AB	4	35.4	6.22	6.5e-11	533.8048	4	1.8	HLQLAIRNDEELNKLLGR	HLQLAIRNDEELNKLLGR		18	V20130429-09_FTMSms2hcd	46.486	83	100	13.2	0.0038	2.1e-5	3	14135.6	HUMAN	Histone H2A type 1-B/E
[65-8]	2	Q7L7L0	H2A3_HUMAN	HIST3H2A	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14121.6	HUMAN	Histone H2A type 3
[65-8]	2	Q7L7L0	H2A3_HUMAN	HIST3H2A	4	35.4	6.22	6.5e-11	650.8475	2	1.7	NDEELNKLLGR	NDEELNKLLGR		11	V20130429-09_FTMSms2hcd	37.234	90	100	45.2	8.8e-8	1.4e-10	3	14121.6	HUMAN	Histone H2A type 3
[65-8]	2	Q7L7L0	H2A3_HUMAN	HIST3H2A	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14121.6	HUMAN	Histone H2A type 3
[65-8]	2	Q7L7L0	H2A3_HUMAN	HIST3H2A	4	35.4	6.22	6.5e-11	533.8048	4	1.8	HLQLAIRNDEELNKLLGR	HLQLAIRNDEELNKLLGR		18	V20130429-09_FTMSms2hcd	46.486	83	100	13.2	0.0038	2.1e-5	3	14121.6	HUMAN	Histone H2A type 3
[65-9]	2	Q93077	H2A1C_HUMAN	HIST1H2AC	4	35.4	6.22	6.5e-11	644.3984	3	6.1	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-09_FTMSms2hcd	65.254	101	119	37.6	6.5e-11	2.1e-12	10	14105.6	HUMAN	Histone H2A type 1-C
[65-9]	2	Q93077	H2A1C_HUMAN	HIST1H2AC	4	35.4	6.22	6.5e-11	650.8475	2	1.7	NDEELNKLLGR	NDEELNKLLGR		11	V20130429-09_FTMSms2hcd	37.234	90	100	45.2	8.8e-8	1.4e-10	3	14105.6	HUMAN	Histone H2A type 1-C
[65-9]	2	Q93077	H2A1C_HUMAN	HIST1H2AC	4	35.4	6.22	6.5e-11	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14105.6	HUMAN	Histone H2A type 1-C
[65-9]	2	Q93077	H2A1C_HUMAN	HIST1H2AC	4	35.4	6.22	6.5e-11	533.8048	4	1.8	HLQLAIRNDEELNKLLGR	HLQLAIRNDEELNKLLGR		18	V20130429-09_FTMSms2hcd	46.486	83	100	13.2	0.0038	2.1e-5	3	14105.6	HUMAN	Histone H2A type 1-C
[65-10]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	2	18.0	2.95	3.2e-7	685.8996	2	1.2	ATIAGGGVIPHIHK	ATIAGGGVIPHIHK		14	V20130429-09_FTMSms2hcd	29.300	103	116	25.8	3.2e-7	1.2e-9	2	13552.8	HUMAN	Histone H2A.Z
[65-10]	1	P0C0S5	H2AZ_HUMAN	H2AFZ	2	18.0	2.95	3.2e-7	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	24	32	27.2	0.0018	2.9e-6	15	13552.8	HUMAN	Histone H2A.Z
[65-11]	1	Q71UI9	H2AV_HUMAN	H2AFV	2	18.0	2.95	3.2e-7	685.8996	2	1.2	ATIAGGGVIPHIHK	ATIAGGGVIPHIHK		14	V20130429-09_FTMSms2hcd	29.300	103	116	25.8	3.2e-7	1.2e-9	2	13508.8	HUMAN	Histone H2A.V
[65-11]	1	Q71UI9	H2AV_HUMAN	H2AFV	2	18.0	2.95	3.2e-7	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	24	32	27.2	0.0018	2.9e-6	15	13508.8	HUMAN	Histone H2A.V
[65-12]	1	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	2	12.3	1.58	1.1e-4	418.7590	2	0.75	HLQLAVR	HLQLAVR		7	V20130429-09_FTMSms2hcd	21.409	83	89	26.6	1.1e-4	1.1e-6	1	13995.4	HUMAN	Histone H2A type 2-B
[65-12]	1	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	2	12.3	1.58	1.1e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	13995.4	HUMAN	Histone H2A type 2-B
[65-13]	0	P16104	H2AX_HUMAN	H2AFX	1	6.3	0.93	0.0018	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	15144.7	HUMAN	Histone H2A.x
[65-14]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	1	6.9	0.93	0.0018	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-09_FTMSms2hcd	36.453	22	30	27.2	0.0018	2.9e-6	15	14233.6	HUMAN	Histone H2A type 1-A
[66]		P09382	LEG1_HUMAN	LGALS1	4	41.5	6.82	5.1e-12	937.4761	3	2.4	EAVFPFQPGSVAEVCITFDQANLTVK	EAVFPFQPGSVAEVCITFDQANLTVK		26	V20130429-09_FTMSms2hcd	75.742	75	100	41.5	5.1e-12	6.3e-15	1	14715.8	HUMAN	Galectin-1
[66]		P09382	LEG1_HUMAN	LGALS1	4	41.5	6.82	5.1e-12	538.7408	2	-1.2	DGGAWGTEQR	DGGAWGTEQR		10	V20130429-09_FTMSms2hcd	16.002	65	74	33.8	2.5e-6	4.9e-9	1	14715.8	HUMAN	Galectin-1
[66]		P09382	LEG1_HUMAN	LGALS1	4	41.5	6.82	5.1e-12	439.2607	2	-0.064	SFVLNLGK	SFVLNLGK		8	V20130429-09_FTMSms2hcd	40.792	30	37	28.1	1.5e-5	6.2e-8	1	14715.8	HUMAN	Galectin-1
[66]		P09382	LEG1_HUMAN	LGALS1	4	41.5	6.82	5.1e-12	477.2267	3	1.0	DSNNLCLHFNPR	DSNNLCLHFNPR		12	V20130429-09_FTMSms2hcd	36.040	38	49	19.4	2.6e-5	3.6e-8	1	14715.8	HUMAN	Galectin-1
[67]		O00299	CLIC1_HUMAN	CLIC1	3	16.2	7.22	9.3e-13	922.9936	2	2.5	LAALNPESNTAGLDIFAK	LAALNPESNTAGLDIFAK		18	V20130429-09_FTMSms2hcd	54.109	96	113	48.5	9.3e-13	1.6e-15	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[67]		O00299	CLIC1_HUMAN	CLIC1	3	16.2	7.22	9.3e-13	533.3122	2	0.55	LFMVLWLK	LFM(Oxidation)VLWLK	Oxidation@32	8	V20130429-09_FTMSms2hcd	60.129	30	37	30.8	2.0e-10	8.1e-13	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[67]		O00299	CLIC1_HUMAN	CLIC1	3	16.2	7.22	9.3e-13	729.8787	2	1.8	MAEEQPQVELFVK	M(Met-loss+Acetyl)AEEQPQVELFVK	Met-loss+Acetyl@1	13	V20130429-09_FTMSms2hcd	49.144	1	13	16.9	1.5e-6	2.1e-9	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[68]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.77	6.2e-12	594.2864	3	1.4	MADKPDMGEIASFDKAK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDKAK	Met-loss+Acetyl@1;Oxidation@7	17	V20130429-09_FTMSms2hcd	28.558	1	17	39.6	6.2e-12	6.7e-15	1	5025.7	HUMAN	Thymosin beta-10
[68]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.77	6.2e-12	791.3604	2	2.2	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-09_FTMSms2hcd	30.981	1	15	43.6	1.5e-9	1.9e-12	1	5025.7	HUMAN	Thymosin beta-10
[68]		P63313	TYB10_HUMAN	TMSB10	3	70.5	6.77	6.2e-12	562.9700	3	-3.9	NTLPTKETIEQEKR	NTLPTKETIEQEKR		14	V20130429-09_FTMSms2hcd	19.778	27	40	46.0	5.1e-8	8.4e-11	1	5025.7	HUMAN	Thymosin beta-10
[69]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.00	1.7e-10	742.3624	2	-0.040	GSFSEQGINEFLR	GSFSEQGINEFLR		13	V20130429-09_FTMSms2hcd	48.234	374	386	42.6	1.7e-10	2.1e-13	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[69]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.00	1.7e-10	764.4313	2	4.2	LAAVDATVNQVLASR	LAAVDATVNQVLASR		15	V20130429-09_FTMSms2hcd	47.392	217	231	43.0	2.4e-9	6.2e-12	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[69]		Q15084	PDIA6_HUMAN	PDIA6	3	9.5	6.00	1.7e-10	693.8895	2	9.4	TGEAIVDAALSALR	TGEAIVDAALSALR		14	V20130429-09_FTMSms2hcd	60.999	119	132	44.0	2.6e-9	5.2e-12	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[70]		P07305	H10_HUMAN	H1F0	3	12.4	6.06	5.4e-11	745.8611	2	-0.41	MTENSTSAPAAKPK	M(Acetyl+Oxidation)TENSTSAPAAKPK		14	V20130429-09_FTMSms2hcd	11.137	1	14	25.8	5.4e-11	6.5e-14	1	20863.1	HUMAN	Histone H1.0
[70]		P07305	H10_HUMAN	H1F0	3	12.4	6.06	5.4e-11	672.3442	2	0.74	MTENSTSAPAAKPK	M(Met-loss+Acetyl)TENSTSAPAAKPK	Met-loss+Acetyl@1	14	V20130429-09_FTMSms2hcd	10.536	1	14	25.9	8.3e-11	1.2e-13	1	20863.1	HUMAN	Histone H1.0
[70]		P07305	H10_HUMAN	H1F0	3	12.4	6.06	5.4e-11	530.7676	2	0.94	VGENADSQIK	VGENADSQIK		10	V20130429-09_FTMSms2hcd	11.832	60	69	37.9	1.2e-7	1.7e-10	1	20863.1	HUMAN	Histone H1.0
[71]		P39019	RS19_HUMAN	RPS19	5	27.6	4.89	9.0e-10	574.2689	2	-0.68	NGVMPSHFSR	NGVM(Oxidation)PSHFSR	Oxidation@88	10	V20130429-09_FTMSms2hcd	13.978	85	94	32.9	9.0e-10	1.6e-12	1	16060.6	HUMAN	40S ribosomal protein S19
[71]		P39019	RS19_HUMAN	RPS19	5	27.6	4.89	9.0e-10	567.7809	2	0.63	DVNQQEFVR	DVNQQEFVR		9	V20130429-09_FTMSms2hcd	23.390	8	16	30.8	8.6e-7	1.3e-9	1	16060.6	HUMAN	40S ribosomal protein S19
[71]		P39019	RS19_HUMAN	RPS19	5	27.6	4.89	9.0e-10	657.3773	2	0.73	LKVPEWVDTVK	LKVPEWVDTVK		11	V20130429-09_FTMSms2hcd	42.239	28	38	26.2	4.2e-6	1.2e-8	1	16060.6	HUMAN	40S ribosomal protein S19
[71]		P39019	RS19_HUMAN	RPS19	5	27.6	4.89	9.0e-10	485.8013	2	2.2	VLQALEGLK	VLQALEGLK		9	V20130429-09_FTMSms2hcd	37.929	103	111	26.6	1.5e-5	6.8e-8	1	16060.6	HUMAN	40S ribosomal protein S19
[71]		P39019	RS19_HUMAN	RPS19	5	27.6	4.89	9.0e-10	563.8514	2	1.1	RVLQALEGLK	RVLQALEGLK		10	V20130429-09_FTMSms2hcd	34.302	102	111	31.4	5.0e-5	3.4e-7	1	16060.6	HUMAN	40S ribosomal protein S19
[72]		P05388	RLA0_HUMAN	RPLP0	4	18.3	7.52	2.6e-13	918.1734	3	14	AFLADPSAFVAAAPVAAATTAAPAAAAAPAK	AFLADPSAFVAAAPVAAATTAAPAAAAAPAK		31	V20130429-09_FTMSms2hcd	59.653	267	297	41.1	2.6e-13	1.1e-15	1	34273.8	HUMAN	60S acidic ribosomal protein P0
[72]		P05388	RLA0_HUMAN	RPLP0	4	18.3	7.52	2.6e-13	611.3149	2	0.24	GHLENNPALEK	GHLENNPALEK		11	V20130429-09_FTMSms2hcd	15.245	67	77	37.8	1.2e-6	1.9e-9	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[72]		P05388	RLA0_HUMAN	RPLP0	4	18.3	7.52	2.6e-13	609.3425	2	0.088	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-09_FTMSms2hcd	45.783	17	26	34.9	8.4e-5	1.8e-7	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[72]		P05388	RLA0_HUMAN	RPLP0	4	18.3	7.52	2.6e-13	374.7454	2	0.94	LLPHIR	LLPHIR		6	V20130429-09_FTMSms2hcd	23.536	78	83	14.1	0.016	1.6e-4	1	34273.8	HUMAN	60S acidic ribosomal protein P0
[72-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.69	1.2e-6	611.3149	2	0.24	GHLENNPALEK	GHLENNPALEK		11	V20130429-09_FTMSms2hcd	15.245	67	77	37.8	1.2e-6	1.9e-9	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[72-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.69	1.2e-6	609.3425	2	0.088	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-09_FTMSms2hcd	45.783	17	26	34.9	8.4e-5	1.8e-7	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[73]		O75531	BAF_HUMAN	BANF1	3	41.6	5.66	2.0e-10	806.0913	3	6.8	DFVAEPMGEKPVGSLAGIGEVLGK	DFVAEPM(Oxidation)GEKPVGSLAGIGEVLGK	Oxidation@15	24	V20130429-09_FTMSms2hcd	53.648	9	32	37.0	2.0e-10	3.4e-13	1	10058.7	HUMAN	Barrier-to-autointegration factor
[73]		O75531	BAF_HUMAN	BANF1	3	41.6	5.66	2.0e-10	493.3093	3	-0.51	AYVVLGQFLVLKK	AYVVLGQFLVLKK		13	V20130429-09_FTMSms2hcd	55.783	42	54	37.0	3.3e-10	1.1e-11	1	10058.7	HUMAN	Barrier-to-autointegration factor
[73]		O75531	BAF_HUMAN	BANF1	3	41.6	5.66	2.0e-10	675.4149	2	2.5	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-09_FTMSms2hcd	63.979	42	53	34.8	1.0e-8	2.0e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[74]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	8.05	2.6e-14	744.8840	2	1.8	IFVGGLSPDTPEEK	IFVGGLSPDTPEEK		14	V20130429-09_FTMSms2hcd	37.851	184	197	46.6	2.6e-14	3.7e-17	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[74]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	8.05	2.6e-14	514.9145	3	-0.39	HSEAATAQREEWK	HSEAATAQREEWK		13	V20130429-09_FTMSms2hcd	12.727	86	98	28.8	5.1e-8	6.3e-11	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[74]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	8.05	2.6e-14	457.7606	2	0.52	GFGFVLFK	GFGFVLFK		8	V20130429-09_FTMSms2hcd	57.271	139	146	25.9	3.9e-5	9.8e-8	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[74-1]	0	O14979	HNRDL_HUMAN	HNRPDL	1	1.9	1.69	3.9e-5	457.7606	2	0.52	GFGFVLFK	GFGFVLFK		8	V20130429-09_FTMSms2hcd	57.271	190	197	25.9	3.9e-5	9.8e-8	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[75]		P08865	RSSA_HUMAN	RPSA	3	14.2	6.94	3.1e-12	870.9791	2	1.1	AIVAIENPADVSVISSR	AIVAIENPADVSVISSR		17	V20130429-09_FTMSms2hcd	47.272	64	80	55.2	3.1e-12	7.2e-15	1	32854.4	HUMAN	40S ribosomal protein SA
[75]		P08865	RSSA_HUMAN	RPSA	3	14.2	6.94	3.1e-12	916.9714	2	2.5	MSGALDVLQMKEEDVLK	M(Met-loss+Acetyl)SGALDVLQM(Oxidation)KEEDVLK	Met-loss+Acetyl@1;Oxidation@10	17	V20130429-09_FTMSms2hcd	54.028	1	17	29.5	4.0e-8	5.3e-11	1	32854.4	HUMAN	40S ribosomal protein SA
[75]		P08865	RSSA_HUMAN	RPSA	3	14.2	6.94	3.1e-12	456.7796	2	0.69	LLVVTDPR	LLVVTDPR		8	V20130429-09_FTMSms2hcd	29.839	121	128	29.6	1.2e-6	7.1e-9	1	32854.4	HUMAN	40S ribosomal protein SA
[76]		P50454	SERPH_HUMAN	SERPINH1	2	6.7	7.78	6.7e-14	830.4050	2	0.85	LYGPSSVSFADDFVR	LYGPSSVSFADDFVR		15	V20130429-09_FTMSms2hcd	51.985	134	148	39.4	6.7e-14	7.9e-17	1	46440.9	HUMAN	Serpin H1
[76]		P50454	SERPH_HUMAN	SERPINH1	2	6.7	7.78	6.7e-14	546.6397	3	13	LFYADHPFIFLVR	LFYADHPFIFLVR		13	V20130429-09_FTMSms2hcd	61.353	381	393	35.8	1.5e-13	4.5e-16	1	46440.9	HUMAN	Serpin H1
[77]		P31948	STIP1_HUMAN	STIP1	3	6.1	6.19	7.4e-11	653.3216	2	0.33	MEQVNELKEK	Acetyl-M(Oxidation)EQVNELKEK	Oxidation@1=6	10	V20130429-09_FTMSms2hcd	22.931	1	10	35.2	7.4e-11	1.0e-13	1	62639.8	HUMAN	Stress-induced-phosphoprotein 1
[77]		P31948	STIP1_HUMAN	STIP1	3	6.1	6.19	7.4e-11	744.9014	2	0.73	LAYINPDLALEEK	LAYINPDLALEEK		13	V20130429-09_FTMSms2hcd	46.473	352	364	43.0	7.0e-8	1.3e-10	1	62639.8	HUMAN	Stress-induced-phosphoprotein 1
[77]		P31948	STIP1_HUMAN	STIP1	3	6.1	6.19	7.4e-11	558.8270	2	2.0	LMDVGLIAIR	LM(Oxidation)DVGLIAIR	Oxidation@535	10	V20130429-09_FTMSms2hcd	44.369	534	543	41.9	2.4e-7	6.2e-10	1	62639.8	HUMAN	Stress-induced-phosphoprotein 1
[78]		Q00610	CLH1_HUMAN	CLTC	3	1.9	7.25	8.1e-13	667.8207	2	0.45	IYIDSNNNPER	IYIDSNNNPER		11	V20130429-09_FTMSms2hcd	21.397	882	892	43.9	8.1e-13	1.0e-15	1	191616.3	HUMAN	Clathrin heavy chain 1
[78]		Q00610	CLH1_HUMAN	CLTC	3	1.9	7.25	8.1e-13	652.8352	2	2.9	NNLAGAEELFAR	NNLAGAEELFAR		12	V20130429-09_FTMSms2hcd	43.409	355	366	30.6	5.9e-7	7.7e-10	1	191616.3	HUMAN	Clathrin heavy chain 1
[78]		Q00610	CLH1_HUMAN	CLTC	3	1.9	7.25	8.1e-13	555.8383	2	2.1	LLLPWLEAR	LLLPWLEAR		9	V20130429-09_FTMSms2hcd	61.607	857	865	35.1	7.6e-6	6.0e-8	1	191616.3	HUMAN	Clathrin heavy chain 1
[79]		P23284	PPIB_HUMAN	PPIB	4	22.2	5.43	1.9e-9	554.5267	4	1.7	VIKDFMIQGGDFTRGDGTGGK	VIKDFM(Oxidation)IQGGDFTRGDGTGGK	Oxidation@101	21	V20130429-09_FTMSms2hcd	34.871	96	116	34.7	1.9e-9	1.9e-12	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[79]		P23284	PPIB_HUMAN	PPIB	4	22.2	5.43	1.9e-9	682.8572	2	1.1	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-09_FTMSms2hcd	45.324	72	84	41.2	1.4e-7	1.9e-10	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[79]		P23284	PPIB_HUMAN	PPIB	4	22.2	5.43	1.9e-9	440.7688	2	1.4	VIFGLFGK	VIFGLFGK		8	V20130429-09_FTMSms2hcd	52.712	60	67	25.2	9.0e-5	6.4e-7	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[79]		P23284	PPIB_HUMAN	PPIB	4	22.2	5.43	1.9e-9	406.7191	2	0.99	VYFDLR	VYFDLR		6	V20130429-09_FTMSms2hcd	36.412	46	51	18.1	0.0034	8.7e-6	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[80]		Q14974	IMB1_HUMAN	KPNB1	3	4.1	6.40	3.1e-11	803.4349	2	-14	LAATNALLNSLEFTK	LAATNALLNSLEFTK		15	V20130429-09_FTMSms2hcd	57.654	192	206	50.2	3.1e-11	5.4e-14	1	97171.1	HUMAN	Importin subunit beta-1
[80]		Q14974	IMB1_HUMAN	KPNB1	3	4.1	6.40	3.1e-11	613.3358	2	-0.36	VLANPGNSQVAR	VLANPGNSQVAR		12	V20130429-09_FTMSms2hcd	18.207	43	54	47.3	2.6e-9	6.3e-12	1	97171.1	HUMAN	Importin subunit beta-1
[80]		Q14974	IMB1_HUMAN	KPNB1	3	4.1	6.40	3.1e-11	574.3223	2	8.2	MELITILEK	M(Acetyl+Oxidation)ELITILEK		9	V20130429-09_FTMSms2hcd	65.192	1	9	10.7	9.5e-5	2.3e-7	1	97171.1	HUMAN	Importin subunit beta-1
[81]		P43487	RANG_HUMAN	RANBP1	2	16.9	9.51	5.2e-17	671.3414	4	11	AWVWNTHADFADECPKPELLAIR	AWVWNTHADFADECPKPELLAIR		23	V20130429-09_FTMSms2hcd	59.666	119	141	43.0	5.2e-17	6.6e-20	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[81]		P43487	RANG_HUMAN	RANBP1	2	16.9	9.51	5.2e-17	691.3242	2	3.0	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-09_FTMSms2hcd	44.168	40	50	36.2	7.3e-9	1.0e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[82]		Q02878	RL6_HUMAN	RPL6	3	12.8	5.54	1.2e-9	443.2516	4	-1.3	VLATVTKPVGGDKNGGTR	VLATVTKPVGGDKNGGTR		18	V20130429-09_FTMSms2hcd	17.907	88	105	31.6	1.2e-9	4.0e-12	1	32728.2	HUMAN	60S ribosomal protein L6
[82]		Q02878	RL6_HUMAN	RPL6	3	12.8	5.54	1.2e-9	579.8365	2	2.4	AIPQLQGYLR	AIPQLQGYLR		10	V20130429-09_FTMSms2hcd	43.155	263	272	41.6	4.1e-8	9.0e-11	1	32728.2	HUMAN	60S ribosomal protein L6
[82]		Q02878	RL6_HUMAN	RPL6	3	12.8	5.54	1.2e-9	570.2720	2	-0.037	YYPTEDVPR	YYPTEDVPR		9	V20130429-09_FTMSms2hcd	25.958	115	123	32.2	1.7e-7	2.3e-10	1	32728.2	HUMAN	60S ribosomal protein L6
[83]		P62269	RS18_HUMAN	RPS18	4	24.3	5.00	1.2e-8	541.3181	3	-1.7	MSLVIPEKFQHILR	M(Met-loss+Acetyl)SLVIPEKFQHILR	Met-loss+Acetyl@1	14	V20130429-09_FTMSms2hcd	54.687	1	14	43.8	1.2e-8	8.5e-11	1	17718.8	HUMAN	40S ribosomal protein S18
[83]		P62269	RS18_HUMAN	RPS18	4	24.3	5.00	1.2e-8	501.2716	2	-1.5	VLNTNIDGR	VLNTNIDGR		9	V20130429-09_FTMSms2hcd	21.367	15	23	30.4	1.8e-6	3.1e-9	1	17718.8	HUMAN	40S ribosomal protein S18
[83]		P62269	RS18_HUMAN	RPS18	4	24.3	5.00	1.2e-8	408.2194	2	0.50	HFWGLR	HFWGLR		6	V20130429-09_FTMSms2hcd	30.828	125	130	18.2	1.3e-4	3.2e-7	1	17718.8	HUMAN	40S ribosomal protein S18
[83]		P62269	RS18_HUMAN	RPS18	4	24.3	5.00	1.2e-8	530.7829	2	1.0	IPDWFLNR	IPDWFLNR		8	V20130429-09_FTMSms2hcd	49.531	79	86	34.3	3.0e-4	3.8e-7	1	17718.8	HUMAN	40S ribosomal protein S18
[84]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	2.3e-10	892.9663	2	7.5	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-09_FTMSms2hcd	57.866	153	166	33.9	2.3e-10	3.5e-13	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[84]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	2.3e-10	622.8181	2	1.6	MAAQGEPQVQFK	M(Met-loss+Acetyl)AAQGEPQVQFK	Met-loss+Acetyl@1	12	V20130429-09_FTMSms2hcd	31.437	1	12	34.4	1.2e-7	1.6e-10	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[84]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	2.3e-10	607.8088	2	4.2	NLQYYDISAK	NLQYYDISAK		10	V20130429-09_FTMSms2hcd	32.020	143	152	24.1	2.4e-5	3.9e-8	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[84]		P62826	RAN_HUMAN	RAN	4	19.4	5.36	2.3e-10	379.7190	2	-0.080	SIVFHR	SIVFHR		6	V20130429-09_FTMSms2hcd	17.658	135	140	23.2	1.6e-4	3.3e-7	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[85]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	10.07	4.9e-18	1137.8650	3	2.8	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-09_FTMSms2hcd	61.126	548	577	53.3	4.9e-18	4.8e-21	1	66408.9	HUMAN	Lamin-B1
[85]		P20700	LMNB1_HUMAN	LMNB1	2	6.8	10.07	4.9e-18	586.3315	2	-0.99	IQELEDLLAK	IQELEDLLAK		10	V20130429-09_FTMSms2hcd	46.449	321	330	32.8	5.3e-6	1.2e-8	1	66408.9	HUMAN	Lamin-B1
[86]		P40926	MDHM_HUMAN	MDH2	2	10.4	6.88	4.0e-12	897.0503	2	2.1	VAVLGASGGIGQPLSLLLK	VAVLGASGGIGQPLSLLLK		19	V20130429-09_FTMSms2hcd	67.390	27	45	45.4	4.0e-12	1.4e-13	1	35503.6	HUMAN	Malate dehydrogenase, mitochondrial
[86]		P40926	MDHM_HUMAN	MDH2	2	10.4	6.88	4.0e-12	735.8547	2	1.1	AGAGSATLSMAYAGAR	AGAGSATLSM(Oxidation)AYAGAR	Oxidation@251	16	V20130429-09_FTMSms2hcd	25.984	242	257	47.8	6.9e-12	8.5e-15	1	35503.6	HUMAN	Malate dehydrogenase, mitochondrial
[87]		P08708	RS17_HUMAN	RPS17	2	26.7	6.73	7.5e-12	574.8100	2	-0.45	IAGYVTHLMK	IAGYVTHLM(Oxidation)K	Oxidation@58	10	V20130429-09_FTMSms2hcd	23.377	50	59	41.9	7.5e-12	1.3e-14	2	15550.3	HUMAN	40S ribosomal protein S17
[87]		P08708	RS17_HUMAN	RPS17	2	26.7	6.73	7.5e-12	1002.8293	3	7.8	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-09_FTMSms2hcd	59.344	82	107	35.5	8.9e-12	1.0e-14	2	15550.3	HUMAN	40S ribosomal protein S17
[87-1]	0	P0CW22	RS17L_HUMAN	RPS17L	2	26.7	6.73	7.5e-12	574.8100	2	-0.45	IAGYVTHLMK	IAGYVTHLM(Oxidation)K	Oxidation@58	10	V20130429-09_FTMSms2hcd	23.377	50	59	41.9	7.5e-12	1.3e-14	2	15550.3	HUMAN	40S ribosomal protein S17-like
[87-1]	0	P0CW22	RS17L_HUMAN	RPS17L	2	26.7	6.73	7.5e-12	1002.8293	3	7.8	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-09_FTMSms2hcd	59.344	82	107	35.5	8.9e-12	1.0e-14	2	15550.3	HUMAN	40S ribosomal protein S17-like
[88]		P36578	RL4_HUMAN	RPL4	3	10.8	6.43	1.7e-11	579.0766	4	11	IEEVPELPLVVEDKVEGYKK	IEEVPELPLVVEDKVEGYKK		20	V20130429-09_FTMSms2hcd	50.937	144	163	39.0	1.7e-11	8.1e-14	1	47697.7	HUMAN	60S ribosomal protein L4
[88]		P36578	RL4_HUMAN	RPL4	3	10.8	6.43	1.7e-11	498.2895	4	0.84	APIRPDIVNFVHTNLRK	APIRPDIVNFVHTNLRK		17	V20130429-09_FTMSms2hcd	42.119	30	46	20.6	1.7e-6	1.2e-8	1	47697.7	HUMAN	60S ribosomal protein L4
[88]		P36578	RL4_HUMAN	RPL4	3	10.8	6.43	1.7e-11	361.8890	3	0.35	ILKSPEIQR	ILKSPEIQR		9	V20130429-09_FTMSms2hcd	20.778	292	300	23.7	1.7e-5	1.0e-7	1	47697.7	HUMAN	60S ribosomal protein L4
[89]		Q16658	FSCN1_HUMAN	FSCN1	2	6.9	8.68	1.8e-15	873.4489	3	3.0	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-09_FTMSms2hcd	73.167	248	271	58.1	1.8e-15	2.6e-18	1	54530.4	HUMAN	Fascin
[89]		Q16658	FSCN1_HUMAN	FSCN1	2	6.9	8.68	1.8e-15	414.2677	3	-0.23	LINRPIIVFR	LINRPIIVFR		10	V20130429-09_FTMSms2hcd	41.042	380	389	39.6	1.2e-7	2.1e-9	1	54530.4	HUMAN	Fascin
[90]		P62913	RL11_HUMAN	RPL11	2	15.2	6.48	2.2e-11	730.8253	2	-0.074	MAQDQGEKENPMR	M(Met-loss+Acetyl)AQDQGEKENPM(Oxidation)R	Met-loss+Acetyl@1;Oxidation@12	13	V20130429-09_FTMSms2hcd	8.906	1	13	30.0	2.2e-11	3.1e-14	1	20252.6	HUMAN	60S ribosomal protein L11
[90]		P62913	RL11_HUMAN	RPL11	2	15.2	6.48	2.2e-11	773.9273	2	-0.14	VLEQLTGQTPVFSK	VLEQLTGQTPVFSK		14	V20130429-09_FTMSms2hcd	42.401	39	52	46.5	6.1e-11	1.4e-13	1	20252.6	HUMAN	60S ribosomal protein L11
[91]		P46776	RL27A_HUMAN	RPL27A	2	22.3	6.59	1.3e-11	860.4427	3	8.3	NQSFCPTVNLDKLWTLVSEQTR	NQSFCPTVNLDKLWTLVSEQTR		22	V20130429-09_FTMSms2hcd	71.789	66	87	38.8	1.3e-11	1.8e-14	1	16561.5	HUMAN	60S ribosomal protein L27a
[91]		P46776	RL27A_HUMAN	RPL27A	2	22.3	6.59	1.3e-11	556.3280	2	1.6	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-09_FTMSms2hcd	38.870	95	105	43.8	1.0e-10	5.6e-13	1	16561.5	HUMAN	60S ribosomal protein L27a
[92]		P50395	GDIB_HUMAN	GDI2	3	11.0	5.88	4.1e-11	1071.0682	2	11	SPYLYPLYGLGELPQGFAR	SPYLYPLYGLGELPQGFAR		19	V20130429-09_FTMSms2hcd	66.879	222	240	35.5	4.1e-11	7.6e-14	2	50663.7	HUMAN	Rab GDP dissociation inhibitor beta
[92]		P50395	GDIB_HUMAN	GDI2	3	11.0	5.88	4.1e-11	717.7017	3	1.7	FDLGQDVIDFTGHALALYR	FDLGQDVIDFTGHALALYR		19	V20130429-09_FTMSms2hcd	73.943	175	193	22.3	1.8e-7	2.3e-10	2	50663.7	HUMAN	Rab GDP dissociation inhibitor beta
[92]		P50395	GDIB_HUMAN	GDI2	3	11.0	5.88	4.1e-11	609.3623	2	2.7	FVSISDLLVPK	FVSISDLLVPK		11	V20130429-09_FTMSms2hcd	59.249	380	390	24.2	1.8e-5	8.6e-8	1	50663.7	HUMAN	Rab GDP dissociation inhibitor beta
[92-1]	0	P31150	GDIA_HUMAN	GDI1	2	8.5	5.88	4.1e-11	1071.0682	2	11	SPYLYPLYGLGELPQGFAR	SPYLYPLYGLGELPQGFAR		19	V20130429-09_FTMSms2hcd	66.879	222	240	35.5	4.1e-11	7.6e-14	2	50583.2	HUMAN	Rab GDP dissociation inhibitor alpha
[92-1]	0	P31150	GDIA_HUMAN	GDI1	2	8.5	5.88	4.1e-11	717.7017	3	1.7	FDLGQDVIDFTGHALALYR	FDLGQDVIDFTGHALALYR		19	V20130429-09_FTMSms2hcd	73.943	175	193	22.3	1.8e-7	2.3e-10	2	50583.2	HUMAN	Rab GDP dissociation inhibitor alpha
[93]		P26641	EF1G_HUMAN	EEF1G	2	5.5	6.89	3.7e-12	792.3782	2	0.15	MAAGTLYTYPENWR	M(Met-loss+Acetyl)AAGTLYTYPENWR	Met-loss+Acetyl@1	14	V20130429-09_FTMSms2hcd	50.381	1	14	40.0	3.7e-12	4.5e-15	1	50119.2	HUMAN	Elongation factor 1-gamma
[93]		P26641	EF1G_HUMAN	EEF1G	2	5.5	6.89	3.7e-12	375.2132	3	-0.72	AKDPFAHLPK	AKDPFAHLPK		10	V20130429-09_FTMSms2hcd	25.389	276	285	25.9	3.7e-9	9.7e-12	1	50119.2	HUMAN	Elongation factor 1-gamma
[94]		P25398	RS12_HUMAN	RPS12	2	25.0	7.16	1.2e-12	1137.0709	2	0.69	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-09_FTMSms2hcd	71.832	1	23	46.4	1.2e-12	1.4e-15	1	14515.1	HUMAN	40S ribosomal protein S12
[94]		P25398	RS12_HUMAN	RPS12	2	25.0	7.16	1.2e-12	533.8000	2	-7.2	TALIHDGLAR	TALIHDGLAR		10	V20130429-09_FTMSms2hcd	24.171	24	33	40.6	1.5e-7	3.3e-10	1	14515.1	HUMAN	40S ribosomal protein S12
[95]		P84103	SRSF3_HUMAN	SRSF3	2	15.9	6.33	4.1e-11	626.3231	3	1.9	VYVGNLGNNGNKTELER	VYVGNLGNNGNKTELER		17	V20130429-09_FTMSms2hcd	27.719	12	28	52.4	4.1e-11	5.3e-14	1	19329.8	HUMAN	Serine/arginine-rich splicing factor 3
[95]		P84103	SRSF3_HUMAN	SRSF3	2	15.9	6.33	4.1e-11	522.2670	2	-4.0	AFGYYGPLR	AFGYYGPLR		9	V20130429-09_FTMSms2hcd	38.114	29	37	24.1	2.0e-8	4.3e-11	1	19329.8	HUMAN	Serine/arginine-rich splicing factor 3
[96]		P25705	ATPA_HUMAN	ATP5A1	2	4.7	6.73	7.6e-12	812.9560	2	8.8	TGAIVDVPVGEELLGR	TGAIVDVPVGEELLGR		16	V20130429-09_FTMSms2hcd	53.902	134	149	42.0	7.6e-12	2.1e-14	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[96]		P25705	ATPA_HUMAN	ATP5A1	2	4.7	6.73	7.6e-12	513.8011	2	0.68	AVDSLVPIGR	AVDSLVPIGR		10	V20130429-09_FTMSms2hcd	36.815	195	204	29.1	2.6e-7	1.1e-9	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[97]		P27797	CALR_HUMAN	CALR	2	10.6	7.65	1.5e-13	1090.1692	3	-0.81	SGTIFDNFLITNDEAYAEEFGNETWGVTK	SGTIFDNFLITNDEAYAEEFGNETWGVTK		29	V20130429-09_FTMSms2hcd	73.866	323	351	45.8	1.5e-13	1.5e-16	1	48141.9	HUMAN	Calreticulin
[97]		P27797	CALR_HUMAN	CALR	2	10.6	7.65	1.5e-13	450.9655	4	0.16	IKDPDASKPEDWDER	IKDPDASKPEDWDER		15	V20130429-09_FTMSms2hcd	23.065	208	222	19.9	1.7e-5	1.7e-8	1	48141.9	HUMAN	Calreticulin
[98]		P62081	RS7_HUMAN	RPS7	2	11.9	5.63	8.1e-10	789.7758	3	14	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-09_FTMSms2hcd	68.505	121	142	25.5	8.1e-10	3.2e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[98]		P62081	RS7_HUMAN	RPS7	2	11.9	5.63	8.1e-10	631.6028	4	3.0	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-09_FTMSms2hcd	64.874	121	143	44.6	4.0e-9	1.8e-11	1	22127.0	HUMAN	40S ribosomal protein S7
[99]		P46778	RL21_HUMAN	RPL21	2	20.6	5.74	5.2e-10	820.9608	2	1.5	VYNVTQHAVGIVVNK	VYNVTQHAVGIVVNK		15	V20130429-09_FTMSms2hcd	34.661	64	78	43.5	5.2e-10	1.5e-12	1	18565.0	HUMAN	60S ribosomal protein L21
[99]		P46778	RL21_HUMAN	RPL21	2	20.6	5.74	5.2e-10	1047.5104	2	1.7	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-09_FTMSms2hcd	57.310	143	160	28.6	1.8e-8	1.8e-11	1	18565.0	HUMAN	60S ribosomal protein L21
[100]		P62750	RL23A_HUMAN	RPL23A	3	23.7	3.94	7.1e-7	685.3918	2	-2.5	VNTLIRPDGEKK	VNTLIRPDGEKK		12	V20130429-09_FTMSms2hcd	16.742	124	135	39.0	7.1e-7	2.3e-9	1	17695.2	HUMAN	60S ribosomal protein L23a
[100]		P62750	RL23A_HUMAN	RPL23A	3	23.7	3.94	7.1e-7	468.7562	2	1.5	LYDIDVAK	LYDIDVAK		8	V20130429-09_FTMSms2hcd	31.337	116	123	26.8	8.1e-7	1.9e-9	1	17695.2	HUMAN	60S ribosomal protein L23a
[100]		P62750	RL23A_HUMAN	RPL23A	3	23.7	3.94	7.1e-7	901.0019	2	12	LAPDYDALDVANKIGII	LAPDYDALDVANKIGII		17	V20130429-09_FTMSms2hcd	63.122	140	156	13.2	1.4e-4	4.1e-7	1	17695.2	HUMAN	60S ribosomal protein L23a
[101]		P68431	H31_HUMAN	HIST1H3A	3	19.1	4.52	9.1e-8	668.3501	2	2.0	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-09_FTMSms2hcd	30.856	74	84	48.5	9.1e-8	1.4e-10	4	15404.2	HUMAN	Histone H3.1
[101]		P68431	H31_HUMAN	HIST1H3A	3	19.1	4.52	9.1e-8	516.8010	2	-0.16	YRPGTVALR	YRPGTVALR		9	V20130429-09_FTMSms2hcd	20.455	42	50	39.6	3.3e-7	9.4e-10	5	15404.2	HUMAN	Histone H3.1
[101]		P68431	H31_HUMAN	HIST1H3A	3	19.1	4.52	9.1e-8	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-09_FTMSms2hcd	23.338	65	70	24.4	0.011	2.1e-5	5	15404.2	HUMAN	Histone H3.1
[101-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	4.52	9.1e-8	668.3501	2	2.0	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-09_FTMSms2hcd	30.856	74	84	48.5	9.1e-8	1.4e-10	4	15328.0	HUMAN	Histone H3.3
[101-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	4.52	9.1e-8	516.8010	2	-0.16	YRPGTVALR	YRPGTVALR		9	V20130429-09_FTMSms2hcd	20.455	42	50	39.6	3.3e-7	9.4e-10	5	15328.0	HUMAN	Histone H3.3
[101-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	4.52	9.1e-8	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-09_FTMSms2hcd	23.338	65	70	24.4	0.011	2.1e-5	5	15328.0	HUMAN	Histone H3.3
[101-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	4.52	9.1e-8	668.3501	2	2.0	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-09_FTMSms2hcd	30.856	74	84	48.5	9.1e-8	1.4e-10	4	15508.4	HUMAN	Histone H3.1t
[101-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	4.52	9.1e-8	516.8010	2	-0.16	YRPGTVALR	YRPGTVALR		9	V20130429-09_FTMSms2hcd	20.455	42	50	39.6	3.3e-7	9.4e-10	5	15508.4	HUMAN	Histone H3.1t
[101-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	4.52	9.1e-8	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-09_FTMSms2hcd	23.338	65	70	24.4	0.011	2.1e-5	5	15508.4	HUMAN	Histone H3.1t
[101-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	4.52	9.1e-8	668.3501	2	2.0	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-09_FTMSms2hcd	30.856	74	84	48.5	9.1e-8	1.4e-10	4	15388.2	HUMAN	Histone H3.2
[101-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	4.52	9.1e-8	516.8010	2	-0.16	YRPGTVALR	YRPGTVALR		9	V20130429-09_FTMSms2hcd	20.455	42	50	39.6	3.3e-7	9.4e-10	5	15388.2	HUMAN	Histone H3.2
[101-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	4.52	9.1e-8	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-09_FTMSms2hcd	23.338	65	70	24.4	0.011	2.1e-5	5	15388.2	HUMAN	Histone H3.2
[101-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	4.18	3.3e-7	516.8010	2	-0.16	YRPGTVALR	YRPGTVALR		9	V20130429-09_FTMSms2hcd	20.455	41	49	39.6	3.3e-7	9.4e-10	5	15213.9	HUMAN	Histone H3.3C
[101-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	4.18	3.3e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-09_FTMSms2hcd	23.338	64	69	24.4	0.011	2.1e-5	5	15213.9	HUMAN	Histone H3.3C
[102]		P02545	LMNA_HUMAN	LMNA	2	4.5	5.70	6.1e-10	876.9357	2	1.0	NSNLVGAAHEELQQSR	NSNLVGAAHEELQQSR		16	V20130429-09_FTMSms2hcd	29.785	281	296	35.0	6.1e-10	6.6e-13	1	74140.1	HUMAN	Prelamin-A/C
[102]		P02545	LMNA_HUMAN	LMNA	2	4.5	5.70	6.1e-10	680.3483	2	2.2	SGAQASSTPLSPTR	SGAQASSTPLSPTR		14	V20130429-09_FTMSms2hcd	18.523	12	25	43.2	3.4e-8	4.6e-11	1	74140.1	HUMAN	Prelamin-A/C
[103]		P52292	IMA2_HUMAN	KPNA2	2	5.3	7.52	1.7e-13	775.4784	2	12	LLGASELPIVTPALR	LLGASELPIVTPALR		15	V20130429-09_FTMSms2hcd	56.566	301	315	39.0	1.7e-13	4.1e-15	1	57862.4	HUMAN	Importin subunit alpha-2
[103]		P52292	IMA2_HUMAN	KPNA2	2	5.3	7.52	1.7e-13	644.2996	2	-0.36	MSTNENANTPAAR	M(Met-loss+Acetyl)STNENANTPAAR	Met-loss+Acetyl@1	13	V20130429-09_FTMSms2hcd	12.128	1	13	23.4	6.7e-5	1.0e-7	1	57862.4	HUMAN	Importin subunit alpha-2
[104]		P26373	RL13_HUMAN	RPL13	3	12.8	5.67	6.9e-10	737.8844	2	0.46	NKSTESLQANVQR	NKSTESLQANVQR		13	V20130429-09_FTMSms2hcd	16.080	104	116	41.2	6.9e-10	9.8e-13	1	24261.7	HUMAN	60S ribosomal protein L13
[104]		P26373	RL13_HUMAN	RPL13	3	12.8	5.67	6.9e-10	475.7516	2	1.8	GFSLEELR	GFSLEELR		8	V20130429-09_FTMSms2hcd	41.850	75	82	31.0	8.5e-5	1.6e-7	1	24261.7	HUMAN	60S ribosomal protein L13
[104]		P26373	RL13_HUMAN	RPL13	3	12.8	5.67	6.9e-10	379.7500	2	0.53	LILFPR	LILFPR		6	V20130429-09_FTMSms2hcd	42.372	124	129	19.1	0.013	6.8e-5	1	24261.7	HUMAN	60S ribosomal protein L13
[105]		P62241	RS8_HUMAN	RPS8	2	11.5	5.80	4.0e-10	753.8943	2	0.98	ISSLLEEQFQQGK	ISSLLEEQFQQGK		13	V20130429-09_FTMSms2hcd	39.612	158	170	41.0	4.0e-10	5.6e-13	1	24205.4	HUMAN	40S ribosomal protein S8
[105]		P62241	RS8_HUMAN	RPS8	2	11.5	5.80	4.0e-10	657.8438	2	1.2	LTPEEEEILNK	LTPEEEEILNK		11	V20130429-09_FTMSms2hcd	32.564	129	139	38.3	1.1e-7	1.8e-10	1	24205.4	HUMAN	40S ribosomal protein S8
[106]		P02768	ALBU_HUMAN	ALB	3	4.8	5.64	7.8e-10	547.3246	3	13	KVPQVSTPTLVEVSR	KVPQVSTPTLVEVSR		15	V20130429-09_FTMSms2hcd	36.483	438	452	42.0	7.8e-10	5.5e-12	1	69367.4	HUMAN	Serum albumin
[106]		P02768	ALBU_HUMAN	ALB	3	4.8	5.64	7.8e-10	464.2510	2	1.4	YLYEIAR	YLYEIAR		7	V20130429-09_FTMSms2hcd	31.073	162	168	31.4	1.0e-3	2.4e-6	1	69367.4	HUMAN	Serum albumin
[106]		P02768	ALBU_HUMAN	ALB	3	4.8	5.64	7.8e-10	395.2393	2	-0.41	LVTDLTK	LVTDLTK		7	V20130429-09_FTMSms2hcd	22.086	258	264	32.0	0.0020	5.8e-6	1	69367.4	HUMAN	Serum albumin
[107]		P17096	HMGA1_HUMAN	HMGA1	2	41.1	6.56	1.5e-11	853.4671	3	1.7	KQPPVSPGTALVGSQKEPSEVPTPK	KQPPVSPGTALVGSQKEPSEVPTPK		25	V20130429-09_FTMSms2hcd	32.386	31	55	43.0	1.5e-11	4.9e-14	1	11676.1	HUMAN	High mobility group protein HMG-I/HMG-Y
[107]		P17096	HMGA1_HUMAN	HMGA1	2	41.1	6.56	1.5e-11	799.6483	3	1.6	KLEKEEEEGISQESSEEEQ	KLEKEEEEGISQES(Phospho)S(Phospho)EEEQ	Phospho@102=7;Phospho@103=7	19	V20130429-09_FTMSms2hcd	21.220	89	107	21.1	7.1e-6	1.3e-8	1	11676.1	HUMAN	High mobility group protein HMG-I/HMG-Y
[108]		P60866	RS20_HUMAN	RPS20	2	26.1	5.11	7.3e-9	510.0255	4	1.9	MAFKDTGKTPVEPEVAIHR	M(Met-loss+Acetyl)AFKDTGKTPVEPEVAIHR	Met-loss+Acetyl@1	19	V20130429-09_FTMSms2hcd	33.822	1	19	42.4	7.3e-9	1.3e-11	1	13372.8	HUMAN	40S ribosomal protein S20
[108]		P60866	RS20_HUMAN	RPS20	2	26.1	5.11	7.3e-9	675.8858	2	1.2	LIDLHSPSEIVK	LIDLHSPSEIVK		12	V20130429-09_FTMSms2hcd	37.971	88	99	39.6	1.9e-8	5.6e-11	1	13372.8	HUMAN	40S ribosomal protein S20
[109]		P14174	MIF_HUMAN	MIF	2	18.3	6.59	1.3e-11	652.3452	2	0.31	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-09_FTMSms2hcd	36.685	1	12	40.4	1.3e-11	1.9e-14	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[109]		P14174	MIF_HUMAN	MIF	2	18.3	6.59	1.3e-11	494.2872	2	1.6	LLCGLLAER	LLCGLLAER		9	V20130429-09_FTMSms2hcd	46.592	79	87	40.5	1.6e-5	3.2e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[110]		P05141	ADT2_HUMAN	SLC25A5	3	13.1	4.55	5.1e-9	610.3389	2	2.0	DFLAGGVAAAISK	DFLAGGVAAAISK		13	V20130429-09_FTMSms2hcd	47.418	11	23	24.9	5.1e-9	1.1e-11	1	32852.5	HUMAN	ADP/ATP translocase 2
[110]		P05141	ADT2_HUMAN	SLC25A5	3	13.1	4.55	5.1e-9	674.0220	3	2.7	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-09_FTMSms2hcd	75.126	281	298	19.2	3.9e-6	5.5e-9	1	32852.5	HUMAN	ADP/ATP translocase 2
[110]		P05141	ADT2_HUMAN	SLC25A5	3	13.1	4.55	5.1e-9	428.7482	2	0.50	TAVAPIER	TAVAPIER		8	V20130429-09_FTMSms2hcd	17.538	24	31	33.5	1.2e-4	4.1e-7	4	32852.5	HUMAN	ADP/ATP translocase 2
[110-1]	0	P12235	ADT1_HUMAN	SLC25A4	1	2.7	2.19	1.2e-4	428.7482	2	0.50	TAVAPIER	TAVAPIER		8	V20130429-09_FTMSms2hcd	17.538	24	31	33.5	1.2e-4	4.1e-7	4	33064.8	HUMAN	ADP/ATP translocase 1
[110-2]	0	P12236	ADT3_HUMAN	SLC25A6	1	2.7	2.19	1.2e-4	428.7482	2	0.50	TAVAPIER	TAVAPIER		8	V20130429-09_FTMSms2hcd	17.538	24	31	33.5	1.2e-4	4.1e-7	4	32866.6	HUMAN	ADP/ATP translocase 3
[110-3]	0	Q9H0C2	ADT4_HUMAN	SLC25A31	1	2.5	2.19	1.2e-4	428.7482	2	0.50	TAVAPIER	TAVAPIER		8	V20130429-09_FTMSms2hcd	17.538	36	43	33.5	1.2e-4	4.1e-7	4	35022.2	HUMAN	ADP/ATP translocase 4
[111]		P55209	NP1L1_HUMAN	NAP1L1	2	9.0	5.38	2.4e-9	930.4927	2	1.7	LDGLVETPTGYIESLPR	LDGLVETPTGYIESLPR		17	V20130429-09_FTMSms2hcd	54.264	56	72	46.8	2.4e-9	3.9e-12	1	45374.5	HUMAN	Nucleosome assembly protein 1-like 1
[111]		P55209	NP1L1_HUMAN	NAP1L1	2	9.0	5.38	2.4e-9	704.3469	3	-3.0	NVDLLSDMVQEHDEPILK	NVDLLSDM(Oxidation)VQEHDEPILK	Oxidation@184	18	V20130429-09_FTMSms2hcd	43.873	177	194	25.9	3.7e-7	3.8e-10	1	45374.5	HUMAN	Nucleosome assembly protein 1-like 1
[112]		P62701	RS4X_HUMAN	RPS4X	3	10.3	4.09	1.7e-7	608.8604	2	1.1	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-09_FTMSms2hcd	72.917	40	49	37.2	1.7e-7	5.7e-10	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[112]		P62701	RS4X_HUMAN	RPS4X	3	10.3	4.09	1.7e-7	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-09_FTMSms2hcd	11.619	212	221	31.4	4.4e-6	9.0e-9	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[112]		P62701	RS4X_HUMAN	RPS4X	3	10.3	4.09	1.7e-7	416.2328	2	1.5	LTIAEER	LTIAEER		7	V20130429-09_FTMSms2hcd	19.430	246	252	24.4	8.8e-4	1.3e-6	2	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[112-1]	0	Q8TD47	RS4Y2_HUMAN	RPS4Y2	2	6.5	2.75	4.4e-6	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-09_FTMSms2hcd	11.619	212	221	31.4	4.4e-6	9.0e-9	3	29295.7	HUMAN	40S ribosomal protein S4, Y isoform 2
[112-1]	0	Q8TD47	RS4Y2_HUMAN	RPS4Y2	2	6.5	2.75	4.4e-6	416.2328	2	1.5	LTIAEER	LTIAEER		7	V20130429-09_FTMSms2hcd	19.430	246	252	24.4	8.8e-4	1.3e-6	2	29295.7	HUMAN	40S ribosomal protein S4, Y isoform 2
[112-2]	0	P22090	RS4Y1_HUMAN	RPS4Y1	1	3.8	2.75	4.4e-6	526.7412	2	-0.42	DANGNSFATR	DANGNSFATR		10	V20130429-09_FTMSms2hcd	11.619	212	221	31.4	4.4e-6	9.0e-9	3	29455.9	HUMAN	40S ribosomal protein S4, Y isoform 1
[113]		P12956	XRCC6_HUMAN	XRCC6	2	5.3	4.85	2.3e-8	837.0975	3	11	LGSLVDEFKELVYPPDYNPEGK	LGSLVDEFKELVYPPDYNPEGK		22	V20130429-09_FTMSms2hcd	65.782	518	539	27.8	2.3e-8	3.4e-11	1	69843.7	HUMAN	X-ray repair cross-complementing protein 6
[113]		P12956	XRCC6_HUMAN	XRCC6	2	5.3	4.85	2.3e-8	586.8484	2	0.86	KQELLEALTK	KQELLEALTK		10	V20130429-09_FTMSms2hcd	35.016	596	605	40.3	7.1e-8	2.3e-10	1	69843.7	HUMAN	X-ray repair cross-complementing protein 6
[114]		P67809	YBOX1_HUMAN	YBX1	2	9.0	7.69	1.2e-13	928.7394	3	-0.54	EDGNEEDKENQGDETQGQQPPQRR	EDGNEEDKENQGDETQGQQPPQRR		24	V20130429-09_FTMSms2hcd	10.393	257	280	43.0	1.2e-13	1.2e-16	1	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[114]		P67809	YBOX1_HUMAN	YBX1	2	9.0	7.69	1.2e-13	361.1931	2	1.3	WFNVR	WFNVR		5	V20130429-09_FTMSms2hcd	31.918	65	69	15.3	0.016	3.3e-5	5	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[115]		P62899	RL31_HUMAN	RPL31	2	25.6	6.37	3.4e-11	891.7910	3	11	NEDEDSPNKLYTLVTYVPVTTFK	NEDEDSPNKLYTLVTYVPVTTFK		23	V20130429-09_FTMSms2hcd	61.314	93	115	41.9	3.4e-11	4.7e-14	1	14463.0	HUMAN	60S ribosomal protein L31
[115]		P62899	RL31_HUMAN	RPL31	2	25.6	6.37	3.4e-11	391.8843	3	0.74	EYTINIHKR	EYTINIHKR		9	V20130429-09_FTMSms2hcd	18.882	24	32	11.3	2.0e-4	3.3e-7	1	14463.0	HUMAN	60S ribosomal protein L31
[116]		P26599	PTBP1_HUMAN	PTBP1	2	5.5	5.22	3.5e-10	680.3723	3	3.1	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-09_FTMSms2hcd	74.822	349	366	33.9	3.5e-10	8.6e-13	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[116]		P26599	PTBP1_HUMAN	PTBP1	2	5.5	5.22	3.5e-10	553.8148	2	1.7	VLFSSNGGVVK	VLFSSNGGVVK		11	V20130429-09_FTMSms2hcd	31.828	472	482	31.8	1.9e-7	5.2e-10	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[117]		O95433	AHSA1_HUMAN	AHSA1	1	7.4	8.94	6.0e-16	672.6124	4	18	VFTTQELVQAFTHAPATLEADRGGK	VFTTQELVQAFTHAPATLEADRGGK		25	V20130429-09_FTMSms2hcd	62.443	225	249	55.2	6.0e-16	1.4e-18	1	38274.6	HUMAN	Activator of 90 kDa heat shock protein ATPase homolog 1
[118]		P61247	RS3A_HUMAN	RPS3A	2	9.5	4.78	3.0e-8	758.4063	2	2.6	EVQTNDLKEVVNK	EVQTNDLKEVVNK		13	V20130429-09_FTMSms2hcd	26.103	175	187	41.5	3.0e-8	5.1e-11	1	29945.2	HUMAN	40S ribosomal protein S3a
[118]		P61247	RS3A_HUMAN	RPS3A	2	9.5	4.78	3.0e-8	443.2548	3	2.3	LIPDSIGKDIEK	LIPDSIGKDIEK		12	V20130429-09_FTMSms2hcd	33.639	188	199	40.5	5.2e-7	1.5e-9	1	29945.2	HUMAN	40S ribosomal protein S3a
[119]		Q9NR30	DDX21_HUMAN	DDX21	2	4.2	4.62	5.8e-9	633.3624	2	2.8	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-09_FTMSms2hcd	62.021	237	247	34.5	5.8e-9	1.9e-11	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[119]		Q9NR30	DDX21_HUMAN	DDX21	2	4.2	4.62	5.8e-9	703.3734	3	-1.8	GAVEALAAALAHISGATSVDQR	GAVEALAAALAHISGATSVDQR		22	V20130429-09_FTMSms2hcd	67.468	606	627	31.2	2.5e-8	4.1e-11	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[120]		P29401	TKT_HUMAN	TKT	2	4.7	4.36	9.7e-8	471.9426	3	2.3	VLDPFTIKPLDR	VLDPFTIKPLDR		12	V20130429-09_FTMSms2hcd	48.834	531	542	38.5	9.7e-8	3.5e-10	1	67878.2	HUMAN	Transketolase
[120]		P29401	TKT_HUMAN	TKT	2	4.7	4.36	9.7e-8	680.3401	3	-2.8	NMAEQIIQEIYSQIQSK	NM(Oxidation)AEQIIQEIYSQIQSK	Oxidation@266	17	V20130429-09_FTMSms2hcd	68.719	265	281	23.8	1.0e-7	1.2e-10	1	67878.2	HUMAN	Transketolase
[121]		P60842	IF4A1_HUMAN	EIF4A1	3	10.6	4.04	7.9e-9	803.4228	2	7.4	KGVAINMVTEEDKR	KGVAINM(Oxidation)VTEEDKR	Oxidation@375	14	V20130429-09_FTMSms2hcd	19.081	369	382	29.4	7.9e-9	1.2e-11	1	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[121]		P60842	IF4A1_HUMAN	EIF4A1	3	10.6	4.04	7.9e-9	545.6281	3	0.89	LQMEAPHIIVGTPGR	LQM(Oxidation)EAPHIIVGTPGR	Oxidation@149	15	V20130429-09_FTMSms2hcd	31.944	147	161	29.4	1.0e-8	1.8e-11	1	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[121]		P60842	IF4A1_HUMAN	EIF4A1	3	10.6	4.04	7.9e-9	697.8585	2	13	GYDVIAQAQSGTGK	GYDVIAQAQSGTGK		14	V20130429-09_FTMSms2hcd	72.715	69	82	14.0	0.018	2.4e-5	2	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[122]		P39023	RL3_HUMAN	RPL3	2	5.0	4.56	4.0e-9	492.2737	2	-2.0	HGSLGFLPR	HGSLGFLPR		9	V20130429-09_FTMSms2hcd	31.892	11	19	32.3	4.0e-9	1.1e-11	1	46109.3	HUMAN	60S ribosomal protein L3
[122]		P39023	RL3_HUMAN	RPL3	2	5.0	4.56	4.0e-9	596.3398	2	-0.73	IGQGYLIKDGK	IGQGYLIKDGK		11	V20130429-09_FTMSms2hcd	23.740	287	297	33.0	4.0e-8	1.1e-10	1	46109.3	HUMAN	60S ribosomal protein L3
[123]		P11766	ADHX_HUMAN	ADH5	1	7.5	8.48	4.3e-15	948.1856	3	7.5	GWGVSVVVGVAASGEEIATRPFQLVTGR	GWGVSVVVGVAASGEEIATRPFQLVTGR		28	V20130429-09_FTMSms2hcd	76.289	285	312	47.1	4.3e-15	1.8e-17	1	39724.6	HUMAN	Alcohol dehydrogenase class-3
[124]		P05787	K2C8_HUMAN	KRT8	2	4.3	4.67	4.6e-9	540.2593	2	-0.27	AQYEDIANR	AQYEDIANR		9	V20130429-09_FTMSms2hcd	19.201	265	273	27.9	4.6e-9	8.6e-12	2	53704.7	HUMAN	Keratin, type II cytoskeletal 8
[124]		P05787	K2C8_HUMAN	KRT8	2	4.3	4.67	4.6e-9	710.3800	2	3.5	LEGLTDEINFLR	LEGLTDEINFLR		12	V20130429-09_FTMSms2hcd	55.928	214	225	34.5	2.0e-7	3.2e-10	1	53704.7	HUMAN	Keratin, type II cytoskeletal 8
[124-1]	0	O95678	K2C75_HUMAN	KRT75	1	1.6	4.01	4.6e-9	540.2593	2	-0.27	AQYEDIANR	AQYEDIANR		9	V20130429-09_FTMSms2hcd	19.201	325	333	27.9	4.6e-9	8.6e-12	2	59560.9	HUMAN	Keratin, type II cytoskeletal 75
[125]		P06576	ATPB_HUMAN	ATP5B	1	3.6	8.44	5.0e-15	960.0505	2	-1.2	VLDSGAPIKIPVGPETLGR	VLDSGAPIKIPVGPETLGR		19	V20130429-09_FTMSms2hcd	48.148	125	143	44.9	5.0e-15	3.2e-17	1	56560.4	HUMAN	ATP synthase subunit beta, mitochondrial
[126]		O43390	HNRPR_HUMAN	HNRNPR	3	5.2	5.72	1.9e-11	805.4152	2	15	DLYEDELVPLFEK	DLYEDELVPLFEK		13	V20130429-09_FTMSms2hcd	61.366	175	187	32.1	1.9e-11	2.5e-14	1	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[126]		O43390	HNRPR_HUMAN	HNRNPR	3	5.2	5.72	1.9e-11	464.2561	2	0.27	AGPIWDLR	AGPIWDLR		8	V20130429-09_FTMSms2hcd	41.784	188	195	20.3	6.1e-4	1.6e-6	2	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[126]		O43390	HNRPR_HUMAN	HNRNPR	3	5.2	5.72	1.9e-11	696.3400	2	-5.9	SAFLCGVMKTYR	SAFLCGVM(Oxidation)KTYR	Oxidation@102	12	V20130429-09_FTMSms2hcd	42.492	95	106	12.2	0.015	2.0e-5	2	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[126-1]	1	O60506	HNRPQ_HUMAN	SYNCRIP	3	5.3	3.25	2.4e-7	797.4194	2	17	DLFEDELVPLFEK	DLFEDELVPLFEK		13	V20130429-09_FTMSms2hcd	69.146	172	184	29.6	2.4e-7	3.4e-10	1	69603.2	HUMAN	Heterogeneous nuclear ribonucleoprotein Q
[126-1]	1	O60506	HNRPQ_HUMAN	SYNCRIP	3	5.3	3.25	2.4e-7	464.2561	2	0.27	AGPIWDLR	AGPIWDLR		8	V20130429-09_FTMSms2hcd	41.784	185	192	20.3	6.1e-4	1.6e-6	2	69603.2	HUMAN	Heterogeneous nuclear ribonucleoprotein Q
[126-1]	1	O60506	HNRPQ_HUMAN	SYNCRIP	3	5.3	3.25	2.4e-7	696.3400	2	-5.9	SAFLCGVMKTYR	SAFLCGVM(Oxidation)KTYR	Oxidation@99	12	V20130429-09_FTMSms2hcd	42.492	92	103	12.2	0.015	2.0e-5	2	69603.2	HUMAN	Heterogeneous nuclear ribonucleoprotein Q
[127]		Q92688	AN32B_HUMAN	ANP32B	2	12.0	5.95	2.1e-10	653.6033	4	0.052	IFGGLDMLAEKLPNLTHLNLSGNK	IFGGLDM(Oxidation)LAEKLPNLTHLNLSGNK	Oxidation@82	24	V20130429-09_FTMSms2hcd	66.079	76	99	46.1	2.1e-10	4.9e-13	1	28787.9	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member B
[127]		Q92688	AN32B_HUMAN	ANP32B	2	12.0	5.95	2.1e-10	390.7401	2	0.35	IHLELR	IHLELR		6	V20130429-09_FTMSms2hcd	26.330	7	12	29.7	0.0016	1.1e-5	2	28787.9	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member B
[127-1]	0	P39687	AN32A_HUMAN	ANP32A	1	2.4	1.20	0.0016	390.7401	2	0.35	IHLELR	IHLELR		6	V20130429-09_FTMSms2hcd	26.330	7	12	29.7	0.0016	1.1e-5	2	28585.6	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member A
[128]		P17844	DDX5_HUMAN	DDX5	2	2.9	5.20	4.1e-9	626.8182	2	0.86	TAQEVETYRR	TAQEVETYRR		10	V20130429-09_FTMSms2hcd	12.102	69	78	39.5	4.1e-9	5.6e-12	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[128]		P17844	DDX5_HUMAN	DDX5	2	2.9	5.20	4.1e-9	493.2883	2	1.7	LLQLVEDR	LLQLVEDR		8	V20130429-09_FTMSms2hcd	34.977	471	478	29.8	8.5e-5	2.2e-7	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[129]		Q15365	PCBP1_HUMAN	PCBP1	1	5.9	7.75	9.4e-14	1089.1140	2	13	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-09_FTMSms2hcd	63.871	326	346	43.1	9.4e-14	5.0e-16	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[130]		Q15843	NEDD8_HUMAN	NEDD8	1	17.3	7.69	1.3e-13	487.6528	3	8.7	ILGGSVLHLVLALR	ILGGSVLHLVLALR		14	V20130429-09_FTMSms2hcd	67.029	61	74	51.1	1.3e-13	1.4e-14	1	9071.6	HUMAN	NEDD8
[131]		P62851	RS25_HUMAN	RPS25	2	15.2	4.22	2.2e-7	542.8224	2	1.3	LITPAVVSER	LITPAVVSER		10	V20130429-09_FTMSms2hcd	32.577	67	76	35.7	2.2e-7	7.7e-10	1	13742.2	HUMAN	40S ribosomal protein S25
[131]		P62851	RS25_HUMAN	RPS25	2	15.2	4.22	2.2e-7	486.7910	2	2.4	AALQELLSK	AALQELLSK		9	V20130429-09_FTMSms2hcd	39.148	86	94	39.0	6.0e-6	1.3e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[132]		P62424	RL7A_HUMAN	RPL7A	1	6.0	7.47	3.2e-13	604.3450	3	1.7	LKVPPAINQFTQALDR	LKVPPAINQFTQALDR		16	V20130429-09_FTMSms2hcd	54.453	74	89	57.5	3.2e-13	1.3e-15	1	29995.9	HUMAN	60S ribosomal protein L7a
[133]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	7.47	2.4e-13	700.7190	3	2.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-09_FTMSms2hcd	70.333	337	355	39.3	2.4e-13	6.0e-16	2	42293.8	HUMAN	Beta-centractin
[133-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	7.47	2.4e-13	700.7190	3	2.3	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-09_FTMSms2hcd	70.333	337	355	39.3	2.4e-13	6.0e-16	2	42614.1	HUMAN	Alpha-centractin
[134]		P13804	ETFA_HUMAN	ETFA	1	7.8	7.43	3.8e-13	675.1217	4	0.21	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-09_FTMSms2hcd	74.639	269	294	40.9	3.8e-13	1.2e-15	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[135]		P16949	STMN1_HUMAN	STMN1	2	12.8	4.94	1.9e-9	583.2778	2	-0.059	AIEENNNFSK	AIEENNNFSK		10	V20130429-09_FTMSms2hcd	16.319	86	95	35.1	1.9e-9	3.1e-12	2	17302.7	HUMAN	Stathmin
[135]		P16949	STMN1_HUMAN	STMN1	2	12.8	4.94	1.9e-9	537.7883	2	1.5	DLSLEEIQK	DLSLEEIQK		9	V20130429-09_FTMSms2hcd	35.458	44	52	26.2	7.1e-5	1.1e-7	2	17302.7	HUMAN	Stathmin
[135-1]	0	Q93045	STMN2_HUMAN	STMN2	2	10.6	4.94	1.9e-9	583.2778	2	-0.059	ALEENNNFSK	ALEENNNFSK		10	V20130429-09_FTMSms2hcd	16.319	120	129	35.1	1.9e-9	3.1e-12	2	20828.2	HUMAN	Stathmin-2
[135-1]	0	Q93045	STMN2_HUMAN	STMN2	2	10.6	4.94	1.9e-9	537.7883	2	1.5	DLSLEEIQK	DLSLEEIQK		9	V20130429-09_FTMSms2hcd	35.458	78	86	26.2	7.1e-5	1.1e-7	2	20828.2	HUMAN	Stathmin-2
[136]		P50502	F10A1_HUMAN	ST13	2	6.5	4.00	1.5e-7	735.8943	2	1.0	VAAIEALNDGELQK	VAAIEALNDGELQK		14	V20130429-09_FTMSms2hcd	37.518	119	132	35.9	1.5e-7	2.5e-10	2	41332.1	HUMAN	Hsc70-interacting protein
[136]		P50502	F10A1_HUMAN	ST13	2	6.5	4.00	1.5e-7	553.8085	2	0.47	AIDLFTDAIK	AIDLFTDAIK		10	V20130429-09_FTMSms2hcd	49.818	133	142	28.6	1.8e-6	3.9e-9	3	41332.1	HUMAN	Hsc70-interacting protein
[136-1]	0	Q8IZP2	ST134_HUMAN	ST13P4	2	10.0	4.00	1.5e-7	735.8943	2	1.0	VAAIEALNDGELQK	VAAIEALNDGELQK		14	V20130429-09_FTMSms2hcd	37.518	115	128	35.9	1.5e-7	2.5e-10	2	27407.0	HUMAN	Putative protein FAM10A4
[136-1]	0	Q8IZP2	ST134_HUMAN	ST13P4	2	10.0	4.00	1.5e-7	553.8085	2	0.47	AIDLFTDAIK	AIDLFTDAIK		10	V20130429-09_FTMSms2hcd	49.818	129	138	28.6	1.8e-6	3.9e-9	3	27407.0	HUMAN	Putative protein FAM10A4
[136-2]	0	Q8NFI4	F10A5_HUMAN	ST13P5	1	2.7	2.68	1.8e-6	553.8085	2	0.47	AIDLFTDAIK	AIDLFTDAIK		10	V20130429-09_FTMSms2hcd	49.818	133	142	28.6	1.8e-6	3.9e-9	3	41378.1	HUMAN	Putative protein FAM10A5
[137]		P48643	TCPE_HUMAN	CCT5	2	4.8	4.03	3.4e-7	547.2677	2	0.79	IADGYEQAAR	IADGYEQAAR		10	V20130429-09_FTMSms2hcd	16.545	133	142	38.2	3.4e-7	6.3e-10	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[137]		P48643	TCPE_HUMAN	CCT5	2	4.8	4.03	3.4e-7	834.4627	2	11	LGFAGLVQEISFGTTK	LGFAGLVQEISFGTTK		16	V20130429-09_FTMSms2hcd	65.743	353	368	21.1	7.8e-6	2.1e-8	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[138]		O75607	NPM3_HUMAN	NPM3	1	9.6	7.33	5.7e-13	803.4259	2	13	MAAGTAAALAFLSQESR	M(Met-loss+Acetyl)AAGTAAALAFLSQESR	Met-loss+Acetyl@1	17	V20130429-09_FTMSms2hcd	63.820	1	17	47.4	5.7e-13	8.7e-16	1	19343.9	HUMAN	Nucleoplasmin-3
[139]		Q96DA6	TIM14_HUMAN	DNAJC19	1	17.2	7.19	6.8e-13	887.4934	2	-3.5	MASTVVAVGLTIAAAGFAGR	M(Met-loss+Acetyl)ASTVVAVGLTIAAAGFAGR	Met-loss+Acetyl@1	20	V20130429-09_FTMSms2hcd	78.127	1	20	39.0	6.8e-13	1.9e-15	1	12498.7	HUMAN	Mitochondrial import inner membrane translocase subunit TIM14
[140]		P08133	ANXA6_HUMAN	ANXA6	1	2.4	7.14	1.3e-12	590.3078	3	0.72	GLGTDEDTIIDIITHR	GLGTDEDTIIDIITHR		16	V20130429-09_FTMSms2hcd	60.650	378	393	42.0	1.3e-12	1.9e-15	1	75873.9	HUMAN	Annexin A6
[141]		P06744	G6PI_HUMAN	GPI	1	2.7	7.01	2.1e-12	860.4768	2	0.070	ILLANFLAQTEALMR	ILLANFLAQTEALM(Oxidation)R	Oxidation@437	15	V20130429-09_FTMSms2hcd	65.622	424	438	39.9	2.1e-12	4.8e-15	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[142]		Q15181	IPYR_HUMAN	PPA1	1	13.1	6.91	3.5e-12	1058.5455	4	17	VLGILAMIDEGETDWKVIAINVDDPDAANYNDINDVKR	VLGILAM(Oxidation)IDEGETDWKVIAINVDDPDAANYNDINDVKR	Oxidation@146	38	V20130429-09_FTMSms2hcd	68.918	140	177	43.2	3.5e-12	8.6e-15	1	32660.3	HUMAN	Inorganic pyrophosphatase
[143]		P62328	TYB4_HUMAN	TMSB4X	2	34.1	5.45	1.7e-9	570.9348	3	0.44	MSDKPDMAEIEKFDK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEKFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-09_FTMSms2hcd	28.171	1	15	41.7	1.7e-9	2.0e-12	1	5052.7	HUMAN	Thymosin beta-4
[143]		P62328	TYB4_HUMAN	TMSB4X	2	34.1	5.45	1.7e-9	660.8005	2	-3.8	MSDKPDMAEIEK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEK	Met-loss+Acetyl@1;Oxidation@7	12	V20130429-09_FTMSms2hcd	16.781	1	12	14.8	0.044	7.2e-5	2	5052.7	HUMAN	Thymosin beta-4
[144]		Q08211	DHX9_HUMAN	DHX9	1	1.4	6.85	4.5e-12	657.6910	3	2.0	AIEPPPLDAVIEAEHTLR	AIEPPPLDAVIEAEHTLR		18	V20130429-09_FTMSms2hcd	58.534	820	837	42.2	4.5e-12	9.8e-15	1	140959.7	HUMAN	ATP-dependent RNA helicase A
[145]		P49411	EFTU_HUMAN	TUFM	1	4.2	6.66	3.4e-12	710.4053	3	17	DLEKPFLLPVEAVYSVPGR	DLEKPFLLPVEAVYSVPGR		19	V20130429-09_FTMSms2hcd	62.189	253	271	37.4	3.4e-12	1.9e-14	1	49542.0	HUMAN	Elongation factor Tu, mitochondrial
[146]		P55060	XPO2_HUMAN	CSE1L	1	1.8	6.65	6.7e-12	1028.0240	2	4.5	MELSDANLQTLTEYLKK	Acetyl-M(Oxidation)ELSDANLQTLTEYLKK		17	V20130429-09_FTMSms2hcd	60.529	1	17	39.0	6.7e-12	7.5e-15	1	110417.6	HUMAN	Exportin-2
[147]		Q5JRK9	GGEE3_HUMAN	PAGE2B	1	10.8	6.60	1.3e-11	649.7969	2	0.48	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-09_FTMSms2hcd	19.937	80	91	44.4	1.3e-11	1.9e-14	2	12041.1	HUMAN	Putative G antigen family E member 3
[147-1]	0	Q7Z2X7	GGEE2_HUMAN	PAGE2	1	10.8	6.60	1.3e-11	649.7969	2	0.48	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-09_FTMSms2hcd	19.937	80	91	44.4	1.3e-11	1.9e-14	2	12090.2	HUMAN	G antigen family E member 2
[148]		P49006	MRP_HUMAN	MARCKSL1	2	10.8	4.41	9.2e-9	494.2554	2	1.2	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=27	8	V20130429-09_FTMSms2hcd	30.103	100	107	33.5	9.2e-9	1.6e-11	1	19528.9	HUMAN	MARCKS-related protein
[148]		P49006	MRP_HUMAN	MARCKSL1	2	10.8	4.41	9.2e-9	664.3282	2	0.22	AAATPESQEPQAK	AAATPESQEPQAK		13	V20130429-09_FTMSms2hcd	10.733	145	157	11.9	2.3e-4	2.9e-7	1	19528.9	HUMAN	MARCKS-related protein
[149]		P47914	RL29_HUMAN	RPL29	1	9.4	6.40	7.2e-12	689.3774	2	-0.70	AQAAAPASVPAQAPK	AQAAAPASVPAQAPK		15	V20130429-09_FTMSms2hcd	20.830	135	149	36.6	7.2e-12	1.3e-14	1	17752.2	HUMAN	60S ribosomal protein L29
[150]		P49368	TCPG_HUMAN	CCT3	1	4.8	6.37	1.2e-11	878.4625	3	4.8	NVLLDPQLVPGGGASEMAVAHALTEK	NVLLDPQLVPGGGASEM(Oxidation)AVAHALTEK	Oxidation@416	26	V20130429-09_FTMSms2hcd	56.433	400	425	37.5	1.2e-11	2.1e-14	1	60534.5	HUMAN	T-complex protein 1 subunit gamma
[151]		O75506	HSBP1_HUMAN	HSBP1	1	39.5	6.35	3.8e-11	871.6913	4	-0.70	TVQDLTSVVQTLLQQMQDKFQTMSDQIIGR	TVQDLTSVVQTLLQQM(Oxidation)QDKFQTM(Oxidation)SDQIIGR	Oxidation@23;Oxidation@30	30	V20130429-09_FTMSms2hcd	71.578	8	37	50.4	3.8e-11	5.2e-14	1	8543.7	HUMAN	Heat shock factor-binding protein 1
[152]		Q07020	RL18_HUMAN	RPL18	1	6.9	6.24	6.1e-11	730.9034	2	0.0010	ILTFDQLALDSPK	ILTFDQLALDSPK		13	V20130429-09_FTMSms2hcd	52.777	120	132	45.5	6.1e-11	1.2e-13	1	21634.7	HUMAN	60S ribosomal protein L18
[153]		Q15056	IF4H_HUMAN	EIF4H	1	9.3	6.20	7.3e-11	784.4255	3	1.7	TVATPLNQVANPNSAIFGGARPR	TVATPLNQVANPNSAIFGGARPR		23	V20130429-09_FTMSms2hcd	45.995	217	239	54.3	7.3e-11	1.8e-13	1	27385.3	HUMAN	Eukaryotic translation initiation factor 4H
[154]		P15880	RS2_HUMAN	RPS2	2	7.8	4.16	2.7e-8	513.3036	2	0.93	GTGIVSAPVPK	GTGIVSAPVPK		11	V20130429-09_FTMSms2hcd	27.257	201	211	33.5	2.7e-8	1.6e-10	1	31324.7	HUMAN	40S ribosomal protein S2
[154]		P15880	RS2_HUMAN	RPS2	2	7.8	4.16	2.7e-8	488.5772	3	0.36	SPYQEFTDHLVK	SPYQEFTDHLVK		12	V20130429-09_FTMSms2hcd	39.664	264	275	13.3	3.5e-4	4.2e-7	1	31324.7	HUMAN	40S ribosomal protein S2
[155]		P62906	RL10A_HUMAN	RPL10A	1	6.0	6.09	1.1e-10	742.9048	2	1.9	KYDAFLASESLIK	KYDAFLASESLIK		13	V20130429-09_FTMSms2hcd	44.603	106	118	42.2	1.1e-10	2.1e-13	1	24831.5	HUMAN	60S ribosomal protein L10a
[156]		P49327	FAS_HUMAN	FASN	1	0.9	6.08	1.2e-10	824.7745	3	2.2	LHLSGIDANPNALFPPVEFPAPR	LHLSGIDANPNALFPPVEFPAPR		23	V20130429-09_FTMSms2hcd	62.085	803	825	47.1	1.2e-10	2.4e-13	1	273429.0	HUMAN	Fatty acid synthase
[157]		Q13765	NACA_HUMAN	NACA	1	7.0	5.88	2.8e-10	807.9210	2	0.86	IEDLSQQAQLAAAEK	IEDLSQQAQLAAAEK		15	V20130429-09_FTMSms2hcd	32.725	128	142	50.4	2.8e-10	3.9e-13	1	23384.1	HUMAN	Nascent polypeptide-associated complex subunit alpha
[158]		P30041	PRDX6_HUMAN	PRDX6	1	7.6	5.74	2.5e-12	677.6769	3	14	FHDFLGDSWGILFSHPR	FHDFLGDSWGILFSHPR		17	V20130429-09_FTMSms2hcd	63.790	25	41	27.6	2.5e-12	2.9e-15	1	25035.2	HUMAN	Peroxiredoxin-6
[159]		P61313	RL15_HUMAN	RPL15	1	7.8	5.43	1.4e-10	853.4616	2	1.6	GATYGKPVHHGVNQLK	GATYGKPVHHGVNQLK		16	V20130429-09_FTMSms2hcd	13.627	78	93	34.0	1.4e-10	2.9e-13	1	24146.3	HUMAN	60S ribosomal protein L15
[160]		P52597	HNRPF_HUMAN	HNRNPF	1	4.1	5.39	1.6e-9	934.4785	2	3.3	ITGEAFVQFASQELAEK	ITGEAFVQFASQELAEK		17	V20130429-09_FTMSms2hcd	60.168	151	167	39.2	1.6e-9	2.2e-12	1	45672.3	HUMAN	Heterogeneous nuclear ribonucleoprotein F
[161]		P63173	RL38_HUMAN	RPL38	1	18.6	5.35	3.3e-10	525.9752	3	0.37	KIEEIKDFLLTAR	KIEEIKDFLLTAR		13	V20130429-09_FTMSms2hcd	45.877	4	16	35.1	3.3e-10	2.1e-12	1	8218.0	HUMAN	60S ribosomal protein L38
[162]		P55854	SUMO3_HUMAN	SUMO3	1	11.7	5.28	3.6e-9	617.8251	2	0.24	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-09_FTMSms2hcd	27.244	21	32	42.7	3.6e-9	5.4e-12	3	11637.1	HUMAN	Small ubiquitin-related modifier 3
[162-1]	0	P61956	SUMO2_HUMAN	SUMO2	1	12.6	5.28	3.6e-9	617.8251	2	0.24	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-09_FTMSms2hcd	27.244	22	33	42.7	3.6e-9	5.4e-12	3	10871.3	HUMAN	Small ubiquitin-related modifier 2
[162-2]	0	Q6EEV6	SUMO4_HUMAN	SUMO4	1	12.6	5.28	3.6e-9	617.8251	2	0.24	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-09_FTMSms2hcd	27.244	22	33	42.7	3.6e-9	5.4e-12	3	10685.2	HUMAN	Small ubiquitin-related modifier 4
[163]		P62263	RS14_HUMAN	RPS14	1	7.3	5.27	3.8e-9	527.7900	2	8.3	TPGPGAQSALR	TPGPGAQSALR		11	V20130429-09_FTMSms2hcd	17.645	107	117	49.3	3.8e-9	7.9e-12	1	16272.9	HUMAN	40S ribosomal protein S14
[164]		P08195	4F2_HUMAN	SLC3A2	1	2.2	5.26	1.0e-9	753.3837	2	0.45	GQSEDPGSLLSLFR	GQSEDPGSLLSLFR		14	V20130429-09_FTMSms2hcd	61.245	511	524	36.8	1.0e-9	1.3e-12	1	67994.6	HUMAN	4F2 cell-surface antigen heavy chain
[165]		Q99623	PHB2_HUMAN	PHB2	1	4.0	5.20	4.9e-9	608.3142	2	-0.36	IVQAEGEAEAAK	IVQAEGEAEAAK		12	V20130429-09_FTMSms2hcd	15.445	225	236	39.9	4.9e-9	6.9e-12	1	33296.7	HUMAN	Prohibitin-2
[166]		P62847	RS24_HUMAN	RPS24	1	9.0	5.15	3.3e-10	699.8815	2	10	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-09_FTMSms2hcd	65.489	50	61	33.1	3.3e-10	7.2e-13	1	15423.3	HUMAN	40S ribosomal protein S24
[167]		P84090	ERH_HUMAN	ERH	1	16.3	5.07	8.2e-10	469.2710	4	0.81	MSHTILLVQPTKRPEGR	M(Met-loss+Acetyl)SHTILLVQPTKRPEGR	Met-loss+Acetyl@1	17	V20130429-09_FTMSms2hcd	30.259	1	17	34.4	8.2e-10	4.2e-12	1	12259.1	HUMAN	Enhancer of rudimentary homolog
[168]		P40925	MDHC_HUMAN	MDH1	1	3.6	5.05	9.6e-9	697.3609	2	2.5	FVEGLPINDFSR	FVEGLPINDFSR		12	V20130429-09_FTMSms2hcd	48.467	299	310	43.4	9.6e-9	1.5e-11	1	36426.4	HUMAN	Malate dehydrogenase, cytoplasmic
[169]		P62861	RS30_HUMAN	FAU	1	16.9	4.94	2.4e-9	554.3135	2	0.015	FVNVVPTFGK	FVNVVPTFGK		10	V20130429-09_FTMSms2hcd	43.941	42	51	35.6	2.4e-9	5.9e-12	1	6647.9	HUMAN	40S ribosomal protein S30
[170]		P10768	ESTD_HUMAN	ESD	1	7.4	4.87	2.1e-9	648.0649	4	-1.2	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-09_FTMSms2hcd	67.682	254	274	34.6	2.1e-9	2.2e-12	1	31463.1	HUMAN	S-formylglutathione hydrolase
[171]		P05386	RLA1_HUMAN	RPLP1	1	14.0	4.85	1.3e-9	851.9531	2	2.2	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-09_FTMSms2hcd	64.311	34	49	33.3	1.3e-9	2.0e-12	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[172]		Q9Y262	EIF3L_HUMAN	EIF3L	1	3.9	4.79	6.7e-10	640.1143	4	14	IWNVHSVLNVLHSLVDKSNINR	IWNVHSVLNVLHSLVDKSNINR		22	V20130429-09_FTMSms2hcd	69.133	221	242	31.2	6.7e-10	5.0e-12	1	66727.6	HUMAN	Eukaryotic translation initiation factor 3 subunit L
[173]		P31943	HNRH1_HUMAN	HNRNPH1	1	3.8	4.75	1.8e-9	921.4504	2	1.1	STGEAFVQFASQEIAEK	STGEAFVQFASQEIAEK		17	V20130429-09_FTMSms2hcd	52.541	151	167	33.0	1.8e-9	1.9e-12	2	49229.9	HUMAN	Heterogeneous nuclear ribonucleoprotein H
[173-1]	0	P55795	HNRH2_HUMAN	HNRNPH2	1	3.8	4.75	1.8e-9	921.4504	2	1.1	STGEAFVQFASQEIAEK	STGEAFVQFASQEIAEK		17	V20130429-09_FTMSms2hcd	52.541	151	167	33.0	1.8e-9	1.9e-12	2	49264.0	HUMAN	Heterogeneous nuclear ribonucleoprotein H2
[174]		Q96AG4	LRC59_HUMAN	LRRC59	1	3.9	4.70	1.4e-8	658.4077	2	7.4	LVTLPVSFAQLK	LVTLPVSFAQLK		12	V20130429-09_FTMSms2hcd	56.844	97	108	37.4	1.4e-8	1.6e-10	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[175]		P05783	K1C18_HUMAN	KRT18	1	5.3	4.62	1.5e-9	896.1332	3	-0.68	YALQMEQLNGILLHLESELAQTR	YALQM(Oxidation)EQLNGILLHLESELAQTR	Oxidation@335	23	V20130429-09_FTMSms2hcd	72.836	331	353	31.3	1.5e-9	2.4e-12	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[176]		P62266	RS23_HUMAN	RPS23	1	7.7	4.50	1.4e-8	595.8620	2	2.0	VANVSLLALYK	VANVSLLALYK		11	V20130429-09_FTMSms2hcd	49.000	125	135	35.4	1.4e-8	1.3e-10	1	15807.7	HUMAN	40S ribosomal protein S23
[177]		P04632	CPNS1_HUMAN	CAPNS1	1	3.4	4.47	3.4e-9	578.8076	2	0.72	MFLVNSFLK	Acetyl-M(Oxidation)FLVNSFLK		9	V20130429-09_FTMSms2hcd	68.784	1	9	31.8	3.4e-9	7.0e-12	1	28316.0	HUMAN	Calpain small subunit 1
[178]		P06454	PTMA_HUMAN	PTMA	1	11.7	4.44	2.3e-8	719.2781	2	-0.73	AAEDDEDDDVDTK	AAEDDEDDDVDTK		13	V20130429-09_FTMSms2hcd	9.583	91	103	36.0	2.3e-8	6.7e-11	1	12203.0	HUMAN	Prothymosin alpha
[179]		P30050	RL12_HUMAN	RPL12	1	5.5	4.44	5.3e-8	441.2769	2	1.2	IGPLGLSPK	IGPLGLSPK		9	V20130429-09_FTMSms2hcd	33.884	32	40	37.9	5.3e-8	6.3e-10	1	17818.7	HUMAN	60S ribosomal protein L12
[180]		P60660	MYL6_HUMAN	MYL6	1	10.6	4.35	4.3e-9	635.3448	3	11	VLDFEHFLPMLQTVAK	VLDFEHFLPM(Oxidation)LQTVAK	Oxidation@73	16	V20130429-09_FTMSms2hcd	63.188	64	79	31.1	4.3e-9	7.8e-12	1	16930.2	HUMAN	Myosin light polypeptide 6
[181]		Q9Y696	CLIC4_HUMAN	CLIC4	1	4.7	4.35	1.9e-7	693.3438	2	2.6	NSRPEANEALER	NSRPEANEALER		12	V20130429-09_FTMSms2hcd	14.322	131	142	44.0	1.9e-7	2.4e-10	1	28772.4	HUMAN	Chloride intracellular channel protein 4
[182]		P25205	MCM3_HUMAN	MCM3	1	2.6	4.34	1.9e-9	820.4168	3	0.73	TVDLQDAEEAVELVQYAYFKK	TVDLQDAEEAVELVQYAYFKK		21	V20130429-09_FTMSms2hcd	69.387	636	656	29.1	1.9e-9	2.5e-12	1	90981.6	HUMAN	DNA replication licensing factor MCM3
[183]		P55884	EIF3B_HUMAN	EIF3B	1	1.7	4.33	2.7e-9	680.8063	2	-2.5	AQAVSEDAGGNEGR	AQAVSEDAGGNEGR		14	V20130429-09_FTMSms2hcd	8.982	121	134	29.8	2.7e-9	4.0e-12	1	92482.4	HUMAN	Eukaryotic translation initiation factor 3 subunit B
[184]		P62829	RL23_HUMAN	RPL23	1	14.3	4.33	8.5e-10	957.0125	2	0.86	ISLGLPVGAVINCADNTGAK	ISLGLPVGAVINCADNTGAK		20	V20130429-09_FTMSms2hcd	59.012	16	35	27.1	8.5e-10	1.6e-12	1	14865.6	HUMAN	60S ribosomal protein L23
[185]		Q9UK76	HN1_HUMAN	HN1	1	9.7	4.25	3.8e-9	526.5884	3	-0.48	SSGGREDLESSGLQR	SSGGREDLESSGLQR		15	V20130429-09_FTMSms2hcd	18.618	70	84	29.8	3.8e-9	4.4e-12	1	16014.6	HUMAN	Hematological and neurological expressed 1 protein
[186]		P22234	PUR6_HUMAN	PAICS	1	2.8	4.20	3.6e-7	593.3460	2	0.81	MATAEVLNIGKK	M(Met-loss+Acetyl)ATAEVLNIGKK	Met-loss+Acetyl@1	12	V20130429-09_FTMSms2hcd	36.931	1	12	45.1	3.6e-7	7.3e-10	1	47079.7	HUMAN	Multifunctional protein ADE2
[187]		P62917	RL8_HUMAN	RPL8	1	4.3	4.20	4.5e-8	471.2798	2	-0.39	AVVGVVAGGGR	AVVGVVAGGGR		11	V20130429-09_FTMSms2hcd	20.856	164	174	35.1	4.5e-8	2.0e-10	1	28024.9	HUMAN	60S ribosomal protein L8
[188]		Q09028	RBBP4_HUMAN	RBBP4	1	7.3	4.18	3.4e-8	860.4348	4	6.1	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK		31	V20130429-09_FTMSms2hcd	67.600	221	251	34.3	3.4e-8	4.6e-11	1	47656.1	HUMAN	Histone-binding protein RBBP4
[189]		P00441	SODC_HUMAN	SOD1	1	8.4	4.11	2.2e-8	700.8801	2	-0.23	ESNGPVKVWGSIK	ESNGPVKVWGSIK		13	V20130429-09_FTMSms2hcd	32.822	25	37	32.6	2.2e-8	3.9e-11	1	15935.9	HUMAN	Superoxide dismutase [Cu-Zn]
[190]		P62249	RS16_HUMAN	RPS16	1	6.8	4.07	1.4e-8	547.8668	2	7.3	LLEPVLLLGK	LLEPVLLLGK		10	V20130429-09_FTMSms2hcd	56.977	51	60	31.1	1.4e-8	5.5e-10	1	16445.5	HUMAN	40S ribosomal protein S16
[191]		P49321	NASP_HUMAN	NASP	1	3.0	3.94	9.1e-9	832.7869	3	7.3	HLVMGDIPAAVNAFQEAASLLGKK	HLVM(Oxidation)GDIPAAVNAFQEAASLLGKK	Oxidation@56	24	V20130429-09_FTMSms2hcd	65.916	53	76	28.8	9.1e-9	2.5e-11	1	85238.4	HUMAN	Nuclear autoantigenic sperm protein
[192]		Q8NC51	PAIRB_HUMAN	SERBP1	1	3.4	3.92	2.8e-7	784.4193	2	0.89	VGRRPDQQLQGEGK	VGRRPDQQLQGEGK		14	V20130429-09_FTMSms2hcd	12.063	109	122	36.6	2.8e-7	4.3e-10	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[193]		P35268	RL22_HUMAN	RPL22	1	10.2	3.82	1.2e-6	621.8444	2	1.2	AGNLGGGVVTIER	AGNLGGGVVTIER		13	V20130429-09_FTMSms2hcd	31.763	53	65	39.0	1.2e-6	2.2e-9	1	14787.1	HUMAN	60S ribosomal protein L22
[194]		P34932	HSP74_HUMAN	HSPA4	2	5.1	2.38	5.3e-7	1041.8860	3	6.0	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK		29	V20130429-09_FTMSms2hcd	72.353	74	102	22.7	5.3e-7	1.2e-9	1	94331.8	HUMAN	Heat shock 70 kDa protein 4
[194]		P34932	HSP74_HUMAN	HSPA4	2	5.1	2.38	5.3e-7	748.3544	2	-0.54	AGGIETIANEYSDR	AGGIETIANEYSDR		14	V20130429-09_FTMSms2hcd	35.819	20	33	19.9	3.3e-5	4.0e-8	1	94331.8	HUMAN	Heat shock 70 kDa protein 4
[195]		P46779	RL28_HUMAN	RPL28	1	9.5	3.77	6.2e-8	768.8881	2	2.4	NKQTYSTEPNNLK	NKQTYSTEPNNLK		13	V20130429-09_FTMSms2hcd	15.112	21	33	31.6	6.2e-8	8.0e-11	1	15747.6	HUMAN	60S ribosomal protein L28
[196]		P32969	RL9_HUMAN	RPL9	1	9.9	3.70	8.4e-8	1057.0780	2	4.7	TILSNQTVDIPENVDITLK	TILSNQTVDIPENVDITLK		19	V20130429-09_FTMSms2hcd	54.067	3	21	31.6	8.4e-8	2.1e-10	1	21863.6	HUMAN	60S ribosomal protein L9
[197]		P50991	TCPD_HUMAN	CCT4	1	2.4	3.65	2.4e-7	679.3705	2	1.1	VIDPATATSVDLR	VIDPATATSVDLR		13	V20130429-09_FTMSms2hcd	36.854	194	206	33.6	2.4e-7	4.0e-10	1	57924.8	HUMAN	T-complex protein 1 subunit delta
[198]		P22102	PUR2_HUMAN	GART	1	1.3	3.62	6.6e-8	676.3776	2	16	VDLGGFAGLFDLK	VDLGGFAGLFDLK		13	V20130429-09_FTMSms2hcd	69.159	468	480	30.2	6.6e-8	1.4e-10	1	107768.1	HUMAN	Trifunctional purine biosynthetic protein adenosine-3
[199]		Q99832	TCPH_HUMAN	CCT7	2	3.1	2.57	9.8e-7	354.8822	3	1.4	LLDVVHPAAK	LLDVVHPAAK		10	V20130429-09_FTMSms2hcd	26.615	68	77	25.8	9.8e-7	5.3e-9	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[199]		Q99832	TCPH_HUMAN	CCT7	2	3.1	2.57	9.8e-7	406.2558	2	0.87	ALEIIPR	ALEIIPR		7	V20130429-09_FTMSms2hcd	34.675	441	447	26.1	8.5e-4	7.5e-6	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[200]		P62753	RS6_HUMAN	RPS6	2	8.0	3.01	4.2e-8	642.8443	2	1.5	DIPGLTDTTVPR	DIPGLTDTTVPR		12	V20130429-09_FTMSms2hcd	38.961	120	131	23.1	4.2e-8	8.0e-11	1	28680.9	HUMAN	40S ribosomal protein S6
[200]		P62753	RS6_HUMAN	RPS6	2	8.0	3.01	4.2e-8	494.7510	2	0.16	LIEVDDER	LIEVDDER		8	V20130429-09_FTMSms2hcd	22.380	15	22	20.6	0.0023	4.3e-6	1	28680.9	HUMAN	40S ribosomal protein S6
[201]		P22314	UBA1_HUMAN	UBA1	2	3.9	2.90	1.3e-6	954.9985	2	-2.9	SLVASLAEPDFVVTDFAK	SLVASLAEPDFVVTDFAK		18	V20130429-09_FTMSms2hcd	63.429	305	322	29.9	1.3e-6	1.7e-9	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[201]		P22314	UBA1_HUMAN	UBA1	2	3.9	2.90	1.3e-6	842.0984	3	7.4	QLLHNFPPDQLTSSGAPFWSGPK	QLLHNFPPDQLTSSGAPFWSGPK		23	V20130429-09_FTMSms2hcd	47.379	724	746	11.8	0.038	5.0e-5	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[202]		P31949	S10AB_HUMAN	S100A11	1	8.6	3.36	1.0e-6	510.2534	2	-0.84	ISSPTETER	ISSPTETER		9	V20130429-09_FTMSms2hcd	12.557	4	12	34.1	1.0e-6	1.6e-9	1	11740.6	HUMAN	Protein S100-A11
[203]		P83731	RL24_HUMAN	RPL24	2	10.8	1.98	1.3e-5	483.7741	2	0.20	VFQFLNAK	VFQFLNAK		8	V20130429-09_FTMSms2hcd	40.725	28	35	26.2	1.3e-5	3.5e-8	1	17779.1	HUMAN	60S ribosomal protein L24
[203]		P83731	RL24_HUMAN	RPL24	2	10.8	1.98	1.3e-5	596.8281	2	1.3	QINWTVLYR	QINWTVLYR		9	V20130429-09_FTMSms2hcd	48.677	48	56	21.6	1.7e-4	3.5e-7	1	17779.1	HUMAN	60S ribosomal protein L24
[204]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	3.28	6.6e-7	597.3412	2	9.6	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-09_FTMSms2hcd	37.156	61	71	32.2	6.6e-7	2.0e-9	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[205]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	3.23	7.9e-7	516.3102	2	-0.42	TLFPLIEAK	TLFPLIEAK		9	V20130429-09_FTMSms2hcd	50.697	535	543	32.1	7.9e-7	3.4e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[206]		P46783	RS10_HUMAN	RPS10	1	5.5	3.13	4.9e-7	555.3347	2	1.5	IAIYELLFK	IAIYELLFK		9	V20130429-09_FTMSms2hcd	64.792	9	17	30.0	4.9e-7	3.3e-9	1	18897.9	HUMAN	40S ribosomal protein S10
[207]		Q15233	NONO_HUMAN	NONO	1	3.2	3.12	4.1e-7	801.8300	2	2.2	MGQMAMGGAMGINNR	M(Oxidation)GQM(Oxidation)AM(Oxidation)GGAM(Oxidation)GINNR	Oxidation@384;Oxidation@387;Oxidation@389;Oxidation@393	15	V20130429-09_FTMSms2hcd	10.446	384	398	29.5	4.1e-7	8.2e-10	1	54232.0	HUMAN	Non-POU domain-containing octamer-binding protein
[208]		P49591	SYSC_HUMAN	SARS	2	4.1	1.74	3.7e-4	495.7856	2	2.1	MVLDLDLFR	M(Met-loss)VLDLDLFR	Met-loss@1	9	V20130429-09_FTMSms2hcd	55.203	1	9	31.6	3.7e-4	8.6e-7	1	58777.8	HUMAN	Serine--tRNA ligase, cytoplasmic
[208]		P49591	SYSC_HUMAN	SARS	2	4.1	1.74	3.7e-4	800.8662	2	-1.2	GYIPIYTPFFMR	GYIPIYT(Phospho)PFFM(Oxidation)R	Phospho@225=15;Oxidation@229	12	V20130429-09_FTMSms2hcd	59.210	219	230	10.6	0.0019	2.4e-6	1	58777.8	HUMAN	Serine--tRNA ligase, cytoplasmic
[209]		P12268	IMDH2_HUMAN	IMPDH2	1	2.1	2.86	4.5e-6	578.8203	2	1.1	NLIDAGVDALR	NLIDAGVDALR		11	V20130429-09_FTMSms2hcd	46.258	312	322	32.5	4.5e-6	1.0e-8	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[210]		O95487	SC24B_HUMAN	SEC24B	1	1.2	2.84	1.2e-8	654.8212	2	4.6	MSAPAGSSHPAASAR	M(Met-loss+Acetyl)SAPAGSSHPAASAR	Met-loss+Acetyl@1	15	V20130429-09_FTMSms2hcd	10.811	1	15	18.4	1.2e-8	1.3e-11	1	137418.9	HUMAN	Protein transport protein Sec24B
[211]		Q01469	FABP5_HUMAN	FABP5	1	7.4	2.75	1.9e-5	522.2783	2	1.3	MATVQQLEGR	M(Met-loss+Acetyl)ATVQQLEGR	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	30.910	1	10	34.8	1.9e-5	3.6e-8	1	15164.6	HUMAN	Fatty acid-binding protein, epidermal
[212]		P62195	PRS8_HUMAN	PSMC5	1	3.2	2.70	6.1e-7	645.7993	2	-0.56	LEGGSGGDSEVQR	LEGGSGGDSEVQR		13	V20130429-09_FTMSms2hcd	10.694	259	271	26.3	6.1e-7	9.1e-10	1	45626.4	HUMAN	26S protease regulatory subunit 8
[213]		Q15417	CNN3_HUMAN	CNN3	1	4.0	2.66	1.9e-8	666.7865	2	-1.0	CASQAGMTAYGTR	CASQAGM(Oxidation)TAYGTR	Oxidation@179	13	V20130429-09_FTMSms2hcd	11.267	173	185	17.8	1.9e-8	3.8e-11	1	36414.0	HUMAN	Calponin-3
[214]		O60925	PFD1_HUMAN	PFDN1	1	9.0	2.61	3.1e-7	563.3302	2	1.5	MAAPVDLELKK	M(Met-loss+Acetyl)AAPVDLELKK	Met-loss+Acetyl@1	11	V20130429-09_FTMSms2hcd	35.510	1	11	23.8	3.1e-7	1.5e-9	1	14210.6	HUMAN	Prefoldin subunit 1
[215]		P07237	PDIA1_HUMAN	P4HB	1	1.8	2.59	5.1e-6	533.7626	2	1.5	TVIDYNGER	TVIDYNGER		9	V20130429-09_FTMSms2hcd	21.246	453	461	30.1	5.1e-6	8.3e-9	1	57116.8	HUMAN	Protein disulfide-isomerase
[216]		Q02790	FKBP4_HUMAN	FKBP4	3	8.3	1.15	5.7e-5	544.8088	2	0.42	VLQLYPNNK	VLQLYPNNK		9	V20130429-09_FTMSms2hcd	29.878	379	387	21.4	5.7e-5	1.1e-7	1	51805.0	HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP4
[216]		Q02790	FKBP4_HUMAN	FKBP4	3	8.3	1.15	5.7e-5	566.6282	3	-1.0	RGEAHLAVNDFELAR	RGEAHLAVNDFELAR		15	V20130429-09_FTMSms2hcd	35.960	359	373	17.5	2.4e-4	3.1e-7	1	51805.0	HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP4
[216]		Q02790	FKBP4_HUMAN	FKBP4	3	8.3	1.15	5.7e-5	704.8123	2	-0.95	SNTAGSQSQVETEA	SNTAGSQSQVETEA		14	V20130429-09_FTMSms2hcd	15.258	446	459	10.7	0.0014	2.1e-6	1	51805.0	HUMAN	Peptidyl-prolyl cis-trans isomerase FKBP4
[217]		P35637	FUS_HUMAN	FUS	1	3.2	2.30	5.4e-7	632.3224	3	10	AAIDWFDGKEFSGNPIK	AAIDWFDGKEFSGNPIK		17	V20130429-09_FTMSms2hcd	52.479	349	365	21.9	5.4e-7	6.5e-10	1	53426.2	HUMAN	RNA-binding protein FUS
[218]		O00148	DX39A_HUMAN	DDX39A	1	2.3	2.29	8.2e-6	552.3317	2	-0.93	ILVATNLFGR	ILVATNLFGR		10	V20130429-09_FTMSms2hcd	48.691	339	348	28.2	8.2e-6	4.0e-8	2	49130.0	HUMAN	ATP-dependent RNA helicase DDX39A
[218-1]	0	Q13838	DX39B_HUMAN	DDX39B	1	2.3	2.29	8.2e-6	552.3317	2	-0.93	ILVATNLFGR	ILVATNLFGR		10	V20130429-09_FTMSms2hcd	48.691	340	349	28.2	8.2e-6	4.0e-8	2	48991.8	HUMAN	Spliceosome RNA helicase DDX39B
[219]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.25	0.0010	920.4266	2	14	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-09_FTMSms2hcd	28.453	260	274	29.1	0.0010	1.1e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[219]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.25	0.0010	928.4109	2	-0.79	SLSVNEMTLSTLKEK	S(Phospho)LSVNEM(Oxidation)T(Phospho)LSTLKEK	Oxidation@266;Phospho@260&262|260&267|260&269|260&270|262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-09_FTMSms2hcd	28.605	260	274	20.6	0.0027	3.1e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[220]		P62244	RS15A_HUMAN	RPS15A	1	6.9	2.25	1.1e-5	495.7686	2	1.1	MNVLADALK	M(Oxidation)NVLADALK	Oxidation@4	9	V20130429-09_FTMSms2hcd	35.003	4	12	28.5	1.1e-5	1.5e-8	1	14839.6	HUMAN	40S ribosomal protein S15a
[221]		P38159	RBMX_HUMAN	RBMX	1	3.6	2.20	1.5e-7	821.3495	2	1.8	DYGHSSSRDDYPSR	DYGHSSSRDDYPSR		14	V20130429-09_FTMSms2hcd	11.527	245	258	18.0	1.5e-7	2.4e-10	2	42332.2	HUMAN	RNA-binding motif protein, X chromosome
[221-1]	0	Q96E39	RMXL1_HUMAN	RBMXL1	1	3.6	2.20	1.5e-7	821.3495	2	1.8	DYGHSSSRDDYPSR	DYGHSSSRDDYPSR		14	V20130429-09_FTMSms2hcd	11.527	245	258	18.0	1.5e-7	2.4e-10	2	42141.9	HUMAN	RNA binding motif protein, X-linked-like-1
[222]		Q9NR33	DPOE4_HUMAN	POLE4	1	9.4	2.19	6.9e-7	636.3217	2	6.2	AAELFVETIAK	AAELFVET(Phospho)IAK	Phospho@77	11	V20130429-09_FTMSms2hcd	35.352	70	80	21.4	6.9e-7	1.1e-9	1	12208.9	HUMAN	DNA polymerase epsilon subunit 4
[223]		P42766	RL35_HUMAN	RPL35	1	10.6	2.16	6.3e-6	519.6271	3	1.6	QLDDLKVELSQLR	QLDDLKVELSQLR		13	V20130429-09_FTMSms2hcd	46.606	20	32	26.3	6.3e-6	1.5e-8	1	14551.6	HUMAN	60S ribosomal protein L35
[224]		Q56VL3	OCAD2_HUMAN	OCIAD2	1	9.1	2.15	3.1e-7	700.3266	2	0.79	HGLSEKGDSQPSAS	HGLSEKGDSQPSAS		14	V20130429-09_FTMSms2hcd	10.002	141	154	19.2	3.1e-7	4.3e-10	1	16953.7	HUMAN	OCIA domain-containing protein 2
[225]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.85	4.4e-6	610.8139	2	1.2	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-09_FTMSms2hcd	37.493	1959	1968	22.4	4.4e-6	6.4e-9	1	333188.0	HUMAN	WD repeat-containing protein 87
[226]		P09132	SRP19_HUMAN	SRP19	1	10.4	1.85	1.2e-6	731.8420	2	-0.080	TGGADQSLQQGEGSK	TGGADQSLQQGEGSK		15	V20130429-09_FTMSms2hcd	10.968	122	136	19.2	1.2e-6	1.4e-9	1	16155.8	HUMAN	Signal recognition particle 19 kDa protein
[227]		P15153	RAC2_HUMAN	RAC2	1	4.2	1.83	1.4e-5	475.7509	2	0.37	TVFDEAIR	TVFDEAIR		8	V20130429-09_FTMSms2hcd	32.412	167	174	24.9	1.4e-5	2.5e-8	3	21429.0	HUMAN	Ras-related C3 botulinum toxin substrate 2
[227-1]	0	P60763	RAC3_HUMAN	RAC3	1	4.2	1.83	1.4e-5	475.7509	2	0.37	TVFDEAIR	TVFDEAIR		8	V20130429-09_FTMSms2hcd	32.412	167	174	24.9	1.4e-5	2.5e-8	3	21379.1	HUMAN	Ras-related C3 botulinum toxin substrate 3
[227-2]	0	P63000	RAC1_HUMAN	RAC1	1	4.2	1.83	1.4e-5	475.7509	2	0.37	TVFDEAIR	TVFDEAIR		8	V20130429-09_FTMSms2hcd	32.412	167	174	24.9	1.4e-5	2.5e-8	3	21450.3	HUMAN	Ras-related C3 botulinum toxin substrate 1
[228]		P05204	HMGN2_HUMAN	HMGN2	1	16.7	1.74	6.0e-7	396.9919	4	-0.90	LSAKPAPPKPEPKPK	LSAKPAPPKPEPKPK		15	V20130429-09_FTMSms2hcd	13.762	28	42	16.6	6.0e-7	5.7e-9	1	9392.7	HUMAN	Non-histone chromosomal protein HMG-17
[229]		P14678	RSMB_HUMAN	SNRPB	1	2.9	1.71	9.8e-5	413.2476	2	1.2	IFIGTFK	IFIGTFK		7	V20130429-09_FTMSms2hcd	39.041	26	32	28.2	9.8e-5	6.1e-7	2	24610.3	HUMAN	Small nuclear ribonucleoprotein-associated proteins B and B'
[229-1]	0	P63162	RSMN_HUMAN	SNRPN	1	2.9	1.71	9.8e-5	413.2476	2	1.2	IFIGTFK	IFIGTFK		7	V20130429-09_FTMSms2hcd	39.041	26	32	28.2	9.8e-5	6.1e-7	2	24614.3	HUMAN	Small nuclear ribonucleoprotein-associated protein N
[230]		Q7Z2K8	GRIN1_HUMAN	GPRIN1	1	1.6	1.70	1.0e-4	807.4614	2	2.9	VGSLPLEKGSPVTTTK	VGSLPLEKGSPVTTTK		16	V20130429-09_FTMSms2hcd	74.371	606	621	28.2	1.0e-4	3.2e-7	1	102400.1	HUMAN	G protein-regulated inducer of neurite outgrowth 1
[231]		Q58FF3	ENPLL_HUMAN	HSP90B2P	1	1.8	1.61	4.5e-5	438.7332	2	2.0	TFEINPR	TFEINPR		7	V20130429-09_FTMSms2hcd	26.130	323	329	25.4	4.5e-5	7.2e-8	2	45859.4	HUMAN	Putative endoplasmin-like protein
[232]		P61254	RL26_HUMAN	RPL26	1	6.2	1.55	1.0e-5	539.7815	2	1.5	HFNAPSHIR	HFNAPSHIR		9	V20130429-09_FTMSms2hcd	15.364	18	26	21.3	1.0e-5	1.5e-8	1	17258.4	HUMAN	60S ribosomal protein L26
[233]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	1.48	3.7e-6	723.3579	2	2.5	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=18	11	V20130429-09_FTMSms2hcd	42.783	1367	1377	18.3	3.7e-6	4.6e-9	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[234]		P45880	VDAC2_HUMAN	VDAC2	1	2.7	1.42	1.7e-5	412.7374	2	1.2	GFGFGLVK	GFGFGLVK		8	V20130429-09_FTMSms2hcd	44.433	32	39	21.2	1.7e-5	4.9e-8	1	31566.8	HUMAN	Voltage-dependent anion-selective channel protein 2
[235]		P61353	RL27_HUMAN	RPL27	1	5.9	1.33	3.2e-4	413.7799	2	2.0	VVLVLAGR	VVLVLAGR		8	V20130429-09_FTMSms2hcd	34.095	10	17	27.2	3.2e-4	4.0e-6	1	15797.9	HUMAN	60S ribosomal protein L27
[236]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	1.30	1.5e-4	695.3226	2	1.9	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-09_FTMSms2hcd	23.909	166	177	25.2	1.5e-4	2.0e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[237]		Q99729	ROAA_HUMAN	HNRNPAB	1	2.4	1.29	6.2e-5	464.7683	2	0.24	GFGFILFK	GFGFILFK		8	V20130429-09_FTMSms2hcd	60.142	111	118	23.0	6.2e-5	1.4e-7	1	36225.2	HUMAN	Heterogeneous nuclear ribonucleoprotein A/B
[238]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.29	0.0017	435.2588	2	1.4	LEPLLER	LEPLLER		7	V20130429-09_FTMSms2hcd	30.742	769	775	30.8	0.0017	7.7e-6	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[239]		P09874	PARP1_HUMAN	PARP1	1	1.0	1.27	6.8e-4	555.7756	2	1.2	MAESSDKLYR	M(Met-loss+Acetyl)AESSDKLYR	Met-loss+Acetyl@1	10	V20130429-09_FTMSms2hcd	19.590	1	10	28.4	6.8e-4	1.0e-6	1	113084.8	HUMAN	Poly [ADP-ribose] polymerase 1
[240]		P40227	TCPZ_HUMAN	CCT6A	2	5.5	0.73	1.4e-4	884.5212	2	-0.91	AQLGVQAFADALLIIPK	AQLGVQAFADALLIIPK		17	V20130429-09_FTMSms2hcd	75.677	433	449	19.3	1.4e-4	1.4e-6	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[240]		P40227	TCPZ_HUMAN	CCT6A	2	5.5	0.73	1.4e-4	631.8360	2	1.6	GIDPFSLDALSK	GIDPFSLDALSK		12	V20130429-09_FTMSms2hcd	53.831	296	307	14.7	7.3e-4	1.1e-6	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[241]		O60333	KIF1B_HUMAN	KIF1B	1	0.6	1.03	9.7e-7	727.2903	2	-8.1	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@852;Oxidation@855;Phospho@856	10	V20130429-09_FTMSms2hcd	29.200	849	858	10.6	9.7e-7	2.3e-9	2	204478.0	HUMAN	Kinesin-like protein KIF1B
[241-1]	0	Q12756	KIF1A_HUMAN	KIF1A	1	0.6	1.03	9.7e-7	727.2903	2	-8.1	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@812;Oxidation@815;Phospho@816	10	V20130429-09_FTMSms2hcd	29.200	809	818	10.6	9.7e-7	2.3e-9	2	191065.8	HUMAN	Kinesin-like protein KIF1A
[242]		A6NHP6	YR011_HUMAN		1	3.1	1.03	9.7e-7	727.2903	2	-6.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-09_FTMSms2hcd	29.200	173	182	10.6	9.7e-7	2.3e-9	2	37918.4	HUMAN	NPIP-like protein LOC729602
[242-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.03	9.7e-7	727.2903	2	-6.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-09_FTMSms2hcd	29.200	173	182	10.6	9.7e-7	2.3e-9	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[243]		P52566	GDIR2_HUMAN	ARHGDIB	1	3.5	1.01	1.3e-5	523.7293	2	5.5	YVQHTYR	YVQHT(Phospho)YR	Phospho@129=18	7	V20130429-09_FTMSms2hcd	16.093	125	131	16.6	1.3e-5	3.0e-8	1	22988.2	HUMAN	Rho GDP-dissociation inhibitor 2
[244]		Q13263	TIF1B_HUMAN	TRIM28	1	3.8	1.01	1.0e-5	862.3991	3	-14	MAASAAAASAAAASAASGSPGPGEGSAGGEKR	M(Met-loss+Acetyl)AASAAAASAAAASAASGSPGPGEGSAGGEKR	Met-loss+Acetyl@1	32	V20130429-09_FTMSms2hcd	35.714	1	32	15.9	1.0e-5	9.4e-9	1	88550.5	HUMAN	Transcription intermediary factor 1-beta
[245]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.99	4.5e-4	569.2686	2	-0.049	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-09_FTMSms2hcd	17.078	622	631	24.6	4.5e-4	8.1e-7	1	121854.6	HUMAN	Formin-like protein 1
[246]		P08758	ANXA5_HUMAN	ANXA5	1	5.0	0.89	4.4e-6	568.9730	3	1.8	GLGTDEESILTLLTSR	GLGTDEESILTLLTSR		16	V20130429-09_FTMSms2hcd	67.442	30	45	12.8	4.4e-6	7.1e-9	1	35937.1	HUMAN	Annexin A5
[247]		Q96MF6	CQ10A_HUMAN	COQ10A	1	5.3	0.85	4.7e-5	771.3944	2	15	QNVAAFERRAATK	QNVAAFERRAAT(Phospho)K	Phospho@227	13	V20130429-09_FTMSms2hcd	24.621	216	228	17.9	4.7e-5	6.5e-8	1	27686.5	HUMAN	Coenzyme Q-binding protein COQ10 homolog A, mitochondrial
[248]		Q6ZVZ8	ASB18_HUMAN	ASB18	1	4.9	0.85	1.4e-4	1106.0562	2	12	GAHVDARNGRGETALSAACGAAR	GAHVDARNGRGETALSAACGAAR		23	V20130429-09_FTMSms2hcd	45.440	242	264	20.4	1.4e-4	1.5e-7	1	50803.8	HUMAN	Ankyrin repeat and SOCS box protein 18
[249]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.83	8.6e-5	668.3320	2	17	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-09_FTMSms2hcd	29.495	376	386	19.2	8.6e-5	1.2e-7	1	46099.6	HUMAN	Zinc finger protein 763
[250]		P48681	NEST_HUMAN	NES	1	0.8	0.79	6.0e-5	686.8301	2	-13	DNLAEELEGVAGR	DNLAEELEGVAGR		13	V20130429-09_FTMSms2hcd	49.158	82	94	17.9	6.0e-5	7.7e-8	1	177440.2	HUMAN	Nestin
[251]		P26639	SYTC_HUMAN	TARS	1	1.1	0.76	1.5e-4	474.7539	2	0.92	TISETIER	TISETIER		8	V20130429-09_FTMSms2hcd	19.577	700	707	19.8	1.5e-4	2.4e-7	1	83435.8	HUMAN	Threonine--tRNA ligase, cytoplasmic
[252]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.72	6.6e-4	426.2717	2	1.4	HILDIIK	HILDIIK		7	V20130429-09_FTMSms2hcd	36.292	994	1000	22.8	6.6e-4	9.3e-6	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[253]		P46781	RS9_HUMAN	RPS9	1	4.6	0.68	5.7e-4	516.7953	2	-0.32	LFEGNALLR	LFEGNALLR		9	V20130429-09_FTMSms2hcd	40.198	71	79	22.1	5.7e-4	1.3e-6	1	22591.6	HUMAN	40S ribosomal protein S9
[254]		P18077	RL35A_HUMAN	RPL35A	1	6.4	0.68	0.0023	404.2209	2	-1.7	IEGVYAR	IEGVYAR		7	V20130429-09_FTMSms2hcd	16.999	30	36	25.4	0.0023	5.0e-6	1	12537.8	HUMAN	60S ribosomal protein L35a
[255]		Q5UIP0	RIF1_HUMAN	RIF1	1	0.3	0.67	1.8e-4	478.2449	2	-0.82	TLRRSSR	TLRRS(Phospho)SR	Phospho@1417=11	7	V20130429-09_FTMSms2hcd	13.838	1413	1419	19.2	1.8e-4	3.1e-7	1	274468.0	HUMAN	Telomere-associated protein RIF1
[256]		P84074	HPCA_HUMAN	HPCA	1	5.2	0.64	0.0035	643.8452	2	-4.2	LRPEMLQDLR	LRPEM(Oxidation)LQDLR	Oxidation@12	10	V20130429-09_FTMSms2hcd	15.781	8	17	25.9	0.0035	5.5e-6	1	22427.6	HUMAN	Neuron-specific calcium-binding protein hippocalcin
[257]		P27708	PYR1_HUMAN	CAD	1	0.6	0.63	4.7e-5	642.8685	2	11	MAALVLEDGSVLR	M(Met-loss+Acetyl)AALVLEDGSVLR	Met-loss+Acetyl@1	13	V20130429-09_FTMSms2hcd	59.719	1	13	15.7	4.7e-5	1.3e-7	1	242985.9	HUMAN	CAD protein
[258]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.59	0.032	665.3596	2	-5.7	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-09_FTMSms2hcd	19.980	311	322	30.6	0.032	5.5e-5	1	37425.1	HUMAN	Transmembrane protein 68
[259]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.56	2.2e-4	775.7774	3	8.4	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLTNKKGFPVLS(Phospho)K	Phospho@238|247	21	V20130429-09_FTMSms2hcd	59.761	228	248	18.6	2.2e-4	1.6e-6	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[260]		P27635	RL10_HUMAN	RPL10	1	5.1	0.55	9.5e-5	634.8609	2	0.13	VHIGQVIMSIR	VHIGQVIM(Oxidation)SIR	Oxidation@136	11	V20130429-09_FTMSms2hcd	36.655	129	139	16.6	9.5e-5	2.8e-7	2	24604.1	HUMAN	60S ribosomal protein L10
[260-1]	0	Q96L21	RL10L_HUMAN	RPL10L	1	5.1	0.55	9.5e-5	634.8609	2	0.13	VHIGQVIMSIR	VHIGQVIM(Oxidation)SIR	Oxidation@136	11	V20130429-09_FTMSms2hcd	36.655	129	139	16.6	9.5e-5	2.8e-7	2	24519.0	HUMAN	60S ribosomal protein L10-like
[261]		Q9Y4D1	DAAM1_HUMAN	DAAM1	2	2.9	0.34	0.0082	1068.5439	2	16	IHTSLIGCIKALMNNSQGR	IHTSLIGCIKALMNNS(Phospho)QGR	Phospho@192=37	19	V20130429-09_FTMSms2hcd	50.464	177	195	12.9	0.0082	9.5e-6	2	123474.5	HUMAN	Disheveled-associated activator of morphogenesis 1
[261]		Q9Y4D1	DAAM1_HUMAN	DAAM1	2	2.9	0.34	0.0082	735.4019	2	0.47	LEKETTEHKQVK	LEKETTEHKQVK		12	V20130429-09_FTMSms2hcd	14.495	494	505	24.9	0.017	3.4e-5	1	123474.5	HUMAN	Disheveled-associated activator of morphogenesis 1
[262]		P49773	HINT1_HUMAN	HINT1	1	11.1	0.45	2.1e-4	472.9246	3	-0.100	AQVARPGGDTIFGK	AQVARPGGDTIFGK		14	V20130429-09_FTMSms2hcd	27.976	8	21	17.4	2.1e-4	3.6e-7	1	13802.0	HUMAN	Histidine triad nucleotide-binding protein 1
[263]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.42	3.9e-4	728.7961	2	17	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=15	13	V20130429-09_FTMSms2hcd	11.771	44	56	18.6	3.9e-4	8.3e-7	1	14669.2	HUMAN	Lymphocyte antigen 6H
[264]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.34	0.010	416.7422	2	-0.40	GVLSDLTK	GVLSDLTK		8	V20130429-09_FTMSms2hcd	44.797	45	52	25.4	0.010	2.0e-5	1	30691.1	HUMAN	Tetraspanin-14
[265]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.31	1.5e-4	646.3285	2	2.6	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-09_FTMSms2hcd	54.806	1	11	15.2	1.5e-4	2.1e-7	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[266]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.21	0.0019	617.8665	2	-9.8	HLDALLRQIR	HLDALLRQIR		10	V20130429-09_FTMSms2hcd	46.913	608	617	20.3	0.0019	9.3e-6	1	141327.7	HUMAN	Cohesin subunit SA-2
[267]		Q01995	TAGL_HUMAN	TAGLN	1	6.0	0.20	2.8e-4	613.2838	2	-2.2	MANKGPSYGMSR	M(Met-loss+Acetyl)ANKGPSYGM(Oxidation)SR	Met-loss+Acetyl@1;Oxidation@10	12	V20130429-09_FTMSms2hcd	11.450	1	12	15.6	2.8e-4	4.3e-7	1	22611.1	HUMAN	Transgelin
[268]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.18	0.0013	488.2707	2	-1.6	LSEEIEKK	LSEEIEKK		8	V20130429-09_FTMSms2hcd	28.571	2022	2029	19.0	0.0013	2.3e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[269]		Q8NEF9	SRFB1_HUMAN	SRFBP1	1	3.3	0.13	0.0030	754.8703	2	-1.5	AVTIANSPSKPSEK	AVTIANSPSKPS(Phospho)EK	Phospho@208=22	14	V20130429-09_FTMSms2hcd	40.805	197	210	20.5	0.0030	3.6e-6	1	48634.3	HUMAN	Serum response factor-binding protein 1
[270]		Q9UKZ4	TEN1_HUMAN	ODZ1	1	0.3	0.13	6.6e-4	535.8160	2	-10	RVLYKYTK	RVLYKYTK		8	V20130429-09_FTMSms2hcd	44.851	1967	1974	16.9	6.6e-4	2.2e-6	1	305014.0	HUMAN	Teneurin-1
[271]		Q08257	QOR_HUMAN	CRYZ	1	3.3	0.13	0.0032	407.8877	3	-2.3	VFEFGGPEVLK	VFEFGGPEVLK		11	V20130429-09_FTMSms2hcd	18.817	13	23	20.6	0.0032	5.7e-6	1	35206.9	HUMAN	Quinone oxidoreductase
[272]		Q8NF50	DOCK8_HUMAN	DOCK8	1	0.6	0.12	4.2e-4	727.3230	2	14	LPPNYSMHSAEK	LPPNYS(Phospho)MHSAEK	Phospho@698|701	12	V20130429-09_FTMSms2hcd	16.438	693	704	15.8	4.2e-4	6.2e-7	1	238531.2	HUMAN	Dedicator of cytokinesis protein 8
[273]		Q8NEM8	CBPC3_HUMAN	AGBL3	1	1.5	0.12	4.6e-4	974.0007	2	-12	TLYLQQRIFPLMLSK	TLYLQQRIFPLM(Oxidation)LS(Phospho)K	Oxidation@492;Phospho@494=60	15	V20130429-09_FTMSms2hcd	74.982	481	495	16.0	4.6e-4	5.9e-7	1	116012.5	HUMAN	Cytosolic carboxypeptidase 3
[274]		Q8NI99	ANGL6_HUMAN	ANGPTL6	1	2.6	0.12	1.9e-4	688.8051	2	9.4	DSYSGNCALYQR	DSYSGNCALYQR		12	V20130429-09_FTMSms2hcd	12.206	404	415	13.9	1.9e-4	2.7e-7	1	51694.7	HUMAN	Angiopoietin-related protein 6
[275]		P12270	TPR_HUMAN	TPR	1	0.5	0.12	1.1e-4	638.3200	2	3.1	ASTALSNEQQAR	ASTALSNEQQAR		12	V20130429-09_FTMSms2hcd	11.514	1054	1065	12.5	1.1e-4	1.6e-7	1	267294.8	HUMAN	Nucleoprotein TPR
[276]		Q96KB5	TOPK_HUMAN	PBK	1	3.4	0.10	3.6e-4	730.3337	2	-16	SLNDLIEERYK	S(Phospho)LNDLIEERYK	Phospho@122=54	11	V20130429-09_FTMSms2hcd	56.353	122	132	15.2	3.6e-4	4.7e-7	1	36085.4	HUMAN	Lymphokine-activated killer T-cell-originated protein kinase
[277]		P23471	PTPRZ_HUMAN	PTPRZ1	1	0.4	0.06	1.5e-4	577.2516	2	0.019	VTLMAEEHK	VT(Phospho)LM(Oxidation)AEEHK	Phospho@2150;Oxidation@2152	9	V20130429-09_FTMSms2hcd	17.179	2149	2157	12.8	1.5e-4	3.2e-7	1	254589.3	HUMAN	Receptor-type tyrosine-protein phosphatase zeta
[278]		Q96JP0	FEM1C_HUMAN	FEM1C	1	3.2	0.01	0.0013	765.0309	3	11	ADLEVSNRHGHTCLMISCYK	ADLEVSNRHGHTCLM(Oxidation)ISCYK	Oxidation@154	20	V20130429-09_FTMSms2hcd	22.279	140	159	17.4	0.0013	1.3e-6	1	68674.0	HUMAN	Protein fem-1 homolog C
